000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1599|3065|lyfalmen|V1070|1887|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1599||1599|3065| 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|39578|51553|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||39578||39578|51553| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|59706|76814|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||59706||59706|76814| 000149|A02BC0102|Losec|sh-tfl|10|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|3,5000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10752|15585|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10752||10752|15585| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31992|42429|lyfalmen|||00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||31992||31992|42429| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|41606|54495|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||41606||41606|54495| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|20931|28547|lyfalmen|V0813|28547|00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20931||20931|28547| 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|DKK|8723|12810|lyfalmen|||02|0|0|0,0000|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8723||8723|12810| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6131|8849|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||6131||6131|8849| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7878|15300|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7878||7878|15300| 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|16859|23041|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||16859||16859|23041| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|20980|28609|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||20980||20980|28609| 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5728|8267|lyfsjukr|||00|3000|0|3,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5728||5728|8267| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|41617|54508|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||41617||41617|54508| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5525|8435|lyfalmen|||00|6|0|6,0000|Icepharma hf|M.S.D.|Rizatriptan||5525||5525|8435| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3302|5394|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3302|5394| 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|28986|38657|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||28986||28986|38657| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2030|3654|lyfalmen|||06|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||2030||2030|3654| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5387|8246|lyfalmen|||23|2|0|2,0000|Vistor hf|Pfizer ApS|Alprostadíl||5387||5387|8246| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4749|7374|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4749||4749|7374| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5563|8487|lyfalmen|||00|24|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5563||5563|8487| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15506|21343|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||15506||15506|21343| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4749|7374|lyfalmen|||00|30|0|60,0000|Vistor hf|Pfizer ApS|Amlódipín||||4749|7374| 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|USD|12041|16994|lyfsjukr|||00|1|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||12041||12041|16994| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3928|6251|lyfalmen|||23|2|0|1,0000|Vistor hf|Pfizer ApS|Alprostadíl||3928||3928|6251| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|169374|214447|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||169374||169374|214447| 000957|H01AC0101|Genotropin|sts|5|mg|1|hgl|1|pakki|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|23273|31090|lyfsjukr|||02|1|0|7,4963|Vistor hf|Pfizer ApS|Sómatrópín||23273||23273|31090| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6554|9459|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||6554||6554|9459| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1778|3309|lyfalmen|||00|10|0|10,0000|Vistor hf|Pfizer ApS|Celekoxíb||1778||1778|3309| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12270|17678|lyfalmen|||00|30|0|120,0000|Vistor hf|Pfizer ApS|Atorvastatín||12270||12270|17678| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|23480|31746|lyfalmen|||00|100|0|400,0000|Vistor hf|Pfizer ApS|Atorvastatín||23480||23480|31746| 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2626|4469|lyfalmen|V0091|3798|43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2626||2626|4469| 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|0|0|SOP|0|0|0|100|XEU|12187|17574|lyfalmen|||00|98|0|98,0000|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||12187||12187|17574| 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|465800|586462|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||465800||465800|586462| 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001|31.05.2010|R|A|3|0|0|0|0|SOP|0|0|0|100|XEU|4962|7665|lyfalmen|||00|56|0|37,3330|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||4962||4962|7665| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|33658|44123|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||33658||33658|44123| 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2147|lyfalmen|||00|28|0|18,6667|Actavis Group hf|Actavis hf|Simvastatín||928||928|2147| 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4571|lyfalmen|||00|28|0|37,3400|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4571| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6909|10328|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6909||6909|10328| 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5161|7937|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||5161||5161|7937| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2085|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2085| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4237|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4237| 001574|C09AA0209|Enalapril Mylan|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|540|1616|lyfalmen|||00|50|1|12,5000|Distica|Distica - óskráð lyf|Enalapríl||540||540|1616| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22884|30602|lyfsjukr|||00|4104|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||22884||22884|30602| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14495|20470|lyfalmen|V0011|20470|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||14495||14495|20470| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37620|49096|lyfsjukr|||00|6160|0|6,1600|Icepharma hf|Fresenius Kabi|Blöndur||37620||37620|49096| 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26242|34816|lyfsjukr|||00|5132|0|5,1300|Icepharma hf|Fresenius Kabi|Blöndur||26242||26242|34816| 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7170|10348|lyfsjukr|||02|50|0|0,0000|Vistor hf|Octapharma AB|Albúmín||7170||7170|10348| 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|8540|12325|lyfsjukr|||02|100|0|0,0000|Vistor hf|Octapharma AB|Albúmín||8540||8540|12325| 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAI|0|0|1|100|IKR|||lyflausa|||00|20|0|2,1600|Icepharma hf|Bayer A/S|Acetýlsalicýlsýra|||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1344|1940|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1344||1344|1940| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4347|6824|lyfalmen|||06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíð||4347||4347|6824| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1187|2501|lyfalmen|||00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1187||1187|2501| 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|82500|105420|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||82500||82500|105420| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4103|lyfalmen|V0791|4103|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4103| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18555|lyfalmen|V0795|18555|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18555| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|5068|7810|lyfalmen|||00|45|0|45,0000|Icepharma hf|Bioglan AB|Capsaicin||5068||5068|7810| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|4691|7294|lyfalmen|V0793|7294|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||4691||4691|7294| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9329|13639|lyfalmen|V0456|13518|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9329||9329|13639| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4285|6739|lyfalmen|V0084|6738|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4285||4285|6739| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11833|lyfalmen|V0794|11833|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11833| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8375|12334|lyfalmen|||0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8375||8375|12334| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1566|3019|lyfalmen|||00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1566||1566|3019| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5863|8898|lyfalmen|V0085|8565|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5863||5863|8898| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5369|8222|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5369||5369|8222| 002169|B05BA1010|Kabiven Peripheral|irþ|||2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22787|30480|lyfsjukr|||00|4800|0|4,8000|Icepharma hf|Fresenius Kabi|Blöndur||22787||22787|30480| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7166|10680|lyfalmen|||00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7166||7166|10680| 002186|B05BA1010|Kabiven Peripheral|irþ|||1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20381|27461|lyfsjukr|||00|3840|0|3,8400|Icepharma hf|Fresenius Kabi|Blöndur||20381||20381|27461| 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32442|42597|lyfsjukr|||00|5760|0|5,7600|Icepharma hf|Fresenius Kabi|Blöndur||32442||32442|42597| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14742|20780|lyfalmen|V0087|20779|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||14742||14742|20780| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9351|13669|lyfalmen|||00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9351||9351|13669| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|3256|5331|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín aspart||3256||3256|5331| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|20897|28505|lyfalmen|V0089|28088|00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||20897||20897|28505| 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7378|10970|lyfalmen|V0092|10766|00|120|0|120,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||7378||7378|10970| 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4294|6751|lyfalmen|||00|60|0|60,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||4294||4294|6751| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|17827|24652|lyfalmen|||00|98|0|39,2000|Icepharma hf|M.S.D.|Montelúkast||17827||17827|24652| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|105610|134423|lyfsjukr|||00|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||105610||105610|134423| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|53831|69440|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||53831||53831|69440| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|32979|43271|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||32979||32979|43271| 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3076|5085|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||3076|5085| 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3076|5085|lyfalmen|||00|84|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3076||3076|5085| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1679|3174|lyfalmen|V0984|3174|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1679||1679|3174| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|205286|259516|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||205286||205286|259516| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|2980|5198|vetorma|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2980|5198| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1312|2672|lyfalmen|||07|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||1312||1312|2672| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|32577|42767|lyfsjukr|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||32577||32577|42767| 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|73650|94710|lyfalmen|||00|1|0|14,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||73650||73650|94710| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|14733|15848|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||10944||10944|15848| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|10913|15806|lyfalmen|||00|100|0|12,5000|Vistor hf|U.C.B|Levetíracetam||10913||10913|15806| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|288702|364204|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||288702||288702|364204| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|18842|25926|lyfalmen|V1710|25925|00|100|0|25,0000|Vistor hf|U.C.B|Levetíracetam||18842||18842|25926| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|36610|48225|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Levetíracetam||36610||36610|48225| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|9898|14417|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||9898||9898|14417| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|14767|20812|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||14767||14767|20812| 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|19445|26286|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||19445||19445|26286| 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28969|38239|lyfsjukr|||00|2|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||28969||28969|38239| 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28155|37217|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||28155||28155|37217| 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1639|lyfalmen|||00|0|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||557||557|1639| 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|41966|54550|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||41966||41966|54550| 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|55257|71230|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||55257||55257|71230| 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|68393|87716|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||68393||68393|87716| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|231292|292154|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||231292||231292|292154| 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9076|13293|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9076||9076|13293| 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|81957|104739|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||81957||81957|104739| 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8294|12223|lyfalmen|||00|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8294||8294|12223| 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|109247|138987|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||109247||109247|138987| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|62025|80120|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||62025||62025|80120| 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|136001|172564|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||136001||136001|172564| 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|198385|250856|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||198385||198385|250856| 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|99167|126337|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||99167||99167|126337| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4308|6770|lyfalmen|||00|28|0|14,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4308||4308|6770| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3703|5943|lyfalmen|||00|60|0|15,0000|Vistor hf|Pfizer ApS|Mísóprostól||3703||3703|5943| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|14460|20426|lyfalmen|||00|98|0|49,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||14460||14460|20426| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6624|9939|lyfalmen|||00|28|0|28,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||6624||6624|9939| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|21234|28928|lyfalmen|||00|98|0|98,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||21234||21234|28928| 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|915|2129|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||915||915|2129| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|0|0|ACA|0|1|0|100|IKR|1017|2268|lyfalmen|V0931|2067|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||1017||1017|2268| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|668|1791|lyfalmen|||67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||668||668|1791| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|3016|5003|lyfalmen|V0933|5003|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||3016||3016|5003| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|98578|125598|lyfsjukr|||00|60|0|7,5000|Vistor hf|Abbott Laboratories A/S|Lopinavír||98578||98578|125598| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2231|3929|lyfalmen|V0608|2245|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2231||2231|3929| 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|34765|45513|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||34765||34765|45513| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8304|12237|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8304||8304|12237| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|Janssen-Cilag AB|Lóperamíð|||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|0|0|GSK|0|0|0|100|GBP|4268|6716|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4268||4268|6716| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|0|0|PFI|0|1|0|100|DKK|621|1727|lyfalmen|||00|7|0|3,5000|Vistor hf|Pfizer ApS|Sertralín||621||621|1727| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1111|2397|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1111||1111|2397| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6488|9753|lyfalmen|||00|14|0|7,0000|Vistor hf|Pfizer ApS|Ziprasidon||6488||6488|9753| 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|6227|9395|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6227||6227|9395| 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|8668|12735|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8668||8668|12735| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|786|1952|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||786||786|1952| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|0|0|ORG|0|1|0|100|DKK|6219|9385|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6219||6219|9385| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|23341|31175|lyfsjukr|||00|1|0|0,5000|Vistor hf|Pfizer ApS|Voricónazól||23341||23341|31175| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1738|3255|lyfalmen|V1901|3252|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1738||1738|3255| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8674|12743|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8674||8674|12743| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4859|7524|lyfalmen|||00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4859||4859|7524| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4792|9374|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||4792||4792|9374| 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3407|5538|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3407||3407|5538| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|723|1866|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||723||723|1866| 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3345|5453|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3345||3345|5453| 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4544|7093|lyfalmen|||00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4544||4544|7093| 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|34458|45127|lyfsjukr|||00|21|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||34458||34458|45127| 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6417|9655|lyfalmen|||00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6417||6417|9655| 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8542|12562|lyfalmen|||00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8542||8542|12562| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2063|3699|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||2063||2063|3699| 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|57430|73957|lyfsjukr|||00|35|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||57430||57430|73957| 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|68917|88373|lyfsjukr|||00|42|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||68917||68917|88373| 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKA|0|0|0|100|DKK|45945|59543|lyfsjukr|||00|28|0|0,0000|Icepharma hf|Merck KgaA|Tegafur||45945||45945|59543| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4812|7460|lyfalmen|||00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríð||4812||4812|7460| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4374|lyfalmen|V0926|4374|00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4374| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|41703|54220|lyfsjukr|||00|1|0|4,0000|Icepharma hf|E. Merck AB|Sómatrópín||41703||41703|54220| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2016|3635|lyfalmen|||20|25|0|25,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||2016||2016|3635| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2673|4534|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||2673||2673|4534| 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4997|7713|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4997||4997|7713| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|2062|lyfalmen|V0927|2062|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2062| 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|0|0|ACA|0|1|0|100|IKR|5188|5699|lyfalmen|||00|56|0|112,0000|Actavis Group hf|Actavis hf|Cítalópram||2374||3525|5699|31.05.2010 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|0|0|ACA|0|1|0|100|IKR|5614|8557|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8557|30.04.2010 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1939|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|1939|31.03.2010 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4575|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4575|30.04.2010 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|2062|lyfalmen|V0923|2062|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2062| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1699| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|44837|58153|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||44837||44837|58153| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3309|lyfalmen|||00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3309|31.05.2010 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|130287|165393|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||130287||130287|165393| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|208517|263571|lyfsjukr|||00|5|0|20,0000|Icepharma hf|E. Merck AB|Sómatrópín||208517||208517|263571| 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11238|16250|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11238||11238|16250| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9235|7662|lyfalmen|||0|100|0|16,6667|Vistor hf|Pfizer ApS|Gabapentín||4960||4960|7662| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12098|10160|lyfalmen|V0715|8599|10|100|0|22,2222|Vistor hf|Pfizer ApS|Gabapentín||6786||6786|10160| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|681|1809|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||681||681|1809| 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|60216|77454|lyfsjukr|||00|2|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||60216||60216|77454| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5682|8201|lyfsjukr|||00|1|0|1,0000|Vistor hf|Pfizer ApS|Azitrómýcín||5682||5682|8201| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|403|1429|lyfalmen|||41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||403||403|1429| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|688|1818|lyfalmen|||41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||688||688|1818| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1302|2658|lyfalmen|||41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1302||1302|2658| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1800|3340|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1800||1800|3340| 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2429|4200|lyfalmen|||00|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2429|4200| 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|9195|7279|lyfalmen|V0437|5191|00|90|0|90,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4680||4680|7279| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1909|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1909| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1921|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1921| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2349|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2349| 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|27227|36449|lyfalmen|||00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27227||27227|36449| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|49317|64172|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||49317||49317|64172| 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3253|5327|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3253||3253|5327| 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1181|2493|lyfalmen|||00|2|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1181||1181|2493| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|67999|87618|lyfalmen|V0565|87618|00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||67999||67999|87618| 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|GAN|0|0|0|100|NOK|45010|58767|lyfalmen|||00|2|0|0,0000|Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||45010||45010|58767| 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1559|3010|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1559||1559|3010| 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|30994|18925|lyfalmen|V0815|15999|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13264||13264|18925| 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|5560|8483|lyfalmen|||00|4|0|28,0000|Icepharma hf|M.S.D.|Alendrónsýra||5560||5560|8483| 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|39419|51750|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39419||39419|51750| 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1194|2511|lyfalmen|V2200|2478|23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1194||1194|2511| 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13796|5762|lyfalmen|V0718|5762|00|12|0|84,0000|Icepharma hf|M.S.D.|Alendrónsýra||3571||3571|5762| 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6565|9858|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6565||6565|9858| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6918|10341|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||||6918|10341| 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4370|6855|lyfalmen|||00|0|0|0,0000|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4370||4370|6855| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1676|3170|lyfalmen|||00|30|0|5,6300|Icepharma hf|Servier|Glíklazíð||1676||1676|3170| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2921|4873|lyfalmen|||00|60|0|11,2500|Icepharma hf|Servier|Glíklazíð||2921||2921|4873| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7755|11486|lyfalmen|||00|180|0|33,7500|Icepharma hf|Servier|Glíklazíð||7755||7755|11486| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4262|6707|lyfalmen|||00|90|0|16,8800|Icepharma hf|Servier|Glíklazíð||4262||4262|6707| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6451|9702|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Estradíól||6451||6451|9702| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|1875|3442|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1875||1875|3442| 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEU|0|0|0|100|SEK|5152|7436|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Serono Europe Ltd|Cetrorelix||5152||5152|7436| 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|78679|100625|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||78679||78679|100625| 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEU|0|0|0|100|SEK|40390|52572|lyfsjukr|||00|7|0|0,0000|Icepharma hf|Serono Europe Ltd|Cetrorelix||40390||40390|52572| 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEU|0|0|0|100|SEK|40390|52572|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Serono Europe Ltd|Cetrorelix||40390||40390|52572| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6970|9372|lyfalmen|V0940|7188|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6210||6210|9372| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|3305|5051|lyfalmen|V0939|4044|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3051||3051|5051| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17327|30226|vetorma|||16|5|0|0,0000|Vistor hf|Merial (MSD)|||17327||17327|30226| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6732|10086|lyfalmen|||00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6732||6732|10086| 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|87721|111972|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||87721||87721|111972| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|11083|14748|lyfalmen|V0938|11828|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||10140||10140|14748| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5308|7695|lyfalmen|V0941|6137|00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4984||4984|7695| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3296|5386|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3296||3296|5386| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3129|5158|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3129||3129|5158| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|925|2143|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||925||925|2143| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|10784|15629|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||10784||10784|15629| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|17158|21498|lyfalmen|V0942|18935|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15314||15314|21498| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3858|6155|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3858||3858|6155| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6780|9044|lyfalmen|V0943|7256|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5970||5970|9044| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9903|12958|lyfalmen|V2209|3872|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8831||8831|12958| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|13285|18952|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13285||13285|18952| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4920|7608|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4920||4920|7608| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13459|18315|lyfalmen|V2210|3915|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12778||12778|18315| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|89340|114004|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||89340||89340|114004| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6063|9171|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6063||6063|9171| 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|129726|164689|lyfsjukr|||00|1|0|1,4000|Icepharma hf|M.S.D.|Caspofungin||129726||129726|164689| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|5882|8924|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||5882||5882|8924| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|159465|202011|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||159465||159465|202011| 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|83427|106583|lyfsjukr|||00|1|0|1,0000|Icepharma hf|M.S.D.|Caspofungin||83427||83427|106583| 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2839|lyfalmen|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||1434||1434|2839| 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9961|14503|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9961||9961|14503| 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|43106|55981|lyfsjukr|||00|1200|0|4,8000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||43106||43106|55981| 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|69145|88659|lyfsjukr|||00|2400|0|9,6000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||69145||69145|88659| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2772|4669|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2772||2772|4669| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2816|4729|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2816||2816|4729| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9245|17924|vetalmen|||00|50|0|0,0000|Vistor hf|Boehringer Ingelheim|||9245||9245|17924| 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7653|11346|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7653||7653|11346| 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12975|18563|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12975||12975|18563| 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|36759|48412|lyfalmen|||02|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||36759||36759|48412| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|16285|22717|lyfalmen|||10|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||16285||16285|22717| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|15326|21513|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan||15326||15326|21513| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4406|6904|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4406||4406|6904| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|817|1995|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||817||817|1995| 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|29420|39201|lyfalmen|V1200|39201|00|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||29420||29420|39201| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|25380|48906|vetalmen|||27|20|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||25380||25380|48906| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14015|19868|lyfalmen|V2208|19867|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14015||14015|19868| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2129|3790|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2129||2129|3790| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6601|9907|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6601||6601|9907| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21003|28638|lyfalmen|V0341|28637|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21003||21003|28638| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|6888|10300|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||6888||6888|10300| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8763|12865|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8763||8763|12865| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|27093|36281|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||27093||27093|36281| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|174764|221211|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||174764||174764|221211| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|308714|389319|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||308714||308714|389319| 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2211|3902|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2211||2211|3902| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|3085|5097|lyfalmen|||00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3085||3085|5097| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|156720|198566|lyfsjukr|||00|1|0|20,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||156720||156720|198566| 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|241194|304581|lyfsjukr|||00|1|0|40,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||241194||241194|304581| 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|209694|265048|lyfsjukr|||00|1|0|30,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||209694||209694|265048| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|136831|173605|lyfsjukr|||00|3000|0|5,0000|Vistor hf|Pfizer ApS|Linezolíd||136831||136831|173605| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|331815|418310|lyfsjukr|||00|30|0|15,0000|Vistor hf|Pfizer ApS|Linezolíd||331815||331815|418310| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3387|5510|lyfalmen|V0988|5509|06|2|0|0,0000|Vistor hf|Pfizer ApS|Tímólól í blöndum||3387||3387|5510| 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8310|11993|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Clintec parenteral SA|||8310||8310|11993| 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|126499|160639|lyfsjukr|||00|100|0|0,0000|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||126499||126499|160639| 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|25535|33929|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Sevóflúran||25535||25535|33929| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2065|3602|vetorma|||16|7|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2065|3602| 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6550|9837|lyfalmen|||00|30|0|10,5000|Vistor hf|Pfizer ApS|Tólteródín||6550||6550|9837| 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|5199|7989|lyfalmen|||00|60|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5199||5199|7989| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3517|5688|lyfalmen|V2215|5688|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3517||3517|5688| 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|5199|7989|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5199||5199|7989| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9542|13771|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||9542||9542|13771| 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22531|30555|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||22531||22531|30555| 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|10133|14739|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||10133||10133|14739| 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11190|16185|lyfalmen|V2216|16185|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||11190||11190|16185| 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2653|3829|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2653||2653|3829| 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2679|4542|lyfalmen|V2211|4542|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2679||2679|4542| 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7532|11181|lyfalmen|||00|30|0|21,0000|Vistor hf|Pfizer ApS|Tólteródín||7532||7532|11181| 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|22830|30931|lyfalmen|||00|100|0|70,0000|Vistor hf|Pfizer ApS|Tólteródín||22830||22830|30931| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3241|lyfalmen|V1075|3241|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3241| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4197|6619|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4197||4197|6619| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0,0000|Icepharma hf|Baxter|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007920|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2460|4242|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|||2460||2460|4242| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1389|2777|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Ólópatadín||1389||1389|2777| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|166936|211387|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||166936||166936|211387| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23316|31144|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||23316||23316|31144| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1874|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1874| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|42063|54672|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||42063||42063|54672| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|585|1677|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||585||585|1677| 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3716|5961|lyfalmen|||00|1|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3716||3716|5961| 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|28279|37373|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||28279||28279|37373| 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|35350|46247|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||35350||35350|46247| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5763|8761|lyfalmen|||00|6|0|3,0000|Icepharma hf|M.S.D.|Rizatriptan||5763||5763|8761| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|96988|123602|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||96988||96988|123602| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|194986|246590|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||194986||194986|246590| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|141396|179334|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||141396||141396|179334| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|161070|204025|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||161070||161070|204025| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|242967|306806|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||242967||242967|306806| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2129|3790|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2129||2129|3790| 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|292|1277|lyfalmen|||20|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||292||292|1277| 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|37241|48620|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||37241||37241|48620| 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29079|38377|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29079||29079|38377| 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|479|1532|lyfalmen|||33|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||479||479|1532| 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|36442|47617|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||36442||36442|47617| 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8258|12174|lyfalmen|V2212|12174|00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8258||8258|12174| 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1233|2564|lyfalmen|V0733|2564|00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||1233||1233|2564| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2877|4813|lyfalmen|V2213|4813|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2877||2877|4813| 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1261|2602|lyfalmen|||33|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1261||1261|2602| 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9158|13405|lyfalmen|V2214|13405|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9158||9158|13405| 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|3862|6160|lyfalmen|V0734|6160|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||3862||3862|6160| 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5927|8985|lyfalmen|V0736|8985|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||5927||5927|8985| 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|8974|13153|lyfalmen|V0738|13153|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||8974||8974|13153| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|216814|273984|lyfsjukr|||02|2|0|0,0000|Vistor hf|Genzyme BV|Thýrótrópín||216814||216814|273984| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|XEU|793|1962|lyfalmen|V0431|1962|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||793||793|1962| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|XEU|689|1820|lyfalmen|V0430|1820|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||689||689|1820| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5354|9340|vetorma|||00|1000|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||5354||5354|9340| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|11430|22120|vetalmen|||00|50|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||11430||11430|22120| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|4285|6739|lyfalmen|||00|100|0|100,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4285||4285|6739| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3031|5024|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3031||3031|5024| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|137818|174844|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||137818||137818|174844| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|128917|163673|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||128917||128917|163673| 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2743|4785|vetorma|||00|500|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||2743||2743|4785| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3227|5292|lyfalmen|||00|15|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3227||3227|5292| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3517|5688|lyfalmen|V2222|5688|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3517||3517|5688| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2399|4159|lyfalmen|||20|60|0|60,0000|Vistor hf|Pfizer ApS|Klindamýcín||2399||2399|4159| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6335|9543|lyfalmen|||00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6335|9543| 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|DKK|1189|2335|lyfalmen|||02|5|1|13,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||1066||1066|2335| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12480|17941|lyfalmen|||00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12480|17941| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5445|8326|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5445||5445|8326| 009079|D11AH0201|Elidel|krem|1|%|100|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|16901|23490|lyfalmen|||00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||16901||16901|23490| 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002|30.04.2010|R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|8006|11829|lyfalmen|||03|5|0|5,0000|Vistor hf|Pfizer Limited|Parekoxíb||8006||8006|11829| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|14624|20632|lyfalmen|||03|10|0|10,0000|Vistor hf|Pfizer Limited|Parekoxíb||14624||14624|20632| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|63902|82080|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer ApS|Voricónazól||63902||63902|82080| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||1750| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5817|8835|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5817||5817|8835| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1428|2831|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1428||1428|2831| 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1534|2976|lyfalmen|||23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1534||1534|2976| 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1808|3350|lyfalmen|||23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1808||1808|3350| 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2080|3723|lyfalmen|||23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||2080||2080|3723| 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7873|11363|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7873||7873|11363| 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7873|11363|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7873||7873|11363| 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7873|11363|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7873||7873|11363| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|248181|313350|lyfsjukr|||00|30|0|15,0000|Vistor hf|Pfizer ApS|Voricónazól||248181||248181|313350| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5966|9038|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5966||5966|9038| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|66750|85654|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||66750||66750|85654| 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11188|16182|lyfalmen|V2223|16182|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||11188||11188|16182| 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006|30.04.2010|R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|45019|58381|lyfsjukr|||00|1|0|20,0000|Icepharma hf|Roche|Epóetín||45019||45019|58381| 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|881|2082|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||881||881|2082| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6891|10304|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||6891||6891|10304| 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6765|10131|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|||6765||6765|10131| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7891|11672|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||7891||7891|11672| 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|576|1665|lyfalmen|||00|6|0|3,0000|Vistor hf|N.V. Organon|Mirtazapín||576||576|1665| 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7299|10862|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|||7299||7299|10862| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8047|11885|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||8047||8047|11885| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6191|9346|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||6191||6191|9346| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|2444|4221|lyfalmen|V1151|2465|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2444||2444|4221| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|4337|6810|lyfalmen|V1152|4363|00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4337||4337|6810| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|9263|13549|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||9263||9263|13549| 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|171987|217726|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||171987||171987|217726| 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003|30.04.2010|R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|5416|8286|lyfalmen|||00|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||5416||5416|8286| 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1262|2604|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1262||1262|2604| 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003|30.04.2010|R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|55647|72116|lyfalmen|||00|10|0|10,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||55647||55647|72116| 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003|30.04.2010|R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|33390|44184|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||33390||33390|44184| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|237530|299983|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche Registration Limited|Valgancíklóvír||237530||237530|299983| 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|439956|554027|lyfsjukr|||00|30|0|30,0000|Vistor hf|Pfizer ApS|Pegvisómant||439956||439956|554027| 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|157274|199261|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||157274||157274|199261| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|7602|10972|lyfsjukr|||00|1|0|0,0000|Icepharma hf|M.S.D.|Ertapenem||7602||7602|10972| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|13463|19175|lyfalmen|V1153|6902|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13463||13463|19175| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|18982|26101|lyfalmen|||00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18982||18982|26101| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|24324|32806|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||24324||24324|32806| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|4073|6449|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||4073||4073|6449| 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9369|13694|lyfalmen|||51|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||9369||9369|13694| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|13159|18794|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||13159||13159|18794| 010437|QI09AB1301|Stellamune One|stl|0||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|77650|135457|vetorma|||00|1000|0|0,0000|Icepharma hf|Pfizer A/S (Í)|Óvirkar bakteríur í bóluefnum||77650||77650|135457| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|7377|10969|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7377||7377|10969| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|14203|19707|lyfsjukr|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||14203||14203|19707| 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8764|12649|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Amínósýrur||8764||8764|12649| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1245|2580|lyfalmen|||00|5|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||1245||1245|2580| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5733|8720|lyfalmen|||00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5733||5733|8720| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7524|10859|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Kolvetni||7524||7524|10859| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|13798|19199|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Kolvetni||13798||13798|19199| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5251|7579|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||5251||5251|7579| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3009|4343|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||3009||3009|4343| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8581|12616|lyfalmen|||00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8581||8581|12616| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|13798|19199|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||13798||13798|19199| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7574|10931|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Elektrólýtar||7574||7574|10931| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5049|7287|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||5049||5049|7287| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|14866|5869|lyfalmen|||00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3649||3649|5869| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2803|4045|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2803||2803|4045| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|438554|552268|lyfsjukr|||00|56|0|14,0000|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||438554||438554|552268| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|410583|517164|lyfsjukr|||00|56|0|28,0000|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||410583||410583|517164| 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|657538|827093|lyfsjukr|||00|30|0|45,0000|Vistor hf|Pfizer ApS|Pegvisómant||657538||657538|827093| 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|875112|1100148|lyfsjukr|||00|30|0|60,0000|Vistor hf|Pfizer ApS|Pegvisómant||875112||875112|1100148| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2724|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2724| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|SKI|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|Icepharma hf|SmithKline Beecham Ltd (I)|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4936|7629|lyfalmen|V2171|7218|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||4936||4936|7629| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3182|4323|lyfalmen|V2170|4323|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4323| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|67175|86187|lyfsjukr|||03|10|0|0,0000|Icepharma hf|Baxter Medical AB|Bleómýcín||67175||67175|86187| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3150|4546|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3150||3150|4546| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|3115|5138|lyfalmen|||00|28|0|14,0000|Icepharma hf|Wyeth AB|Lansóprazól||3115||3115|5138| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|21241|28937|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21241||21241|28937| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20993|28625|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20993||20993|28625| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|SKI|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|Icepharma hf|SmithKline Beecham Ltd (I)|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|36165|47666|lyfalmen|V1702|47665|00|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||36165||36165|47666| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35919|47357|lyfalmen|V1703|47357|00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35919||35919|47357| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|20176|27600|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníð||20176||20176|27600| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|4735|7354|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4735||4735|7354| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|4919|7606|lyfalmen|||00|28|0|42,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4919||4919|7606| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|21345|27415|lyfalmen|V2172|21492|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||20029||20029|27415| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|XEU|1256|2595|lyfalmen|||00|7|0|14,0000|Icepharma hf|M.S.D.|Etoríkoxíb||1256||1256|2595| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|992|2234|lyfalmen|V0195|2234|00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||992||992|2234| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12928|18504|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12928||12928|18504| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1427|2829|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2829| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|3872|lyfalmen|V0197|3872|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||2189||2189|3872| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9050|13257|lyfalmen|||00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9050||9050|13257| 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7481|11111|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7481||7481|11111| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8789|12685|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Baxter Medical AB|Mannitól||8789||8789|12685| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2538|3663|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pfizer ApS|Esketamín||2538||2538|3663| 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9774|14248|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9774||9774|14248| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1726|3433|vetalmen|||00|25|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||1726||1726|3433| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5076|7326|lyfsjukr|||00|20|0|0,0000|Vistor hf|Pfizer ApS|Esketamín||5076||5076|7326| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1546|2992|lyfalmen|||00|64|0|28,8000|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1546||1546|2992| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|103251|131463|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche Registration Limited|Ribavirin||103251||103251|131463| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|10833|15696|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||10833||10833|15696| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|0|0|ACA|0|1|0|100|IKR|1773|3303|lyfalmen|V0935|2067|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||1773||1773|3303| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5098|7218|lyfalmen|V0937|7174|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4635||4635|7218| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4619|6666|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4619||4619|6666| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4195|6054|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4195||4195|6054| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8403|12372|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8403|12372| 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4698|7304|lyfalmen|||00|28|0|37,3400|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||4698||4698|7304| 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|16170|22572|lyfalmen|||00|98|0|130,6667|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||16170||16170|22572| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|42696|55466|lyfsjukr|||00|30|0|30,0000|Icepharma hf|M.S.D.|Efavirenz||42696||42696|55466| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11647|16810|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||11647||11647|16810| 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1461|2876|lyfalmen|||00|20|0|35,7143|Vistor hf|Meda AB|Azelastínum||1461||1461|2876| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6314|9514|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6314||6314|9514| 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|6058|10568|vetorma|||00|20|0|0,0000|Icepharma hf|Icepharma hf|||6058||6058|10568| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|956|2185|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríð||956||956|2185| 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|11583|16722|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11583||11583|16722| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|28469|49663|vetorma|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||28469||28469|49663| 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|470356|592179|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Díbótermín alfa||470356||470356|592179| 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1859|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1859| 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4637|7220|lyfalmen|||00|9|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4637||4637|7220| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|7169|10684|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7169||7169|10684| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6489|9754|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6489||6489|9754| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7115|13834|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7115||7115|13834| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9797|14279|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9797||9797|14279| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1845|3670|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1845||1845|3670| 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|1190|2505|lyfalmen|||00|14|0|7,0000|Icepharma hf|Wyeth AB|Lansóprazól||1190||1190|2505| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23316|31144|lyfsjukr|||00|2|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||23316||23316|31144| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|10271|14773|lyfsjukr|||17|2|0|0,0000|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||10271||10271|14773| 013259|B02BD0901|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|31093|40904|lyfsjukr|||00|250|0|0,8300|Icepharma hf|Wyeth Europe|Storkuþáttur IX||31093||31093|40904| 013270|B02BD0901|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|62190|79931|lyfsjukr|||00|500|0|1,4300|Icepharma hf|Wyeth Europe|Storkuþáttur IX||62190||62190|79931| 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3543|5167|lyfalmen|V2120|5167|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||3136||3136|5167| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4673|9145|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4673||4673|9145| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11232|21740|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||11232||11232|21740| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1178|2343|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1178||1178|2343| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|210695|266305|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||210695||210695|266305| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|466688|587576|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||466688||466688|587576| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|35115|45952|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||35115||35115|45952| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|121771|154705|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||121771||121771|154705| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|60887|78296|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||60887||60887|78296| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|5691|8662|lyfalmen|||00|28|0||Icepharma hf|M.S.D.|Ezetimíb||5691||5691|8662| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|19761|27079|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb||19761||19761|27079| 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|178382|225752|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||178382||178382|225752| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1282|2631|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||||1282|2631| 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0,0000|Actavis Group hf|Actavis Group hf|Blöndur|||||1408| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2463|4247|lyfalmen|||00|5|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||||2463|4247| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1474|2894|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1474||1474|2894| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|395|1418|lyfalmen|||00|30|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||395||395|1418| 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|41153|53530|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||41153||41153|53530| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|4940|7635|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4940||4940|7635| 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|14922|21006|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14922||14922|21006| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|1015|2266|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||1015|2266| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2539|lyfalmen|V0465|2539|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2539| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|7315|10884|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||7315||7315|10884| 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5682|8650|lyfalmen|||51|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||5682||5682|8650| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2784|4686|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2784||2784|4686| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|4875|7546|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||4875||4875|7546| 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|192630|243633|lyfsjukr|||00|60|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||192630||192630|243633| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|379428|478065|lyfsjukr|||00|30|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||379428||379428|478065| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2760|4653|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2760||2760|4653| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|14847|20515|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||14847||14847|20515| 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|24674|33245|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||24674||24674|33245| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|60156|77775|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||60156||60156|77775| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37809|49333|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||37809||37809|49333| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|27150|36352|lyfalmen|||00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||27150|36352| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1482|2905|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1482||1482|2905| 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23943|31931|lyfsjukr|||00|3940|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||23943||23943|31931| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0,0000|Vistor hf|Janssen-Cilag AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20813|28003|lyfsjukr|||00|3944|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||20813||20813|28003| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27247|36077|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||27247||27247|36077| 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23943|31931|lyfsjukr|||00|3940|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||23943||23943|31931| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|4043|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Metrónídazól||||2314|4043| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2409|4792|vetalmen|||00|45|0|0,0000|Dýraheilsa ehf|Vetcare Ltd.|||||2409|4792| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|17834|24661|lyfalmen|||23|1|0|1825,0000|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||17834||17834|24661| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|87040|111118|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|||||87040|111118| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PAL|0|0|0|100|XEU|5989|11672|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5989||5989|11672| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|253629|320187|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíð||253629||253629|320187| 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2536|4346|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2536||2536|4346| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1324|2688|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||1324|2688| 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5005|7724|lyfalmen|V2217|7724|00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5005||5005|7724| 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15720|22008|lyfalmen|V2218|22008|00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||15720||15720|22008| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|66291|85078|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||66291||66291|85078| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|106062|134990|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||106062||106062|134990| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|851|2041|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||851|2041| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|20312|27771|lyfalmen|||00|60|0|10,0000|Icepharma hf|Novartis Healthcare A/S|Everolímus||20312||20312|27771| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|61292|79201|lyfalmen|||00|60|0|30,0000|Icepharma hf|Novartis Healthcare A/S|Everolímus||61292||61292|79201| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|40798|53481|lyfalmen|||00|60|0|20,0000|Icepharma hf|Novartis Healthcare A/S|Everolímus||40798||40798|53481| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|744|1895|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||744||744|1895| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7365|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||4743||4743|7365| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|9050|13257|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||9050||9050|13257| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|0|0|ACA|0|1|0|100|IKR|1920|3504|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1920||1920|3504| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4653|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4653| 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1147|2446|lyfalmen|||23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1147||1147|2446| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3500|lyfalmen|V0832|3500|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3500| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4623|lyfalmen|V0831|4623|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4623| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|11143|16120|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||11143||11143|16120| 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|363719|458350|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||363719||363719|458350| 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|96674|123208|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||96674||96674|123208| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6450|9701|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6450||6450|9701| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14214|20118|lyfalmen|V1732|20116|00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14214||14214|20118| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6450|9701|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6450||6450|9701| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15366|21563|lyfalmen|V1731|21561|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15366||15366|21563| 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992|30.04.2010|R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|39847|52287|lyfalmen|||00|1000|0|1000,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||39847||39847|52287| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84142|107481|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||84142||84142|107481| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84142|107481|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||84142||84142|107481| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|68144|87403|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68144||68144|87403| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6450|9701|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6450||6450|9701| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14064|19929|lyfalmen|V1730|19928|00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14064||14064|19929| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|84142|107481|lyfsjukr|||43|60|0|0,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||84142||84142|107481| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|23779|32122|lyfalmen|||00|120|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||23779||23779|32122| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|50813|66049|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||50813||50813|66049| 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1036|2294|lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Cýklópentólat||1036||1036|2294| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3354|5851|vetorma|||16|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3354||3354|5851| 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4713|8222|vetorma|||16|12|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4713||4713|8222| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2992|5219|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2992||2992|5219| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3751|6543|vetorma|||16|3|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3751||3751|6543| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4780|7416|lyfalmen|||10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4780||4780|7416| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4203|7332|vetorma|||16|8|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4203||4203|7332| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2112|3766|lyfalmen|||0|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||||2112|3766| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2371|4121|lyfalmen|||00|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||2371||2371|4121| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1588|3050|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1588||1588|3050| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3354|5851|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3354||3354|5851| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|0|0|GSK|0|1|0|100|GBP|1528|2967|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1528||1528|2967| 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|16304|22741|lyfalmen|||00|90|0|180,0000|Icepharma hf|Servier|Perindópríl||16304||16304|22741| 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|5707|8684|lyfalmen|||00|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5707||5707|8684| 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|5484|8379|lyfalmen|||00|30|0|60,0000|Icepharma hf|Servier|Perindópríl||5484||5484|8379| 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|8080|11930|lyfalmen|||00|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||8080||8080|11930| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14337|20272|lyfalmen|V2208|20272|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14337||14337|20272| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1180|2491|lyfalmen|||02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1180||1180|2491| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21468|29221|lyfalmen|V0341|29221|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21468||21468|29221| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1250|2587|lyfalmen|||02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1250||1250|2587| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|2946|4907|lyfalmen|||00|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2946||2946|4907| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen|||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8224|12127|lyfalmen|||00|112|0|56,0000|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||8224||8224|12127| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8560|12587|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||8560||8560|12587| 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4600|7170|lyfalmen|||00|112|0|56,0000|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4600||4600|7170| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3459|5609|lyfalmen|||00|14|0|7,0000|Vistor hf|Pfizer ApS|Pregabalín||3459||3459|5609| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7043|10512|lyfalmen|||00|56|0|14,0000|Vistor hf|Pfizer ApS|Pregabalín||7043||7043|10512| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|MSE|0|0|0|100|SEK|5324|8160|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5324||5324|8160| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10682|15490|lyfalmen|||00|56|0|28,0000|Vistor hf|Pfizer ApS|Pregabalín||10682||10682|15490| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2324|4056|lyfalmen|||00|14|0|3,5000|Vistor hf|Pfizer ApS|Pregabalín||2324||2324|4056| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|15517|21753|lyfalmen|V0103|21753|00|56|0|56,0000|Vistor hf|Pfizer ApS|Pregabalín||15517||15517|21753| 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11749|16949|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||11749||11749|16949| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4822|7473|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4822||4822|7473| 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6179|8918|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pfizer ApS|Metótrexat||6179||6179|8918| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|147974|187590|lyfsjukr|||00|70|0|7,0000|Vistor hf|Pfizer ApS|Voricónazól||147974||147974|187590| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|8975|12953|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pfizer ApS|Cýtarabín||8975||8975|12953| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2753|4643|lyfalmen|||00|56|0|4,6667|Vistor hf|Pfizer ApS|Pregabalín||2753||2753|4643| 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8298|11976|lyfsjukr|||00|20|0|0,0000|Vistor hf|Pfizer ApS|Metótrexat||8298||8298|11976| 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|28131|37187|lyfsjukr|||00|25|0|0,0000|Vistor hf|Pfizer ApS|Karbóplatín||28131||28131|37187| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|236241|298365|lyfsjukr|||00|225|0|0,0000|Vistor hf|Pfizer ApS|Karbóplatín||236241||236241|298365| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|82853|105863|lyfsjukr|||00|75|0|0,0000|Vistor hf|Pfizer ApS|Karbóplatín||82853||82853|105863| 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|18514|25514|lyfalmen|V1701|25513|00|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18514||18514|25514| 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7382| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|36165|47666|lyfalmen|V0106|47665|00|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||36165||36165|47666| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2266|lyfalmen|V0466|2266|00|12|0|12,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2266| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|252896|319267|lyfsjukr|||00|2|0|180,0000|Icepharma hf|Roche|Epóetín||252896||252896|319267| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|221089|279349|lyfsjukr|||00|6|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||221089||221089|279349| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8254|12168|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8254||8254|12168| 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|73697|94372|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||73697||73697|94372| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3231|5297|lyfalmen|V0789|5297|10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3231||3231|5297| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5964|9036|lyfalmen|V0713|9036|10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5964||5964|9036| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|67917|87515|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||67917||67917|87515| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|100390|128269|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||100390||100390|128269| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|32669|43279|lyfalmen|||00|28|0|0,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||32669||32669|43279| 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|60811|78597|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||60811||60811|78597| 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|23261|31472|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||23261||23261|31472| 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|34888|46064|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||34888||34888|46064| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|2205|3894|lyfalmen|||00|14|0|14,0000|Icepharma hf|Wyeth AB|Lansóprazól||2205||2205|3894| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|A||0|0|0|0|WAB|0|0|0|100|DKK|3749|6006|lyfalmen|||00|56|0|28,0000|Icepharma hf|Wyeth AB|Lansóprazól||||3749|6006| 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|4280|6732|lyfalmen|||00|28|0|28,0000|Icepharma hf|Wyeth AB|Lansóprazól||4280||4280|6732| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|8334|12278|lyfalmen|||00|98|0|49,0000|Icepharma hf|Wyeth AB|Lansóprazól||8334||8334|12278| 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|6725|10077|lyfalmen|||00|56|0|56,0000|Icepharma hf|Wyeth AB|Lansóprazól||6725||6725|10077| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|42424|55125|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||42424||42424|55125| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|DKK|14711|20741|lyfalmen|||00|98|0|98,0000|Icepharma hf|Wyeth AB|Lansóprazól||14711||14711|20741| 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3647|5866|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3647||3647|5866| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PAL|0|0|0|100|DKK|19842|38272|vetalmen|||16|60|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||19842||19842|38272| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34330|44967|lyfsjukr|||00|4824|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||34330||34330|44967| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1616|3088|lyfalmen|||03|3|0|21,4286|Vistor hf|Pfizer ApS|Medroxýprógesterón||1616||1616|3088| 017111|A09AA0201|Combizym|töflur|||100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1633|3111|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1633||1633|3111| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|304093|383519|lyfsjukr|||00|5|0|0,0000|Icepharma hf|SkyPharma PLC|Cýtarabín||304093||304093|383519| 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7321|10892|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7321||7321|10892| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|184122|232956|lyfsjukr|||00|1|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||184122||184122|232956| 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|47943|62051|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||47943||47943|62051| 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36476|47660|lyfsjukr|||00|5712|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||36476||36476|47660| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1441|2848|lyfalmen|V0221|2848|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1441||1441|2848| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|136421|173091|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||136421||136421|173091| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|53503|69425|lyfalmen|||00|28|0|28,0000|Icepharma hf|Roche|Íbandrónsýra||53503||53503|69425| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|159698|202700|lyfalmen|||00|84|0|84,0000|Icepharma hf|Roche|Íbandrónsýra||159698||159698|202700| 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5766|8765|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5766||5766|8765| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12057|17411|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||12057||12057|17411| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2850|4776|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2850||2850|4776| 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|9520|13740|lyfsjukr|||00|3|0|0,0000|Icepharma hf|M.S.D.|Aprepitant||9520||9520|13740| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1961|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1961| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3316|5413|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3316||3316|5413| 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7641|11330|lyfalmen|||00|100|0|66,6667|Medico ehf|Solvay Duphar |Betahistín||7641||7641|11330| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2539|lyfalmen|V0465|2539|00|20|0|12,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2539| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7081|13769|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7081||7081|13769| 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|40767|53442|lyfalmen|||00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||40767||40767|53442| 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|12757|18289|lyfalmen|V1370|18288|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||12757||12757|18289| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11850|17087|lyfalmen|||00|30|0|30,0000|Vistor hf|Pfizer ApS|Eplerenón||11850||11850|17087| 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|45395|59250|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||45395||45395|59250| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10066|14647|lyfalmen|||00|30|0|15,0000|Vistor hf|Pfizer ApS|Eplerenón||10066||10066|14647| 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2755|lyfalmen|||00|30|1|30,0000|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2755| 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|6927|10353|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||6927||6927|10353| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2857|4785|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2857||2857|4785| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|4219|6649|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||4219||4219|6649| 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|66233|85005|lyfsjukr|||00|5|0|0,0000|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||66233||66233|85005| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|13212|18860|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||13212||13212|18860| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|9280|13572|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9280||9280|13572| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3747|6003|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3747||3747|6003| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4092|6475|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||4092||4092|6475| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|10898|15785|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10898||10898|15785| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2928|lyfalmen|||00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2928| 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18838|25524|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||18838||18838|25524| 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|93150|118786|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||93150||93150|118786| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3548|5731|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3548||3548|5731| 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17013|23234|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||17013||17013|23234| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8734|12825|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8734||8734|12825| 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14462|20032|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||14462||14462|20032| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1543|2988|lyfalmen|||00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1543||1543|2988| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|21401|29137|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||21401||21401|29137| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3088|5101|lyfalmen|||00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3088||3088|5101| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|XEU|938|2160|lyfalmen|||00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||938||938|2160| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6890|10302|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6890||6890|10302| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|17425|24147|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17425||17425|24147| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|39506|51859|lyfalmen|||00|100|0|100,0000|Vistor hf|Pfizer ApS|Eplerenón||39506||39506|51859| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|135649|172122|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||135649||135649|172122| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3291|5379|lyfalmen|||00|30|0|60,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3291||3291|5379| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10182|14806|lyfalmen|||00|100|0|200,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||10182||10182|14806| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|60801|78188|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||60801||60801|78188| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|630|1739|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||630||630|1739| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1344|2673|vetalmen|||27|100|0|0,0000|Icepharma hf|Kela Laboratoria NV|||1344||1344|2673| 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|12754|18285|lyfalmen|V1052|14538|00|5|0|62,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||12754||12754|18285| 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15539|21781|lyfalmen|||00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15539||15539|21781| 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15539|21781|lyfalmen|||00|56|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15539||15539|21781| 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14648|20662|lyfalmen|V1372|20662|00|56|0|18,6700|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14648||14648|20662| 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9174|13427|lyfalmen|V1051|10639|00|5|0|41,6667|Vistor hf|Janssen-Cilag AB|Fentanýl||9174||9174|13427| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|33938|44475|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||33938||33938|44475| 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7769|11505|lyfalmen|||00|28|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7769||7769|11505| 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4963|7666|lyfalmen|V1050|5947|00|5|0|20,8333|Vistor hf|Janssen-Cilag AB|Fentanýl||4963||4963|7666| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|40407|52593|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||40407||40407|52593| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|37283|48673|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||37283||37283|48673| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|42934|55765|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||42934||42934|55765| 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|15717|22004|lyfalmen|V1053|17344|00|5|0|83,3333|Vistor hf|Janssen-Cilag AB|Fentanýl||15717||15717|22004| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|15720|22008|lyfalmen|V2218|22008|00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||15720|22008| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5005|7724|lyfalmen|V2217|7724|00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5005|7724| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|60153|77375|lyfsjukr|||00|1|0|0,0000|Gróco ehf|Nycomed Danmark A/S|||60153||60153|77375| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|783858|985624|lyfsjukr|||00|10|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||783858||783858|985624| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|22333|43055|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||22333|43055| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7210|10740|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7210||7210|10740| 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|55294|71276|lyfsjukr|||AC|4|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||55294||55294|71276| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7210|10740|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7210||7210|10740| 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|17741|24544|lyfalmen|||00|140|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||17741||17741|24544| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|633|1743|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||633||633|1743| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6384|9214|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6384||6384|9214| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|661|1781|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||661||661|1781| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|24997|33254|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||24997||24997|33254| 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|205304|259539|lyfsjukr|||AC|16|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||205304||205304|259539| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1079|2353|lyfalmen|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1079||1079|2353| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|209384|264659|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||209384||209384|264659| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12825|18374|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12825||12825|18374| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12825|18374|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12825||12825|18374| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|58752|76013|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||58752||58752|76013| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12825|18374|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12825||12825|18374| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12825|18374|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12825||12825|18374| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12825|18374|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12825||12825|18374| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|829368|1042739|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||829368||829368|1042739| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|401|1426|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||401||401|1426| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|68898|88349|lyfsjukr|||00|30|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||68898||68898|88349| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1616|3088|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1616||1616|3088| 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|Vistor hf|GlaxoSmithKline CH AB|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020180|C03CC0101|Edecrin|sts|50|mg|1|hgl|1|pakki||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|58520|75325|lyfsjukr|||00|1|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|Etacrínsýra||58520||58520|75325| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4701|7308|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4701||4701|7308| 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|26863|35992|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||26863||26863|35992| 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2858|4787|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2858||2858|4787| 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|762|1920|lyfalmen|V0953|1595|00|7|0|2,6300|Icepharma hf|Wyeth AB|Venlafaxín||762||762|1920| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|7177|10695|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7177||7177|10695| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|56022|72587|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||56022||56022|72587| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4226|6658|lyfalmen|||00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4226||4226|6658| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12217|17611|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12217||12217|17611| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|25975|34878|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||25975||25975|34878| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|765|1924|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||765||765|1924| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7302|10866|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||7302||7302|10866| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2230|3928|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2230||2230|3928| 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4352|6831|lyfalmen|V0709|5196|00|60|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||4352||4352|6831| 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|7165|10679|lyfalmen|V0710|7893|00|60|0|10,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||7165||7165|10679| 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|12942|18521|lyfalmen|V0711|13561|00|60|0|20,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||12942||12942|18521| 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A||0|0|0|0|DAC|0|1|0|100|DKK|3303|5350|lyfalmen|V0939|4044|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Escítalópram||3270||3270|5350| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|21422|29164|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||21422||21422|29164| 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki||G03CA03|01.04.2010||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2063|3699|lyfalmen|||05|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Estradíól||||2063|3699|31.05.2010 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2343|4087|vetorma|||16|8|0|0,0000|Vistor hf|Merial SAS|||2343||2343|4087| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|191870|242679|lyfsjukr|||00|200|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||191870||191870|242679| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2658|4441|lyfalmen|V0429|4441|00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2605||2605|4441| 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6361|9579|lyfalmen|||63|28|0|28,0000|Icepharma hf|M.S.D.|Montelúkast||6361||6361|9579| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2482|4272|lyfalmen|||00|60|0|60,0000|Icepharma hf|Galderma Nordic AB|Adapalen||2482||2482|4272| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1854|lyfalmen|||00|12|0|7,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1854| 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.04.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|3386|5509|lyfalmen|V0988|5509|06|2|0|0,0000|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||||3386|5509| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2266|lyfalmen|V0466|2266|00|12|0|12,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2266| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1478|lyfalmen|V0609|1465|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||439||439|1478| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1072|2344|lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Dexpantenól||1072||1072|2344| 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|0|0|DAC|0|1|0|100|DKK|3256|3464|lyfalmen|||00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Sertralín||1891||1891|3464|30.04.2010 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2501|lyfalmen|V0610|2501|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2501| 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A||0|0|0|0|DAC|0|1|0|100|DKK|1985|3593|lyfalmen|||00|28|0|56,0000|D.A.C. ehf|D.A.C. ehf|Sertralín||1985||1985|3593|30.04.2010 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|17863|24697|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17863||17863|24697| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18159|25069|lyfalmen|||63|98|0|98,0000|Icepharma hf|M.S.D.|Montelúkast||18159||18159|25069| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.12.2009||R|A||0|0|E|0|DAC|0|0|1|100|SEK|1703|3207|lyfalmen|V0108|3207|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1703||1703|3207| 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|23809|32159|lyfalmen|||63|98|0|49,0000|Icepharma hf|M.S.D.|Montelúkast||23809||23809|32159| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1667|2406|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||1667||1667|2406| 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4901|7582|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4901||4901|7582| 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|15487|21715|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||15487||15487|21715| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14017|19870|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14017||14017|19870| 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|8775|12881|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||8775||8775|12881| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16669|22802|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||16669||16669|22802| 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|24221|32676|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||24221||24221|32676| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16669|22802|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||16669||16669|22802| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25658|34480|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||25658||25658|34480| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4406|6904|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4406||4406|6904| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|18096|24593|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||18096||18096|24593| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4837|6981|lyfsjukr|||02|50|0|2,5000|Vistor hf|Pfizer ApS|Tranexamsýra||4837||4837|6981| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||20541||20541|28058| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|4037|6400|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4037||4037|6400| 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.01.2010||R|A||0|0|0|0|DAC|0|0|0|100|SEK|5770|8565|lyfalmen|V0085|8565|00|28|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5620||5620|8565| 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|26961|35719|lyfsjukr|||00|2500|0|2,5000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||26961||26961|35719| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|5579|8509|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5579||5579|8509| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|19227|26409|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||19227||19227|26409| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||20541||20541|28058| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|95733|122027|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||95733||95733|122027| 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|750|1492|vetalmen|||16|20|0|0,0000|Vistor hf|LEO Animal Health A/S|||750||750|1492| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|A||0|0|0|1|BAM|0|0|0|100|SEK|119855|152301|lyfsjukr|||00|1200|0|1,2000|Icepharma hf|Baxter Medical AB|Albúmín||119855||119855|152301| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|7575|11239|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||7575||7575|11239| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|8878|13022|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||8878||8878|13022| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|29469|39263|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||29469||29469|39263| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|9468|13829|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||9468||9468|13829| 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005|31.05.2010|R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|31224|41465|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||31224||31224|41465| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|331123|417442|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||331123||331123|417442| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|341608|430601|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||341608||341608|430601| 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1226|lyfalmen|V0917|1226|00|20|0|20,0000|Actavis Group hf|Actavis hf|Paroxetín||255||255|1226| 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10824|18882|vetorma|||00|24|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||10824||10824|18882| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|27884|37274|lyfalmen|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||27884||27884|37274| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2394|4176|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2394||2394|4176| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3075|5084|lyfalmen|||00|30|0|30,0000|Vistor hf|Pfizer ApS|Amlódipín||3075||3075|5084| 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1457|2542|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1457|2542| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4112|2705|lyfalmen|V0308|2683|00|100|0|100,0000|Vistor hf|Pfizer ApS|Amlódipín||1336||1336|2705| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7107|3779|lyfalmen|V0310|3779|00|100|0|200,0000|Vistor hf|Pfizer ApS|Amlódipín||2121||2121|3779| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2267|3955|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2267||2267|3955| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|783|1948|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||783||783|1948| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2277|3992|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2277||2277|3992| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|1468|2561|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||1468||1468|2561| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4938|7632|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4938||4938|7632| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2400|2754|lyfalmen|V0919|2754|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1372||1372|2754| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|1717|lyfalmen|||00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||614|1717|31.05.2010 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|1301|2524|lyfalmen|||00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Metótrexat||1204||1204|2524| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|14323|20254|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14323||14323|20254| 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|219501|277356|lyfsjukr|||00|3|0|0,0000|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||219501||219501|277356| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2877| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2725|lyfalmen|||67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2725|31.05.2010 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4095|lyfalmen|||67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4095|31.05.2010 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25658|34480|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||25658||25658|34480| 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20541||20541|28058| 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5971|9045|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5971||5971|9045| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|97476|124215|lyfsjukr|||00|30|0|0,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||97476||97476|124215| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|27154|36357|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||27154||27154|36357| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|42394|55484|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||42394||42394|55484| 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21469|29223|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21469||21469|29223| 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6031|9127|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6031||6031|9127| 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21687|29496|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21687||21687|29496| 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|22013|29509|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Roche|Flúmazeníl||22013||22013|29509| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|4775|7409|lyfalmen|V0714|7409|00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||4775||4775|7409| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|5645|8599|lyfalmen|V0715|8599|00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||5645||5645|8599| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|17408|24126|lyfalmen|||00|34|0|0,0000|Vistor hf|Dentsply DeTrey GmbH|Blöndur||17408||17408|24126| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9073|13095|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||9073||9073|13095| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|35715|46705|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||35715||35715|46705| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27031|35806|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||27031||27031|35806| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64349|82640|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||64349||64349|82640| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|42962|55800|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||42962||42962|55800| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|9633|13903|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||9633||9633|13903| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|128615|163294|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||128615||128615|163294| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|24085|32109|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||24085||24085|32109| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17667|24055|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||17667||17667|24055| 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13215|18864|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13215||13215|18864| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|48169|62335|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||48169||48169|62335| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|96337|122785|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||96337||96337|122785| 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9251|13532|lyfalmen|||00|3|0|14,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||9251||9251|13532| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|205703|260040|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||205703||205703|260040| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|177844|225077|lyfsjukr|||00|200|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||177844||177844|225077| 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|18501|25498|lyfalmen|||00|6|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||18501||18501|25498| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13876|19693|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13876||13876|19693| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|147180|186593|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||147180||147180|186593| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|28024|31632|lyfalmen|V0090|30347|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||23389||23389|31632| 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4503|7037|lyfalmen|||00|4|0|7,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4503||4503|7037| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3804|6081|lyfalmen|||00|12|0|60,0000|Icepharma hf|Santen Oy|Tímólól||3804||3804|6081| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|59814|76949|lyfsjukr|||00|120|0|100,0000|Icepharma hf|Roche|Saquínavír||59814||59814|76949| 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11232|16242|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11232||11232|16242| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|85035|108601|lyfsjukr|||00|90|0|36,0000|Vistor hf|Pfizer Limited|Síldenafíl||85035||85035|108601| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3198|5252|lyfalmen|||00|100|0|16,6667|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3198||3198|5252| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|81785|104523|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||81785||81785|104523| 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|6177|8915|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||6177||6177|8915| 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3424|5561|lyfalmen|V0102|5468|00|5|0|9,9900|Vistor hf|Janssen-Cilag AB|Fentanýl||3424||3424|5561| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|20862|28461|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||20862||20862|28461| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2405|3471|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2405||2405|3471| 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9264|13550|lyfalmen|||00|112|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||9264||9264|13550| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|33365|43756|lyfsjukr|||00|3944|0|3,9400|Icepharma hf|Fresenius Kabi|Blöndur||33365||33365|43756| 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15885|22215|lyfalmen|||00|112|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||15885||15885|22215| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|67483|86970|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||67483||67483|86970| 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25658|34480|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||25658||25658|34480| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8077|11926|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8077||8077|11926| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|430|1465|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||430||430|1465| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8077|11926|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8077||8077|11926| 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13610|19360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13610||13610|19360| 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13610|19360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13610||13610|19360| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13632|19387|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13632||13632|19387| 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13610|19360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13610||13610|19360| 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13610|19360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13610||13610|19360| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13772|19563|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13772||13772|19563| 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13610|19360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13610||13610|19360| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8077|11926|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8077||8077|11926| 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13610|19360|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13610||13610|19360| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|76881|98765|lyfalmen|||00|100|0|360,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||76881||76881|98765| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13772|19563|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13772||13772|19563| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1658|3145|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1658||1658|3145| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8077|11926|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8077||8077|11926| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8077|11926|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8077||8077|11926| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8077|11926|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8077||8077|11926| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1658|3145|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1658||1658|3145| 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|6072|9183|lyfalmen|||00|4|0|28,0000|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||6072||6072|9183| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|968|2201|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||968||968|2201| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20541||20541|28058| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2769|4665|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2769||2769|4665| 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2108|3761|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2108||2108|3761| 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4010|6363|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4010||4010|6363| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20541||20541|28058| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|1008|2256|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1008||1008|2256| 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|14556|20547|lyfalmen|||00|12|0|84,0000|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||14556||14556|20547| 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|PAD|0|0|1|100|IKR|794|1963|lyfalmen|||00|14|0|3,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||794||794|1963| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|105659|134485|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||105659||105659|134485| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|104457|132976|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||104457||104457|132976| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10179|19718|vetalmen|||00|20|0|0,0000|Vistor hf|Boehringer Ingelheim|||10179||10179|19718| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|18856|25943|lyfalmen|||00|30|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||18856||18856|25943| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|22933|31060|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||22933||22933|31060| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6689|10027|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6689||6689|10027| 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|33822|44726|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||33822||33822|44726| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|XEU|2083|3727|lyfalmen|||06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||||2083|3727|31.05.2010 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5574|8502|lyfalmen|||00|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5574||5574|8502| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|14537|20523|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14537||14537|20523| 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|45091|lyfsjukr|||00|50|1|0,0000|Distica|Distica - óskráð lyf|||34429||34429|45091| 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|18056|24939|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||18056||18056|24939| 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|26116|35055|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||26116||26116|35055| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|58868|76158|lyfalmen|||00|100|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||58868||58868|76158| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7189|10376|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7189||7189|10376| 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25658|34480|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||25658||25658|34480| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|979|2216|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||979||979|2216| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3706|6465|vetorma|||16|1|0|0,0000|Vistor hf|Merial (MSD)|||3706||3706|6465| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|534|1608|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||534||534|1608| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1800|3340|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1800||1800|3340| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8387|14631|vetorma|||16|2|0|0,0000|Vistor hf|Merial (MSD)|||8387||8387|14631| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20541||20541|28058| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|1930|3517|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1930|3517| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|7314|10882|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||7314|10882| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3813|6093|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3813|6093| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|15104|21235|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||15104|21235| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|22633|30683|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||22633|30683| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|30163|40134|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||30163|40134| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|2020|3641|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||2020||2020|3641| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|420|1452|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||420||420|1452| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2868|4801|lyfalmen|||10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2868||2868|4801| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2609|4446|lyfalmen|||00|5|0|0,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2609||2609|4446| 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|8083|11934|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||8083||8083|11934| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|31365|41642|lyfalmen|V0375|41642|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||||31365|41642| 027294|M03AC0902|Esmeron (Lyfjaver)|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.10.2009||R|K||0|0|0|1|LVR|0|0|0|100|NOK|11661|16517|lyfsjukr|||00|50|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Rókúrón, brómíð||11661||11661|16517| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|35200|46406|lyfalmen|V0376|46406|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||35161||35161|46406| 027306|N03AX1205|Neurontin (Lyfjaver)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|4927|7617|lyfalmen|V0714|7409|00|100|0|16,6667|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||4927||4927|7617| 027317|N03AX1205|Neurontin (Lyfjaver)|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|6739|10096|lyfalmen|V0715|8599|00|100|0|22,2222|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||6739||6739|10096| 027328|N03AX1205|Neurontin (Lyfjaver)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|18154|25062|lyfalmen|V2160|25062|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||18154||18154|25062| 027339|L01XE0502|Nexavar (Lyfjaver)|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.10.2009||R|A||0|1|0|1|LVR|0|0|0|100|SEK|645816|788363|lyfsjukr|||00|112|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Sorafeníb||626678||626678|788363| 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|79496|101650|lyfsjukr|||00|20|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||79496|101650| 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|79677|101877|lyfsjukr|||00|5|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||79677||79677|101877| 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|197840|250172|lyfsjukr|||00|5|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||197840||197840|250172| 027397|G02CX0102|Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|6361|9181|lyfsjukr|||00|1|0|0,0400|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||6361|9181| 027408|G02CX0102|Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|18949|25663|lyfsjukr|||00|5|0|0,2300|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||18949|25663| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|2054|3687|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|Zonisamíð||2054||2054|3687| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8218|12119|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||8218||8218|12119| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10849|15718|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||10849||10849|15718| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|14528|20512|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Zonisamíð||14528||14528|20512| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|892|2097|lyfalmen|V0431|1962|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||892||892|2097| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|892|2097|lyfalmen|V0430|1820|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||892||892|2097| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|106758|135864|lyfsjukr|||00|105|0|0,7500|Vistor hf|SP Europe|Posacónazól||106758||106758|135864| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25176|33875|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25176||25176|33875| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|33899|44822|lyfalmen|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||33899|44822| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25176|33875|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25176||25176|33875| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|48709|63409|lyfalmen|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||48709|63409| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|62923|81247|lyfalmen|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||62923|81247| 028045|G03AB0001|Qlaira|töflur|0||84|stk|1|þpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5054|7791|lyfalmen|||00|84|0||Icepharma hf|Bayer Schering Pharma AG|||||5054|7791| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|A|2|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|XEU|25730|34570|lyfalmen|||00|196|0||Icepharma hf|M.S.D.|||25730||25730|34570| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3522|5226|lyfalmen|V1911|5226|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3179||3179|5226| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4177|6591|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4177|6591| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|19908|27264|lyfalmen|||00|196|0||Icepharma hf|M.S.D.|||||19908|27264| 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14519|20500|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||14519|20500| 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4177|6591|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4177|6591| 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14519|20500|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||14519|20500| 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4814|7463|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4814|7463| 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16746|23295|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||16746|23295| 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4814|7463|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4814|7463| 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16746|23295|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||16746|23295| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2684|4549|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2684||2684|4549| 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22531|30555|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||22531||22531|30555| 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8622|12672|lyfalmen|||02|1|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||8622||8622|12672| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1450|2861|lyfalmen|V0712|2861|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1450||1450|2861| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2066|3703|lyfalmen|||10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2066||2066|3703| 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3489|5650|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||3489||3489|5650| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2625|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2625| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8828|lyfalmen|||00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||5812|8828| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15046|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15046| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|DKK|1491|2383|lyfalmen|V2010|2383|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||1101||1101|2383| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8448|16394|vetalmen|||27|10|0|0,0000|Icepharma hf|Orion Corporation (I)|||8448||8448|16394| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|DKK|8428|9523|lyfalmen|V2020|9523|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||6320||6320|9523| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|DKK|31433|33739|lyfalmen|V2030|33739|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||25068||25068|33739| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1064|2333|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||1064||1064|2333| 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12614|18110|lyfalmen|||00|10|0|5,0000|Icepharma hf|Roche A.S.|Granisetrón||12614||12614|18110| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1740|3257|lyfalmen|V0551|3257|10|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1740||1740|3257| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|7143|8858|lyfalmen|V0552|8858|10|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||5834||5834|8858| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|754|1909|lyfalmen|V0554|1909|10|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||754||754|1909| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1441|2848|lyfalmen|V0555|2848|10|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||1441||1441|2848| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|2500|4297|lyfalmen|V0556|4297|10|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2500||2500|4297| 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2439|4214|lyfalmen|||20|50|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2439||2439|4214| 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1118|2407|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1118|2407| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|7722|11441|lyfalmen|||00|28|0||Icepharma hf|Servier|Agómelatín||7722||7722|11441| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|23165|31351|lyfalmen|||00|84|0||Icepharma hf|Servier|Agómelatín||23165||23165|31351| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|631|1740|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||631||631|1740| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|261|1234|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||||261|1234| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8034|9658|lyfalmen|V0362|2314|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6419||6419|9658| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|33299|43673|lyfsjukr|||00|50|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||33299|43673| 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|6190|8934|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||6190||6190|8934| 029574|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|5158|7444|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group hf|Írinótekan||5158||5158|7444| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5006|7725|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5006|7725| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|15720|22008|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||15720|22008| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5006|7725|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5006|7725| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|15720|22008|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||15720|22008| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|112625|143227|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|||||112625|143227| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|225249|284570|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||||225249|284570| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|19944|26912|lyfsjukr|||00|84|0|7,0000|D.A.C. ehf|D.A.C. ehf|Ritonavír||19944||19944|26912| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|25413|34172|lyfalmen|||00|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||25413||25413|34172| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||00|60|0|25,0000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9818|14308|lyfalmen|V1400|14306|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9818||9818|14308| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3132|5162|lyfalmen|V1401|5160|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||3132||3132|5162| 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|17136|29893|vetorma|||00|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||17136|29893| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|968|2201|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||968||968|2201| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1412|2809|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||1412||1412|2809| 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|886|2089|lyfalmen|||23|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||886||886|2089| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3351|5461|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3351||3351|5461| 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5420|8292|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5420||5420|8292| 031314|L01AX0301|Temodal|hylki|20|mg|20|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|63837|81998|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||63837||63837|81998| 031325|L01AX0301|Temodal|hylki|100|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|77461|99096|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||77461||77461|99096| 031348|L01AX0301|Temodal|hylki|140|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|108460|138000|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||108460||108460|138000| 031371|L01AX0301|Temodal|hylki|180|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|138700|175951|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||138700||138700|175951| 031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|192285|243200|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||192285||192285|243200| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2265|3976|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||2265||2265|3976| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6675|10008|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6675||6675|10008| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|39305|51210|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||39305||39305|51210| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1977|3582|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1977||1977|3582| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10249|14745|lyfsjukr|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||10249|14745| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14980|20682|lyfsjukr|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||14980|20682| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|51831|66930|lyfsjukr|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||51831|66930| 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|26143|35089|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26143||26143|35089| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4041|7049|vetorma|||27|50|0|0,0000|Vistor hf|Merial (MSD)|||4041||4041|7049| 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|150891|191251|lyfsjukr|||0|6|0|0,0000|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||150891|191251| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14372|25071|vetorma|||27|200|0|0,0000|Vistor hf|Merial (MSD)|||14372||14372|25071| 032723|N06AX1609|Venlafaxin Ranbaxy|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2009||R|A||0|0|0|0|RAN|0|1|0|100|XEU|9749|9556|lyfalmen|V0955|7580|00|100|0|75,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||6344||6344|9556| 032756|N06AX1609|Venlafaxin Ranbaxy|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.01.2010||R|A||0|0|0|0|RAN|0|1|0|100|XEU|17847|15025|lyfalmen|V0956|7580|00|100|0|150,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||10342||10342|15025| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|9752|18898|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||9752|18898| 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1342|2713|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||1342||1342|2713| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|93170|118811|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|||93170||93170|118811| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|137578|174543|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|||137578||137578|174543| 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|601933|757308|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|||||601933|757308| 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2641|5244|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2641|5244| 034105|A07AA0905|Vancomycin Axellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A||0|0|E|0|AXE|0|0|1|100|DKK|12791|18332|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Axellia Pharmaceuticals ApS|Vankómýcín||||12791|18332| 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|795|1965|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||795||795|1965| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|23953|31944|lyfsjukr|||00|25|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||23953||23953|31944| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8656|12718|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|||||8656|12718| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8656|12718|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|||||8656|12718| 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2312|4040|lyfalmen|||00|300|0|10,0000|Vistor hf|Astra|Clómetíazól||2312||2312|4040| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1952|3547|lyfalmen|||00|6|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1952||1952|3547| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3347|5456|lyfalmen|||00|12|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3347||3347|5456| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|199925|252788|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||199925|252788| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7952|11477|lyfsjukr|||02|25|0|0,0000|Vistor hf|LEO Pharma A/S|Prótamín||7952||7952|11477| 035099|C02CA0404|Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|3675|5422|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Doxazósín||3322||3322|5422|31.03.2010 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2427|3503|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||2427||2427|3503| 035177|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6375|7662|lyfalmen|V0714|7409|10|100|0|16,6800|D.A.C. ehf|D.A.C. ehf|Gabapentín||4960||4960|7662| 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|17043|23668|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17043||17043|23668| 035222|N06DA0403|Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|12756|18288|lyfalmen|V1370|18288|00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Galantamín||12756||12756|18288| 035234|M01AB5502|Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5152|7925|lyfalmen|V2130|7925|0|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||5152||5152|7925| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3517|5688|lyfalmen|V2215|5688|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3517|5688| 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2840|lyfalmen|||00|56|0|4,6700|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2840| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3400|lyfalmen|V0703|3400|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3400| 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|4805|lyfalmen|||00|56|0|18,6700|Actavis Group hf|Actavis hf|Lamótrigín||2871||2871|4805| 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|7691|lyfalmen|||00|56|0|37,3400|Actavis Group hf|Actavis hf|Lamótrigín||4981||4981|7691| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|128253|162840|lyfsjukr|||00|1|0|0,0000|Vistor hf|Pfizer ApS|Pegaptaníb||128253||128253|162840| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11190|16185|lyfalmen|V2216|16185|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||11190|16185| 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1336|lyfsjukr|||00|10|1|0,0000|Distica|Distica - óskráð lyf|Digoxín||926||926|1336| 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|49385|63861|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||49385||49385|63861| 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|AEG|0|0|0|100|GBP|983|2222|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||983||983|2222| 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|AEG|0|0|0|100|GBP|525|1595|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||525||525|1595| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|32554|43134|lyfalmen|V1200|39201|00|180|0||Vistor hf|Genzyme Europe B.V.|Sevelamer||||32554|43134| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|153670|194738|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||153670|194738| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6234|9405|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6234||6234|9405| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2877|4813|lyfalmen|V2213|4813|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2877|4813| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|9158|13405|lyfalmen|V2214|13405|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||9158|13405| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|209904|265312|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer Limited|Sunitíníb||209904||209904|265312| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|416254|524281|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer Limited|Sunitíníb||416254||416254|524281| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|832105|1046174|lyfsjukr|||00|30|0|0,0000|Vistor hf|Pfizer Limited|Sunitíníb||832105||832105|1046174| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|835|2019|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||835||835|2019| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1410|2806|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1410||1410|2806| 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GCO|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|Vistor hf|GlaxoSmithKline CH AB|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2783|4684|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2783||2783|4684| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|844|2032|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||844||844|2032| 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7020|10480|lyfalmen|||00|42|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7020||7020|10480| 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13768|19558|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13768||13768|19558| 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|26336|35331|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||26336||26336|35331| 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|50467|65615|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||50467||50467|65615| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2680|4543|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2680||2680|4543| 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1191|2506|lyfalmen|||0|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1191||1191|2506| 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2234| 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3724| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8258|12174|lyfalmen|V2212|12174|00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8258|12174| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1397|lyfalmen|V0917|1226|00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1397| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2273|lyfalmen|||00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2273| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3054|lyfalmen|V0919|2754|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3054| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1110|2396|lyfalmen|||00|50|0|50,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1110||1110|2396| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2679|4542|lyfalmen|V2211|4542|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2679|4542| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|227142|286946|lyfsjukr|||00|1|0|0,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||227142||227142|286946| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|91753|117033|lyfsjukr|||00|100|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||||91753|117033| 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|6625|9940|lyfalmen|||00|90|0|90,0000|Icepharma hf|Servier|Perindópríl||6625||6625|9940| 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4673|7270|lyfalmen|||00|100|0|33,3333|Medico ehf|Solvay Duphar |Betahistín||4673||4673|7270| 038915|J01FA1004|Zitromax UNO|forðakyr|||2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3159|5199|lyfalmen|||00|2|0|6,6700|Vistor hf|Pfizer ApS|Azitrómýcín||3159||3159|5199| 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|44729|58017|lyfsjukr|||00|10|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||44729||44729|58017| 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|71309|91375|lyfsjukr|||00|20|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||71309||71309|91375| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|3256|5331|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3256||3256|5331| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|641|1754|lyfalmen|V0290|1631|00|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||641||641|1754| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|633|1743|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||633||633|1743| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1488|2913|lyfalmen|||00|15|0|2,0000|Vistor hf|Pfizer ApS|Azitrómýcín||1488||1488|2913| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2402|4163|lyfalmen|||00|22|0|3,0000|Vistor hf|Pfizer ApS|Azitrómýcín||2402||2402|4163| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|414|598|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||414||414|598| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|3080|lyfalmen|V0367|3063|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1610||1610|3080| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8707|12252|lyfalmen|V0508|12252|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||8315||8315|12252| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|949|1370|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||949||949|1370| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1886|3145|lyfalmen|V0507|3145|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1658||1658|3145| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1684|2430|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1684||1684|2430| 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3219|5281|lyfalmen|||00|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3219||3219|5281| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1621| 041059|J07BH0101|Rotarix|mixtduft|||1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007|30.04.2010|R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|9073|13289|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||9073||9073|13289| 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3256|5331|lyfalmen|||00|63|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3256||3256|5331| 041488|N06AB1002|Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|0|0|DAC|0|1|0|100|DKK|21344|28532|lyfalmen|V2172|21062|00|98|0|196,0000|D.A.C. ehf|D.A.C. ehf|Escítalópram||20919||20919|28532| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4666|8140|vetorma|||AA|100|0|0,0000|Icepharma hf|Intervet International B.V.|||4666||4666|8140| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|199941|253205|lyfalmen|||02|100|0|0,0000|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||199941||199941|253205| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1165|2471|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1165|2471| 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1498|2926|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1498||1498|2926| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|12603|17699|lyfsjukr|||00|500|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||12603||12603|17699| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3868|5582|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3868||3868|5582| 042309|N01BB0902|Naropin|stl/irl|2|mg/ml|200|ml|5|plpok||N01BB09|01.07.2009||R|A||0|0|0|1|AZD|0|0|0|100|SEK|22541|30171|lyfsjukr|||00|1000|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||||22541|30171| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4878|7040|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4878||4878|7040| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4611|6655|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4611||4611|6655| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6990|10088|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6990||6990|10088| 042346|N07BA0137|Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8024|11581|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||8024||8024|11581| 042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2333|4069|lyfalmen|||00|500|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2333|4069| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8777|12667|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Kolvetni||8777||8777|12667| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4455|6430|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4455||4455|6430| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4660|6726|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4660||4660|6726| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3419|4934|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3419||3419|4934| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2948|4255|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2948||2948|4255| 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|10301|14810|lyfsjukr|||00|2000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||10301||10301|14810| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4124|5952|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||4124||4124|5952| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2642|3813|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2642||2642|3813| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1903|2747|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||1903||1903|2747| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6460|9323|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||6460||6460|9323| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2156|3112|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2156||2156|3112| 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|820|1999|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||820||820|1999| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3340|4820|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3340|4820| 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15674|21950|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||15674||15674|21950| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3623|5229|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3623||3623|5229| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|370|1383|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||370||370|1383| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3506|5060|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3506||3506|5060| 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3902|5981|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3731||3731|5981| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6444|9300|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6444||6444|9300| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|598|1695|lyfalmen|||00|30|0|15,0000|Vistor hf|Pfizer ApS|Tríazólam||598||598|1695| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1279|2627|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1279||1279|2627| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|14957|20473|lyfalmen|V0011|20470|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||14497||14497|20473| 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|27155|36359|lyfalmen|||00|100|0|100,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||27155|36359| 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|101710|129925|lyfalmen|||00|100|0|100,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||101710|129925| 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|3466|5619|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||3466|5619| 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|40200|52334|lyfsjukr|||00|5|0|0,0000|Vistor hf|Pfizer ApS|Írinótekan||40200||40200|52334| 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|1380|2765|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1380||1380|2765| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7835|11595|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||7835||7835|11595| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2314|lyfalmen|V0362|2314|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1050|2314| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2065|lyfalmen|V0361|2065|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||868|2065| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|4419|5552|lyfsjukr|||00|750|0|0,2500|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||3847||3847|5552| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|8454|11244|lyfsjukr|||00|1500|0|0,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||7791||7791|11244| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|22445|43270|vetalmen|||27|10|0|0,0000|Icepharma hf|Pfizer vet.|||22445||22445|43270| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3535|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3535| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|5544|8461|lyfalmen|V1088|8461|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||5544||5544|8461| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1929|lyfalmen|V0001|1929|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1929| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2539|lyfalmen|V0002|2539|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2539| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3096|lyfalmen|V0003|3096|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3096| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|8891|13040|lyfalmen|V1089|13040|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||8891||8891|13040| 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|78009|99784|lyfsjukr|||00|100|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||78009||78009|99784| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|998|2242|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||998||998|2242| 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1011|2260|lyfalmen|||23|14|0|7,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1011||1011|2260| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|168834|213769|lyfsjukr|||00|200|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||168834||168834|213769| 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|AZA|0|0|0|100|SEK|10167|14785|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca AB|Zafírlúkast||10167||10167|14785| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5188|7488|lyfsjukr|||02|250|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||5188||5188|7488| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8188|11817|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||8188||8188|11817| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|6105|7188|lyfalmen|V0940|7188|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4613||4613|7188| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2661|4044|lyfalmen|V0939|4044|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2315||2315|4044| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|9531|11828|lyfalmen|V0938|11828|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||8005||8005|11828| 048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|4746|6137|lyfalmen|V0941|6137|00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3845||3845|6137| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|18104|18935|lyfalmen|V0942|18935|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||13272||13272|18935| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|5686|7256|lyfalmen|V0943|7256|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4663||4663|7256| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|19379|21492|lyfalmen|V2172|21492|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||15309||15309|21492| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1243|2578|lyfalmen|||00|100|0|0,0000|Vistor hf|Meda AB|Klídín og geðlyf||1243||1243|2578| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|14733|20769|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||14733||14733|20769| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4611|7185|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||4611||4611|7185| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1905|3483|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1905||1905|3483| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|68912|88764|lyfalmen|||00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||68912||68912|88764| 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994|30.04.2010|R|A|1,5|0|0|E|0|MNA|0|0|0|100|SEK|9882|14395|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Merck NM AB|Selegilín||9882||9882|14395| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|512|1578|lyfalmen|V0772|1396|00|100|0|16,6667|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||512||512|1578| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5349|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5349| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|17981|24845|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17981||17981|24845| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2765|4660|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2765||2765|4660| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól|||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3780|6048|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3780||3780|6048| 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|11126|16097|lyfalmen|||00|8|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||11126||11126|16097| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8886|13033|lyfalmen|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Amorolfín||8886||8886|13033| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2065|lyfalmen|V0361|2065|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||868||868|2065| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2314|lyfalmen|V0362|2314|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||1050||1050|2314| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3125|lyfalmen|V0367|3125|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1643||1643|3125| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4898|lyfalmen|V0343|4501|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4898| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1681|3177|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1681||1681|3177| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2146|3813|lyfalmen|||00|30|0|30,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2146||2146|3813| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|3951|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2247||2247|3951| 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5327|7751|lyfalmen|||10|30|0|3,0000|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5025||5025|7751| 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|19548|25705|lyfalmen|||10|30|0|12,0000|D.A.C. ehf|D.A.C. ehf|Ciklospórín||18666||18666|25705| 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A||0|0|0|0|DAC|0|0|0|100|XEU|14336|7204|lyfalmen|||00|12|0|84,0000|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||4625||4625|7204|30.04.2010 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|79249|101737|lyfalmen|||00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||79249||79249|101737| 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8467|12220|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||8467||8467|12220| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAP|0|0|0|100|SEK|645816|788365|lyfsjukr|||00|112|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||626679||626679|788365| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3984|6327|lyfalmen|||00|14|0|10,5000|Vistor hf|Pfizer ApS|Pregabalín||3984||3984|6327| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14208|20110|lyfalmen|||00|56|0|42,0000|Vistor hf|Pfizer ApS|Pregabalín||14208||14208|20110| 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|5846|5316|lyfalmen|V2120|5167|00|100|0|100,0000|Vistor hf|Pfizer ApS|Doxazósín||3245||3245|5316| 050914|N02BE0101|Panodil|eþ-stíll|1|g|10|stk|1|pakki||N02BE01|01.10.1989|31.05.2010|R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|521|1590|lyfalmen|||04|10|0|3,3333|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||521||521|1590| 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1807|3349|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1807||1807|3349| 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|D.A.C. ehf|D.A.C. ehf|Ketóprófen|||||| 051083|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2500 a.e. anti-Xa/ml/sprautu|B01AB04|01.06.2010||R|A||0|0|0|0|PFI|0|0|1|100|DKK|5494|8393|lyfalmen|||02|2|0|10,0000|Vistor hf|Pfizer ApS|Dalteparín||5494||5494|8393| 051107|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5000 a.e. anti-Xa/ml/sprautu|B01AB04|01.06.2010||R|A||0|0|0|0|PFI|0|0|1|100|DKK|10983|15901|lyfalmen|||02|2|0|20,0000|Vistor hf|Pfizer ApS|Dalteparín||10983||10983|15901| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2174|3851|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2174||2174|3851| 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.12.2009||R|A||0|0|E|0|PCO|0|0|1|100|SEK|673|1798|lyfalmen|||72|25|1|10,0000|Distica|Distica - óskráð lyf|Acetýlcýstein||673||673|1798| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1800|2911|lyfalmen|V1912|2911|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1487||1487|2911| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|5205|7126|lyfalmen|V1913|7126|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4568||4568|7126| 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.12.2009||R|A||0|0|E|0|PCO|0|0|1|100|SEK|2458|4240|lyfalmen|||72|100|1|40,0000|Distica|Distica - óskráð lyf|Acetýlcýstein||2458||2458|4240| 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|37184|48548|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||37184||37184|48548| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|2683|lyfalmen|V0308|2683|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||1320||1320|2683| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|3798|lyfalmen|V0310|3779|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||2135||2135|3798| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|210|1165|lyfalmen|V0858|1165|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||210||210|1165| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|561|1645|lyfalmen|V0859|1645|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||561||561|1645| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|409481|515781|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||409481||409481|515781| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|350|1356|lyfalmen|V0856|1356|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||350|1356| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1122|2412|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1122||1122|2412| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|867|2063|lyfalmen|V0855|2063|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||867|2063| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|825038|1037305|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||825038||825038|1037305| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|834474|1049147|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||834474||834474|1049147| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|4175|6588|lyfalmen|||00|3|0||Vistor hf|Allergan|Tímólól í blöndum||4175||4175|6588| 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|12066|17422|lyfalmen|||00|9|0||Vistor hf|Allergan|Tímólól í blöndum||12066||12066|17422| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|35171|46022|lyfsjukr|||63|25|0|6,2500|Actavis Group hf|Pharmachemie|Kalsíumfólínat||35171||35171|46022| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43400|56350|lyfsjukr|||00|8212|0|8,2000|Icepharma hf|Fresenius Kabi|Blöndur||43400||43400|56350| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34869|45643|lyfsjukr|||00|7698|0|7,7100|Icepharma hf|Fresenius Kabi|Blöndur||34869||34869|45643| 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|46957|60814|lyfsjukr|||63|10|0|8,3333|Actavis Group hf|Pharmachemie|Kalsíumfólínat||46957||46957|60814| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40347|52518|lyfsjukr|||00|7680|0|7,6800|Icepharma hf|Fresenius Kabi|Blöndur||40347||40347|52518| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|28315|37418|lyfsjukr|||00|7200|0|7,2000|Icepharma hf|Fresenius Kabi|Blöndur||28315||28315|37418| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|45445|58916|lyfsjukr|||00|7880|0|7,9000|Icepharma hf|Fresenius Kabi|Blöndur||45445||45445|58916| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|42280|54944|lyfsjukr|||00|7616|0|7,6000|Icepharma hf|Fresenius Kabi|Blöndur||42280||42280|54944| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2919|4870|lyfalmen|V0903|4870|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2919||2919|4870| 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2407|4170|lyfalmen|||23|63|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2407||2407|4170| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|81241|103840|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||81241||81241|103840| 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5738|8727|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5738||5738|8727| 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6286|9476|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6286||6286|9476| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|40490|53094|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||40490||40490|53094| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|38735|50892|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||38735||38735|50892| 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|108705|138307|lyfsjukr|||43|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|||108705||108705|138307| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|622|1728|lyfalmen|V0902|1728|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||622||622|1728| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|16061|22436|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16061||16061|22436| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1649|3133|lyfalmen|||00|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1649||1649|3133| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1230|2560|lyfalmen|||20|30|0|30,0000|Vistor hf|Pfizer ApS|Klindamýcín||1230||1230|2560| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2778|4677|lyfalmen|||02|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2778||2778|4677| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|68834|88269|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche Registration Limited|Ribavirin||68834||68834|88269| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1448|2858|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1448||1448|2858| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|0|0|ACA|0|1|0|100|XEU|1866|3430|lyfalmen|V0914|3174|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1866||1866|3430| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8282|14448|vetorma|||16|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||8282||8282|14448| 054936|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.10.2009||R|A||0|0|0|0|LVR|0|1|0|100|DKK|10860|15733|lyfalmen|V0938|11591|00|98|0|98,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||10860||10860|15733| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|814|1991|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||814||814|1991| 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9922|14450|lyfalmen|||10|100|0|60,0000|Vistor hf|Pfizer ApS|Morfín||9922||9922|14450| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5310|8141|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||5310||5310|8141| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4359|2426|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2426| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3144|lyfalmen|V2207|3144|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3144| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5945|lyfalmen|V0339|5945|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5945| 056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009||R|K||0|1|0|1|SOI|0|0|0|100|SEK|96120|122513|lyfsjukr|||00|3|0||Swedish Orphan International AB|Swedish Orphan International AB|||||96120|122513| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1314|2675|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1314||1314|2675| 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|28110|37161|lyfsjukr|||00|81|0|0,0000|xxxxx|Paranova A/S|||28110||28110|37161| 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|259478|327527|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||259478||259478|327527| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|66750|85654|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||66750||66750|85654| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3517|5688|lyfalmen|V2222|5688|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||3517|5688| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11188|16182|lyfalmen|V2223|16182|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11188|16182| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|20018|27005|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||20018||20018|27005| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|10637|15232|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||10637||10637|15232| 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6926|9996|lyfsjukr|||00|200|0|0,2000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||6926||6926|9996| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|5726|8264|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||5726||5726|8264| 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|26663|35345|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||26663||26663|35345| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|21705|29519|lyfalmen|||0|112|0|56,0000|Vistor hf|Pfizer Limited|Vareniclin||||21705|29519| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|459|1505|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||459||459|1505| 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|174316|304086|vetorma|||00|5000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||174316|304086| 058294|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|264802|461934|vetorma|||00|10000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||264802|461934| 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21628|29422|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||21628||21628|29422| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1008|2256|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1008||1008|2256| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|121865|154823|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||121865||121865|154823| 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1708|3214|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1708||1708|3214| 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2693|4561|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2693||2693|4561| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4447|6961|lyfalmen|||51|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4447||4447|6961| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1683|3180|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíð dínítrat||1683||1683|3180| 059295|S01AA0104|Kloramfenikol|augnsm|1|%|5|g|1|túpa||S01AA01|01.10.2009||R|A||0|0|E|0|LVE|0|0|1|100|IKR|1980|3586|lyfalmen|||07|5|1|0,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Klóramfeníkól||1980||1980|3586| 059353|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.02.2010||R|K||0|1|0|1|CEO|0|0|0|100|DKK|250120|315783|lyfsjukr|||00|1|0||Vistor hf|Centocor B.V.|Golimumab||||250120|315783| 059364|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.02.2010||R|K||0|1|0|1|CEO|0|0|0|100|DKK|250120|315783|lyfsjukr|||00|1|0||Vistor hf|Centocor B.V.|Golimumab||||250120|315783| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|111484|142192|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||111484||111484|142192| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|33951|44888|lyfalmen|||51|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||33951||33951|44888| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|97476|124215|lyfsjukr|||00|30|0|0,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||97476||97476|124215| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|34748|45888|lyfalmen|||00|30|0||Vistor hf|Bial-Portela & C.S.A.|||34748||34748|45888| 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|7781|11230|lyfsjukr|||00|28|0|7,0000|Vistor hf|Schering-Plough|Búprenorfín í blöndum||7781||7781|11230| 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|15024|20738|lyfsjukr|||00|28|0|28,0000|Vistor hf|Schering-Plough|Búprenorfín í blöndum||15024||15024|20738| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|420796|530378|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||420796||420796|530378| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|213103|269723|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||213103||213103|269723| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|106552|136002|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||106552||106552|136002| 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8191|12082|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||8191||8191|12082| 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1995| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1995| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2956|5849|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||2956|5849| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1549|3081|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||1549|3081| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9149|17740|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Animal Health|||||9149|17740| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|7580|11246|lyfalmen|V1030|11246|00|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||||7580|11246| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0,0000|Vistor hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7581|11248|lyfalmen|V1030|11246|00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7581||7581|11248| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|1501|2618|vetorma|||16|26|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||1501|2618| 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|167848|212532|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Temsirolímus||167848||167848|212532| 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8,3333|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra|||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7091|10234|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7091||7091|10234| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|18630|25263|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||18630||18630|25263| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|26370|34977|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||26370||26370|34977| 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|544|1621|lyfalmen|||10|30|0|15,0000|Vistor hf|Pfizer ApS|Alprazólam||544||544|1621| 062343|A10BD0401|Avaglim|filmhtfl|8|mg|28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008|30.04.2010|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5147|7918|lyfalmen|||00|28|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||5147||5147|7918| 062376|C05AA0103|Proctosedyl (D.A.C.)|eþ-smyr|||30|g|1|túpa||C05AA01|01.10.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|D.A.C. ehf|D.A.C. ehf|Hýdrókortisón|||||| 062379|A10BD0401|Avaglim|filmhtfl|12|mg|28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008|30.04.2010|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7701|11412|lyfalmen|||00|28|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||7701||7701|11412| 062387|N04BC0502|Sifrol|forðatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1793|3330|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||1793|3330| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|7157|10329|lyfsjukr|||02|20|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||7157||7157|10329| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|503|726|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||503||503|726| 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|996|2240|lyfalmen|||10|60|0|30,0000|Vistor hf|Pfizer ApS|Alprazólam||996||996|2240| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2196|3881|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2196||2196|3881| 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|19364|33780|vetorma|||16|1000|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||19364||19364|33780| 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|DKK|1862|3424|lyfalmen|||23|63|0|63,0000|Icepharma hf|Wyeth Medica|Gestóden og östrógen||1862||1862|3424| 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|17084|23720|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||17084||17084|23720| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5522|8431|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5522||5522|8431| 063340|D05AX0202|Daivonex (D.A.C.)|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.12.2009||R|A||0|0|B|0|DAC|0|0|0|100|DKK|7229|10766|lyfalmen|V0092|10766|00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól||7229||7229|10766| 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2226|3922|lyfalmen|||23|14|0|10,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2226||2226|3922| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2993| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4501|lyfalmen|V0343|4501|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4501| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1736|3252|lyfalmen|V1901|3252|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1736||1736|3252| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|8368|12077|lyfsjukr|||17|2|0|0,0000|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||8368||8368|12077| 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2724|4752|vetorma|||16|12|0|0,0000|Vistor hf|Fort Dodge Veterinär GmbH|||2724||2724|4752| 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1146|2445|lyfalmen|||10|30|0|30,0000|Vistor hf|Pfizer ApS|Alprazólam||1146||1146|2445| 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2192|3876|lyfalmen|||10|60|0|60,0000|Vistor hf|Pfizer ApS|Alprazólam||2192||2192|3876| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|1165643|1464764|lyfsjukr|||00|1|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1165643|1464764| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|466257|587035|lyfsjukr|||00|1|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||466257|587035| 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2520|4324|lyfalmen|||10|30|0|60,0000|Vistor hf|Pfizer ApS|Alprazólam||2520||2520|4324| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|4662574|5853413|lyfsjukr|||00|1|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4662574|5853413| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|2331288|2927649|lyfsjukr|||00|1|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2331288|2927649| 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|938|2160|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||938||938|2160| 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2099|3749|lyfalmen|||38|25|0|0,0000|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2099||2099|3749| 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|14040|19899|lyfalmen|||51|5|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||14040||14040|19899| 065314|G01AF0201|Canesten|sk-stíll|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|20800|27987|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||||20800|27987| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2692|3827|lyfalmen|V1989|3810|06|2|0|25,0000|Vistor hf|Pfizer ApS|Latanóprost||2156||2156|3827| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|glas|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|8069|11431|lyfalmen|V1989|11431|06|8|0|75,0000|Vistor hf|Pfizer ApS|Latanóprost||7715||7715|11431| 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|17,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009||R|K||0|1|0|1|WTE|0|0|0|100|DKK|170999|216486|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||||170999|216486| 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|6787|9795|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||||6787|9795| 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|2291|4011|lyfalmen|V0195|2234|00|28|0|7,0000|Icepharma hf|M.S.D.|Lósartan||2291||2291|4011| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|7747|11475|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||7747||7747|11475| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|30590|40273|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||30590||30590|40273| 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984|31.05.2010|R|A|2|0|0|0|0|CES|1|0|0|100|XEU|23111|44549|vetalmen|||16|10|0|0,0000|Icepharma hf|Ceva Sante Animale|||23111||23111|44549| 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1007|2255|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Merck NM AB|Klómípramín||1007||1007|2255| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1961|3560|lyfalmen|V0144|3560|70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1961||1961|3560| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|A||0|1|0|1|AGP|0|0|0|100|XEU|82345|105225|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||82345||82345|105225| 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|691|1822|lyfalmen|||23|20|0|2,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||691||691|1822| 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7641|11330|lyfalmen|||00|84|0|56,0000|Medico ehf|Solvay Duphar |Betahistín||7641||7641|11330| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1448|2858|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1448||1448|2858| 067632|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7312|14213|vetalmen|||0|10|0|0,0000|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||7312|14213| 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A||0|0|0|0|DAC|0|0|1|100|DKK|814|1991|lyfalmen|V0901|1991|00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Nítrazepam||814||814|1991| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3257|lyfalmen|V0551|3257|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3257| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5834|8858|lyfalmen|V0552|8858|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||5834||5834|8858| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1909|lyfalmen|V0554|1909|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1909| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2848|lyfalmen|V0555|2848|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2848| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4297|lyfalmen|V0556|4297|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4297| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|22063|29968|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||22063||22063|29968| 068043|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|2|glas|sk-úðari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6555|12759|vetalmen|||27|50|0|0,0000|Icepharma hf|Vétoquinol AG|||6555||6555|12759| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2434|4207|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||2434||2434|4207| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6871|10276|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||6871||6871|10276| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3267|lyfalmen|||00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3267| 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17160|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17160| 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|3356|5468|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3356||3356|5468| 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|1690|3189|lyfalmen|||00|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1690||1690|3189| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|18056|24939|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18056|24939| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|26116|35055|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||26116|35055| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|33822|44726|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||33822|44726| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|75127|96167|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||75127||75127|96167| 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|34168|44763|lyfsjukr|||00|10|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||34168||34168|44763| 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5802|8374|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5802||5802|8374| 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5413|7812|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5413||5413|7812| 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9506|13720|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9506||9506|13720| 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6050|8732|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6050||6050|8732| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5824|11356|vetalmen|||27|100|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||5824||5824|11356| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|18357|25317|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||18357||18357|25317| 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|6167|12014|vetalmen|||16|1250|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||6167||6167|12014| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1873|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||728||728|1873| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|65117|83604|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||65117||65117|83604| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|325585|410492|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||325585||325585|410492| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|NOK|7425|9851|lyfalmen|V1091|9851|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||6560||6560|9851| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8369|16242|vetalmen|||27|5|0|0,0000|Vistor hf|Orion-Farmos|||8369||8369|16242| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|14646|20660|lyfalmen|||00|15|0|5,0000|Icepharma hf|Roche A.S.|Granisetrón||14646||14646|20660| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|NOK|24621|30347|lyfalmen|V0090|30347|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||22365||22365|30347| 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20541||20541|28058| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|655|945|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||655||655|945| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|178382|225752|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||178382||178382|225752| 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|2004|2892|lyfsjukr|||02|5|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||2004||2004|2892| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|15987|22343|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||15987||15987|22343| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|15987|22343|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||15987||15987|22343| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1403|2796|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1403||1403|2796| 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4134|5614|lyfalmen|||10|100|0|100,0000|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3463||3463|5614| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1758|3282|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1758||1758|3282| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|328|1326|lyfalmen|V0858|1165|00|20|0|5,0000|Vistor hf|Pfizer ApS|Alprazólam||328||328|1326| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|883|2085|lyfalmen|V0859|1645|00|50|0|12,5000|Vistor hf|Pfizer ApS|Alprazólam||883||883|2085| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1279|2627|lyfalmen|V0855|2063|00|100|0|25,0000|Vistor hf|Pfizer ApS|Alprazólam||1279||1279|2627| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|554|1635|lyfalmen|V0856|1356|00|20|0|10,0000|Vistor hf|Pfizer ApS|Alprazólam||554||554|1635| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1909|3489|lyfalmen|||00|100|0|50,0000|Vistor hf|Pfizer ApS|Alprazólam||1909||1909|3489| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|4988|7701|lyfalmen|V0096|7701|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4988||4988|7701| 074027|G04BE0303|Viagra (D.A.C.)|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|5633|8583|lyfalmen|V0097|8583|00|4|0|4,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5633||5633|8583| 074038|N02AB0304|Durogesic (D.A.C.)|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2009||R|A||1|0|E|0|DAC|0|0|0|100|SEK|3356|5468|lyfalmen|V0102|5468|00|5|0|9,9900|D.A.C. ehf|D.A.C. ehf|Fentanýl||3356||3356|5468| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|3857|6153|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3857||3857|6153| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|11232|16242|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||11232||11232|16242| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4921|7609|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4921||4921|7609| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|14485|20458|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||14485||14485|20458| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4921|7609|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4921||4921|7609| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|16258|22683|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||16258||16258|22683| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|40625|52867|lyfsjukr|||00|50|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||40625||40625|52867| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|246|1214|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||246||246|1214| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|500|1561|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||500||500|1561| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|22241|38798|vetorma|||58|25|0|0,0000|Vistor hf|Scan Vet Animal Health AS|||22241||22241|38798| 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2338|4076|lyfalmen|||23|4|0|3,5000|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2338||2338|4076| 074736|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.05.2010||R|A|5|0|0|B|0|AEG|0|0|0|100|XEU|421|1453|lyfalmen|||00|100|0|25,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||421||421|1453| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1622|2430|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1135||1135|2430| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5252|8062|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||5252||5252|8062| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15754|22050|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||15754||15754|22050| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|MCS|0|0|1|100|SEK|1780|3312|lyfalmen|||69|10|0|10,0000|Vistor hf|McNeil Sweden AB|Ketókónazól||1780||1780|3312| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5252|8062|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||5252||5252|8062| 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2294|3356|lyfalmen|V1912|2911|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1812||1812|3356| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15754|22050|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||15754||15754|22050| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2929|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2929| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2894|4836|lyfalmen|||00|300|0|300,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2894||2894|4836| 075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|36164|47665|lyfalmen|V0106|47665|00|56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||||36164|47665| 075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A||0|0|E|0|LVR|0|0|1|100|DKK|7841|11603|lyfalmen|||00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||||7841|11603|31.03.2010 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2978|lyfalmen|||10|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2978| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A||0|0|E|0|LVR|0|0|1|100|DKK|14824|20883|lyfalmen|||00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||||14824|20883|30.04.2010 075321|G04BE0803|Cialis (Lyfjaver)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|XEU|12830|18381|lyfalmen|||00|8|0|16,0000|Lyfjaver ehf|Lyfjaver ehf|Tadalafíl||||12830|18381|31.05.2010 075334|G04BE0803|Cialis (Lyfjaver)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|XEU|6583|9882|lyfalmen|||00|4|0|8,0000|Lyfjaver ehf|Lyfjaver ehf|Tadalafíl||||6583|9882|30.04.2010 075367|L02BG0403|Femar (Lyfjaver)|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.12.2009||R|A||0|0|*|0|LVR|0|0|0|100|DKK|58519|75720|lyfalmen|V0563|75720|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Letrózól||||58519|75720| 075379|G03GA0602|Puregon (Lyfjaver)|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.12.2009||R|K||0|1|E|0|LVR|0|0|0|100|DKK|62241|80392|lyfalmen|||00|1|0|12,0000|Lyfjaver ehf|Lyfjaver ehf|Follitrópín beta||||62241|80392|31.03.2010 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|21482|29239|lyfalmen|V0105|29239|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||21482|29239| 075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|7745|11472|lyfalmen|V0104|11472|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||7745|11472| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075436|G04BE0304|Viagra (Lyfjaver)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|DKK|6405|9639|lyfalmen|||00|4|0|8,0000|Lyfjaver ehf|Lyfjaver ehf|Síldenafíl||||6405|9639|30.04.2010 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075447|G04BE0304|Viagra (Lyfjaver)|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|LVR|0|0|0|100|DKK|17533|24283|lyfalmen|||00|12|0|24,0000|Lyfjaver ehf|Lyfjaver ehf|Síldenafíl||||17533|24283|31.05.2010 075458|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|15517|21753|lyfalmen|V0103|21753|00|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||||15517|21753| 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075470|L01CD0201|Taxotere|irþ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|32246|42351|lyfsjukr|||00|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||32246||32246|42351| 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075482|L01CD0201|Taxotere|irþ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|121031|153776|lyfsjukr|||00|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||121031||121031|153776| 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 075724|B02BD0901|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|105104|133788|lyfsjukr|||00|1000|0|2,8600|Icepharma hf|Wyeth Europe|Storkuþáttur IX||105104||105104|133788| 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2235|4446|vetalmen|||13|25|0|0,0000|Vistor hf|VetXX A/S|||2235||2235|4446| 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6403|9241|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6403||6403|9241| 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6403|9241|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6403||6403|9241| 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6287|9074|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6287||6287|9074| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|483|1538|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||483||483|1538| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|XEU|7024|10486|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Sítagliptín||7024||7024|10486| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|24298|32773|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Sítagliptín||24298||24298|32773| 076181|L04AA0603|Cellcept (D.A.C.)|töflur|500|mg|50|stk|1|þpakki||L04AA06|01.12.2009||R|A||0|1|*|0|DAC|0|0|0|100|DKK|22512|30532|lyfalmen|||00|50|0|12,5000|D.A.C. ehf|D.A.C. ehf|Mýcófenólsýra||22512||22512|30532| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1887|lyfalmen|V1070|1887|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||738||738|1887| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3241|lyfalmen|V1075|3241|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1728||1728|3241| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4103|lyfalmen|V0791|4103|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||2358||2358|4103| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|955|2184|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough|Perfenazín||||955|2184| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1324|2688|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough|Perfenazín||||1324|2688| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1887|3459|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough|Perfenazín||||1887|3459| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7651|13347|vetorma|||27|100|0|0,0000|Vistor hf|Merial (MSD)|||7651||7651|13347| 076814|J07AL5201|Synflorix|stl|0||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|7973|11784|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||7973||7973|11784| 076859|M01AH0104|Celebrex (D.A.C.)|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.04.2010||R|A||0|0|E|0|DAC|0|0|1|100|DKK|3004|4987|lyfalmen|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Celekoxíb||||3004|4987|31.05.2010 076871|G01AF0202|Canesten (D.A.C.)|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|6026|9121|lyfalmen|||0|12|0|2,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||6026||6026|9121| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1151|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1151| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1568|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1568| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|731|1877|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||731||731|1877| 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|881|1465|lyfalmen|V0609|1465|10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1465| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078318|L03AB0504|IntronA (D.A.C.)|stl|18|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009||R|K||0|1|0|1|DAC|0|0|0|100|DKK|27914|36915|lyfsjukr|||00|1|0|9,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||27914||27914|36915| 078330|L03AB0504|IntronA (D.A.C.)|stl|30|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009||R|K||0|1|0|1|DAC|0|0|0|100|DKK|45468|58945|lyfsjukr|||00|1|0|15,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||45468||45468|58945| 078341|L03AB0504|IntronA (D.A.C.)|stl|60|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009||R|K||0|1|0|1|DAC|0|0|0|100|DKK|93074|118690|lyfsjukr|||00|1|0|30,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||93074||93074|118690| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|520|1589|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||520||520|1589| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|792|1961|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||792||792|1961| 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|998|2201|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Flúoxetín||968||968|2201| 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6500|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6500|31.05.2010 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994|31.05.2010|R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|3315|5412|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Merck NM AB|Míanserín||3315||3315|5412| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|146700|185991|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||146700||146700|185991| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|9524|6339|lyfalmen|V0197|3872|00|98|0|98,0000|Icepharma hf|M.S.D.|Lósartan||3993||3993|6339| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2588|3735|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||2588||2588|3735| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4598|6636|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||4598||4598|6636| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|7737|11166|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||7737||7737|11166| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3589|5787|lyfalmen|||00|10|0|4,6700|Icepharma hf|Roche Registration Limited|Oseltamivír||3589||3589|5787| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|19758|27075|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough|Perfenazín||19758||19758|27075| 079357|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010|31.05.2010|L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|A||0|0|B|0|ACA|0|1|0|100|XEU|5716|7188|lyfalmen|V0915|7188|00|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||4613||4613|7188| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2218|3201|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2218||2218|3201| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1415|lyfalmen|V0514|1415|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1415| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1750|lyfalmen|V0518|1750|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1750| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1762|lyfalmen|V0522|1762|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1762| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2475|lyfalmen|V0526|2475|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2475| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|A||0|0|0|0|ANI|0|0|0|100|XEU|4291|8412|vetalmen|||27|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||4291||4291|8412| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2406|4169|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2406||2406|4169| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|6378|9602|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6378||6378|9602| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|3169|5212|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3169||3169|5212| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|32567|56812|vetorma|||27|500|0|0,0000|Vistor hf|Merial (MSD)|||32567||32567|56812| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|25735|34180|lyfsjukr|||00|1|0|0,0000|Vistor hf|Pfizer ApS|Ídarúbicín||25735||25735|34180| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|42759|55545|lyfsjukr|||00|1|0|0,0000|Vistor hf|Pfizer ApS|Ídarúbicín||42759||42759|55545| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|41989|54975|lyfalmen|||02|12|0|34,7222|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||41989||41989|54975| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2213|3194|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||2213||2213|3194| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|20931|28547|lyfalmen|V0813|28547|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||||20931|28547| 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|6063|9171|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6063||6063|9171| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10261|14914|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10261||10261|14914| 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3556|5742|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||||3556|5742| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3270|4855|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2908||2908|4855| 082701|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|686|1816|lyfalmen|||00|60|0|3,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||686||686|1816| 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5342|8185|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5342||5342|8185| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|1073|2345|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1073||1073|2345| 082842|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|1715|3223|lyfalmen|||00|200|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1715||1715|3223| 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5391|8252|lyfalmen|||00|100|0|6,2500|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5391||5391|8252| 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5924|8981|lyfalmen|||00|40|0|12,5000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5924||5924|8981| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14027|19883|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14027||14027|19883| 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|18777|25844|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||18777||18777|25844| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14649|20664|lyfalmen|V1372|20662|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14649||14649|20664| 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7533|11182|lyfalmen|||00|40|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7533||7533|11182| 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997|30.04.2010|R|A|2|0|1|E|0|MSE|0|0|0|100|SEK|53018|68817|lyfalmen|||03|10|0|10,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||53018||53018|68817| 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997|30.04.2010|R|A|2|0|1|E|0|MSE|0|0|0|100|SEK|107718|137465|lyfalmen|||03|10|0|20,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||107718||107718|137465| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|81864|104622|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||81864||81864|104622| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|31788|42173|lyfalmen|||00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||31788||31788|42173| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8678|12525|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8678||8678|12525| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|286|1268|lyfalmen|||02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||286||286|1268| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|553|1634|lyfalmen|||02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||553||553|1634| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|67694|86838|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||67694||67694|86838| 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2465|lyfalmen|||00|100|0|6,6667|Actavis Group hf|Actavis hf|Kínín||1161||1161|2465| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|88272|112664|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||88272||88272|112664| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|105244|133964|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||105244||105244|133964| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|22704|30376|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||22704||22704|30376| 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4240|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Kínín||2458||2458|4240| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|33974|44520|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||33974||33974|44520| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|45193|58600|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||45193||45193|58600| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|13473|18791|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13473|18791| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|51358|66337|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||51358|66337| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|158178|200396|lyfsjukr|||00|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||158178|200396| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1104|2387|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||1104||1104|2387| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|12760|18293|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||12760||12760|18293| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|42541|55668|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||42541||42541|55668| 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|16491|22975|lyfalmen|||10|100|0|100,0000|Vistor hf|Pfizer ApS|Morfín||16491||16491|22975| 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7497|lyfalmen|V2206|7497|0|98|0|49,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7497| 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4352|lyfalmen|V2170|4323|0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4352| 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|7074|lyfalmen|V2171|7074|0|98|0|98,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|7074| 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5379|lyfalmen|||0|28|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5379| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3235|5303|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||3235||3235|5303| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|31788|42173|lyfalmen|||00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||31788||31788|42173| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|804|1977|lyfalmen|||00|50|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||804||804|1977| 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|13953|19394|lyfsjukr|||00|4|0|40,0000|Vistor hf|Pfizer ApS|Dalteparín||13953||13953|19394| 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|21632|29427|lyfalmen|||00|375|0|12,5000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||21632||21632|29427| 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|38486|50579|lyfalmen|||00|750|0|25,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||38486||38486|50579| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|3982|lyfalmen|||00|10|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||2270||2270|3982| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5633|5733|lyfalmen|V1911|5226|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3550||3550|5733| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6774|8012|lyfalmen|V1913|7126|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5216||5216|8012| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8463|12214|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8463||8463|12214| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14712|20346|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14712||14712|20346| 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|62357|80141|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||62357||62357|80141| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|51196|66133|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|||||51196|66133| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3445|5590|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3445||3445|5590| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|Janssen-Cilag AB|Silíkonsambönd|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|171273|216830|lyfsjukr|||00|60|0|15,0000|Vistor hf|Pfizer Limited|Maravíroc||171273||171273|216830| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|303|1292|lyfalmen|||00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||303||303|1292| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|266|1241|lyfalmen|V0886|1225|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||266||266|1241| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|3150|5186|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||3150||3150|5186| 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||3485| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|MEC|0|0|0|100|SEK|858|2051|lyfalmen|||00|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||858||858|2051| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|13372|16989|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||11778||11778|16989| 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Lyfjaver ehf|Lyfjaver ehf|Nikótín|||||| 088033|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.09.2009|30.04.2010|L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|29104|38408|lyfsjukr|||00|1|0|9,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||29104||29104|38408| 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|47875|61966|lyfsjukr|||00|1|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||47875||47875|61966| 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|97995|124866|lyfsjukr|||00|1|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||97995||97995|124866| 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1401|2794|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1401||1401|2794| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1804|3345|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1804||1804|3345| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|8943|13111|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||8943||8943|13111| 088393|A03FA0101|Primperan|eþ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|553|1634|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||553||553|1634| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|172994|218990|lyfsjukr|||00|70|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||172994|218990| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|25326|34063|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||25326||25326|34063| 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||5572| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|171273|216830|lyfsjukr|||00|60|0|30,0000|Vistor hf|Pfizer Limited|Maravíroc||171273||171273|216830| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2211|3902|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2211||2211|3902| 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|XEU|43271|56188|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||43271||43271|56188| 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|XEU|216352|273404|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||216352||216352|273404| 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1845|3401|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1845||1845|3401| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|895|2102|lyfalmen|||00|60|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||895||895|2102| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2051|2539|lyfalmen|V0001|1929|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríð||1215||1215|2539| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3690|3512|lyfalmen|V0002|2539|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríð||1926||1926|3512| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4102|6489|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4102|6489| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7748|15050|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7748||7748|15050| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|8212|11034|lyfalmen|V1091|9194|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7425||7425|11034| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|10400|15104|lyfalmen|||00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||10400||10400|15104|31.03.2010 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|28064|37499|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||28064|37499| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|28064|37499|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||28064|37499| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|443|1483|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||443||443|1483| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|576|1665|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||576||576|1665| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|4095|5765|lyfalmen|V0718|5762|00|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||3573||3573|5765| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5550|8469|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5550||5550|8469| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|28023|48885|vetorma|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||28023||28023|48885| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|17228|23504|lyfsjukr|||00|5|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||17228||17228|23504| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|67999|87618|lyfalmen|V0565|87618|00|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||67999||67999|87618| 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|18770|25835|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||18770||18770|25835| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|25393|34147|lyfalmen|V0564|34147|00|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||25393||25393|34147| 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|48227|62804|lyfalmen|||10|98|0|261,3300|Icepharma hf|Norpharma |Oxýcódon||48227||48227|62804| 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998|30.04.2010|R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2220|3914|lyfalmen|||10|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2220||2220|3914| 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972|30.04.2010|R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4439|6950|lyfalmen|||10|100|0|66,6667|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4439||4439|6950| 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2777|4676|lyfalmen|V0385|4676|23|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2777||2777|4676| 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1888|3756|vetalmen|||00|8|0|0,0000|Vistor hf|Boehringer Ingelheim|||1888||1888|3756| 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13767|19557|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13767||13767|19557| 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|19721|27029|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19721||19721|27029| 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|88737|113644|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||88737||88737|113644| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|6841|11934|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6841||6841|11934| 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|42141|55166|lyfalmen|||0|84|0|14,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||42141||42141|55166| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3035|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráð lyf|||1577||1577|3035| 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3504|5671|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||3504||3504|5671| 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17446|24174|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17446||17446|24174| 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|42014|55007|lyfalmen|||00|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||42014||42014|55007| 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17446|24174|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17446||17446|24174| 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|38072|50059|lyfalmen|||00|56|0|56,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||38072||38072|50059| 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17446|24174|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17446||17446|24174| 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|67033|86405|lyfalmen|||00|56|0|84,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||67033||67033|86405| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3852|7569|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3852||3852|7569| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5083|9933|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5083||5083|9933| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9257|17947|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9257||9257|17947| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2807|4051|lyfsjukr|||02|60|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||2807||2807|4051| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|14481|20056|lyfsjukr|||17|10|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||14481||14481|20056| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|105876|134757|lyfsjukr|||17|100|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||105876||105876|134757| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1486|2910|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1486||1486|2910| 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17029|23650|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17029||17029|23650| 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|757|1895|lyfalmen|V1500|1895|07|5|0|0,0000|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||744||744|1895| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1025958|1289460|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||1025958|1289460| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|941995|1184086|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||941995|1184086| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|991267|1245923|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||991267|1245923| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|894075|1123947|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||894075||894075|1123947| 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17029|23650|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17029||17029|23650| 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1629|3106|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1629||1629|3106| 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|34059|45023|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||34059||34059|45023| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|93915|119746|lyfsjukr|||00|1|0|1,0000|Vistor hf|Pfizer Limited|Anidulafungin||93915||93915|119746| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|36188|38525|lyfsjukr|||00|10000|0|10,0000|Actavis Group hf|Braun|Hýdróxyetýl sterkja||29197||29197|38525| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2310|3973|lyfalmen|V0426|3973|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2263||2263|3973| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1176|2486|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1176||1176|2486| 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1|0,0000|Distica|Distica - óskráð lyf|||23026||23026|30780| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4791|4361|lyfalmen|V0003|3096|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríð||2547||2547|4361| 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4623|lyfalmen|V0831|4623|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4623| 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3500|lyfalmen|V0832|3500|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3500| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|1161|2465|lyfalmen|V1151|2465|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1161||1161|2465| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|7494|3872|lyfalmen|V2209|3872|00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||2189||2189|3872| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|11051|3915|lyfalmen|V2210|3915|00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||2221||2221|3915| 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|3353|5398|lyfalmen|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3305||3305|5398| 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|11160|15728|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||10856||10856|15728| 098486|G03GA3001|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA30|01.03.2009||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|13553|19288|lyfalmen|||0|1|0|0,0000|Icepharma hf|Serono Europe Ltd|||||13553|19288| 098504|G03GA3001|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA30|01.03.2009||R|A|3|0|1|E|0|SEU|0|0|0|100|SEK|125723|160061|lyfalmen|||0|1|0|0,0000|Icepharma hf|Serono Europe Ltd|||||125723|160061| 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2500|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráð lyf|||1186||1186|2500| 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21402|29139|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||21402||21402|29139| 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|757|1913|lyfalmen|V1500|1895|07|5|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||757||757|1913| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|6029|9125|lyfalmen|V0725|9125|00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||6029||6029|9125| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|13768|19558|lyfalmen|V0726|19558|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||13768||13768|19558| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|22280|30240|lyfalmen|V0727|30240|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||22280||22280|30240| 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|628|1665|lyfalmen|||10|20|0|3,3333|D.A.C. ehf|D.A.C. ehf|Tramadól||576||576|1665|30.04.2010 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|50501|65261|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||50501||50501|65261| 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|74756|95701|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||74756||74756|95701| 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|54682|70508|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||54682||54682|70508| 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|121413|154256|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||121413||121413|154256| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13880|19698|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13880|19698| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13880|19698|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13880|19698| 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|MSE|0|0|0|100|SEK|14602|20605|lyfalmen|||00|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Lutropin alfa||14602||14602|20605| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18155|25064|lyfalmen|V2160|25062|0|100|0|33,3300|Vistor hf|Pfizer ApS|Gabapentín||18155||18155|25064| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|30603|40686|lyfalmen|||0|100|0|44,4400|Vistor hf|Pfizer ApS|Gabapentín||30603||30603|40686| 101386|R06AX1301|Clarityn|saft|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995|30.04.2010|L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|MSE|0|0|0|100|SEK|43804|57253|lyfalmen|||00|3|0|3,0000|Icepharma hf|Merck Serono Europe Ltd|Lutropin alfa||43804||43804|57253| 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|MSE|0|0|0|100|SEK|146017|185530|lyfalmen|||00|10|0|10,0000|Icepharma hf|Merck Serono Europe Ltd|Lutropin alfa||146017||146017|185530| 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2180|3859|lyfalmen|||00|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2180||2180|3859| 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|6839|10233|lyfalmen|||00|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6839||6839|10233| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|2548|4363|lyfalmen|V1152|4363|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2548||2548|4363| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|4466|6902|lyfalmen|V1153|6902|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4404||4404|6902| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9314|13074|lyfalmen|V0736|8985|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||8916||8916|13074| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|11647|22537|vetalmen|||0|250|0|0,0000|Vistor hf|Boehringer Ingelheim|||||11647|22537| 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989|31.03.2010|R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1607|3076|lyfalmen|||43|28|0|42,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1607||1607|3076| 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3635|5850|lyfalmen|V0139|2798|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3635||3635|5850| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|2536|3660|lyfsjukr|||02|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||2536||2536|3660| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|5263|7596|lyfsjukr|||00|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||5263||5263|7596| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|IKR|8135|5241|lyfalmen|V2219|5241|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||3190||3190|5241| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|IKR|13469|5241|lyfalmen|||00|98|0|196,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||3190||3190|5241|31.05.2010 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|4295|3873|lyfalmen|V0197|3872|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||2190||2190|3873| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2594|3454|lyfalmen|V0507|3145|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1884||1884|3454| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|10785|12216|lyfalmen|V0508|11669|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||8289||8289|12216| 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|IKR|14730|7580|lyfalmen|V0955|7580|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||4900||4900|7580| 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|IKR|28034|7580|lyfalmen|V0956|7580|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||4900||4900|7580| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1861| 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|21403|28743|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||||21403|28743| 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|0|0|DAC|0|1|0|100|DKK|8463|10127|lyfalmen|||00|98|0|98,0000|D.A.C. ehf|D.A.C. ehf|Sertralín||6762||6762|10127|30.04.2010 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3928|6251|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3928||3928|6251| 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2284|4002|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2284||2284|4002| 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8758|12858|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8758||8758|12858| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5751|8744|lyfalmen|||56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5751||5751|8744| 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5566|8491|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5566||5566|8491| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4284|6738|lyfalmen|V0084|6738|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4284||4284|6738| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|14741|20779|lyfalmen|V0087|20779|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||14741||14741|20779| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|20565|28088|lyfalmen|V0089|28088|00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||20565||20565|28088| 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1170|2478|lyfalmen|V2200|2478|23|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1170||1170|2478| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4177|6591|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4177||4177|6591| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14519|20500|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14519||14519|20500| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4814|7463|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4814||4814|7463| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16746|23295|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||16746||16746|23295| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2565|4386|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2565||2565|4386| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2794|4699|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2794||2794|4699| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3528|5703|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3528||3528|5703| 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1598|lyfalmen|V0167|1598|0|100|0|50,0000|Portfarma ehf|Portfarma|Enalapríl||527||527|1598| 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2078|lyfalmen|V0168|2078|0|100|0|100,0000|Portfarma ehf|Portfarma|Enalapríl||878||878|2078| 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|2374|lyfalmen|V0169|2374|0|100|0|200,0000|Portfarma ehf|Portfarma|Enalapríl||1094||1094|2374| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|19067|25812|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19067||19067|25812| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10544|15115|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10544||10544|15115| 107050|A10BD0401|Avaglim|filmhtfl|8|mg|84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008|30.04.2010|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15249|21417|lyfalmen|||00|84|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||15249||15249|21417| 107061|A10BD0401|Avaglim|filmhtfl|12|mg|84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008|30.04.2010|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|22958|31091|lyfalmen|||00|84|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||22958||22958|31091| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1892|3465|lyfalmen|||10|100|0|25,0000|Vistor hf|Pfizer ApS|Súlfasalazín||1892||1892|3465| 107532|N02BE0106|Parasupp|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis hf|Paracetamól|||||| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|1629|2842|vetorma|||16|6|0|0,0000|Dýraheilsa/Icevet ehf|Icevet ehf|||||1629|2842| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|982|2221|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||982||982|2221| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|3347|5456|lyfalmen|||63|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3347||3347|5456| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3487|5647|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3487||3487|5647| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|10350|15036|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10350||10350|15036| 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1143|2441|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1143||1143|2441| 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1738|3255|lyfalmen|V0108|3207|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1738||1738|3255| 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1278|lyfalmen|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Tramadól||293||293|1278|30.04.2010 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1567|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Tramadól||504||504|1567|31.03.2010 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|255|1226|lyfalmen|V0775|1214|00|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||255||255|1226| 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|974|2210|lyfalmen|V0780|2188|00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||974||974|2210| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25658|34480|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||25658||25658|34480| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20541|28058|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||20541||20541|28058| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7975|11787|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7975||7975|11787| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1396|lyfalmen|V0772|1396|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||379||379|1396| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|675|1801|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||675||675|1801| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|753|1907|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||753||753|1907| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1627|3103|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1627||1627|3103| 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4767|7398|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4767||4767|7398| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|792|1961|lyfalmen|||00|100|0|33,3300|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||792||792|1961| 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|852|2043|lyfalmen|||06|5|0|0,0000|Vistor hf|Schering-Plough|Gentamícín||852||852|2043| 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4169|6580|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4169||4169|6580| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8678|5762|lyfalmen|V0718|5762|00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||3571||3571|5762| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|10195|14823|lyfalmen|||00|60|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||10195|14823| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|28064|37499|lyfalmen|||00|180|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||28064|37499| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|10195|14823|lyfalmen|||00|60|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||10195|14823| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4031|6391|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4031||4031|6391| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|28064|37499|lyfalmen|||00|180|0|0,0000|Vistor hf|Novartis Europharm Ltd|||||28064|37499| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6973|10416|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6973||6973|10416| 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|41839|54390|lyfsjukr|||00|20|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||41839||41839|54390| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|778237|978570|lyfsjukr|||00|112|0|0,0000|Vistor hf|Novartis Europharm Ltd|Nilotiníb||778237||778237|978570| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|699|1833|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||699||699|1833| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|888|2092|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||888||888|2092| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1354|2729|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1354||1354|2729| 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|808|1983|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||808||808|1983| 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008|31.05.2010|R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|2619|lyfalmen|||00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1273||1273|2619| 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008|31.05.2010|R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|1717|lyfalmen|||00|60|0|60,0000|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||614||614|1717| 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008|31.05.2010|R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1082|lyfalmen|||00|20|0|20,0000|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||150||150|1082| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|XEU|4358|6839|lyfalmen|||00|28|0|14,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4358||4358|6839| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2486|4278|lyfalmen|||06|5|0|0,0000|Icepharma hf|M.S.D.|Tímólól í blöndum||2486||2486|4278| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3728|5977|lyfalmen|||0|750|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3728||3728|5977| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1971|3573|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1971||1971|3573| 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11175|16164|lyfalmen|||0|2250|0|10,2300|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11175||11175|16164| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|22351|30330|lyfalmen|||0|4500|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||22351||22351|30330| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3728|5977|lyfalmen|||0|1100|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3728||3728|5977| 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11175|16164|lyfalmen|||0|3300|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11175||11175|16164| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|22351|30330|lyfalmen|||0|6600|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||22351||22351|30330| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2027|3650|lyfalmen|||06|5|0|16,6667|Icepharma hf|M.S.D.|Dorzólamíð||2027||2027|3650| 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3731|5981|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3731||3731|5981| 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3804|5490|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3804||3804|5490| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1988|2869|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1988||1988|2869| 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10,0000|Icepharma hf|Galderma Nordic AB||||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3165|5207|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3165|5207| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3165|5207|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3165|5207| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|835|2019|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||835||835|2019| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|468|1517|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||468||468|1517| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1083|2359|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||1083||1083|2359| 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|19254|26443|lyfalmen|||00|84|0|84,0000|Vistor hf|Pfizer Limited|||||19254|26443| 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6814|10198|lyfalmen|||00|28|0|28,0000|Vistor hf|Pfizer Limited|||||6814|10198| 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7238|10778|lyfalmen|||00|28|0|56,0000|Vistor hf|Pfizer Limited|||||7238|10778| 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|21808|29648|lyfalmen|||00|84|0|168,0000|Vistor hf|Pfizer Limited|||||21808|29648| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|8724|12811|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8724||8724|12811| 116985|N06AX1607|Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|0|0|DAC|0|1|0|100|USD|13350|19033|lyfalmen|V0955|7428|00|98|0|73,5000|D.A.C. ehf|D.A.C. ehf|Venlafaxín||13350||13350|19033| 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|36164|47665|lyfalmen|V1702|47665|00|56|0|37,3330|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||36164||36164|47665| 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|35919|47357|lyfalmen|V1703|47357|00|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||35919||35919|47357| 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10881|21066|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||10881||10881|21066| 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|9292|13588|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||9292||9292|13588| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6168|9315|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||6168||6168|9315| 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14402|20354|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14402|20354| 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|25454|34224|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||25454|34224| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2543|4356|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2543||2543|4356| 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4401|6898|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4401|6898| 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|44014|57517|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||44014|57517| 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|50909|66170|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||50909|66170| 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB||||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10274|17922|vetorma|||00|250|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||10274||10274|17922| 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|3067|5073|lyfalmen|||61|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3067||3067|5073| 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|5396|8259|lyfalmen|||61|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5396||5396|8259| 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|8773|12878|lyfalmen|||61|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8773||8773|12878| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7601|14768|vetalmen|||00|1200|0|0,0000|Icepharma hf|Kela Laboratoria NV|||7601||7601|14768| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|13331|25770|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||13331||13331|25770| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4220|4385|lyfalmen|V0809|4385|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2564||2564|4385| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5998|5476|lyfalmen|V0810|5476|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3362||3362|5476| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|23263|20441|lyfalmen|V0812|20441|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||14472||14472|20441| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17772|15999|lyfalmen|V0815|15999|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11054||11054|15999| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1802|3342|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1802||1802|3342| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118315|M01AB0505|Voltaren|eþ-stíll|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|752|1906|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||752||752|1906| 118323|M01AB0505|Voltaren|eþ-stíll|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7537|11187|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||7537||7537|11187| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2330|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2330| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18289|16436|lyfalmen|V0811|16436|00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11374||11374|16436| 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|9716|14168|lyfalmen|||00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9716||9716|14168| 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|28578|38144|lyfalmen|||00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||28578||28578|38144| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3131|5160|lyfalmen|V1401|5160|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3131||3131|5160| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9817|14306|lyfalmen|V1400|14306|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9817||9817|14306| 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|88827|113360|lyfsjukr|||00|5|0|0,0000|Vistor hf|Amgen Europe B.V.|Panitúmúmab||88827||88827|113360| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|495950|624696|lyfalmen|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||||495950|624696| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|495950|624696|lyfalmen|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||||495950|624696| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1038|2297|lyfalmen|||06|10|0|0,0000|K.Pétursson hf|Alcon|Cýklópentólat||1038||1038|2297| 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|49683|64235|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||49683|64235| 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|12756|18288|lyfalmen|V1370|18288|00|28|0|14,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||12756||12756|18288| 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|41859|54812|lyfalmen|||00|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||41859||41859|54812|30.04.2010 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|0|0|LVR|0|1|0|100|DKK|3303|5396|lyfalmen|V0939|4044|00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3303||3303|5396| 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|0|0|LVR|0|1|0|100|NOK|24385|32882|lyfalmen|||00|200|0|200,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||24385||24385|32882| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|18841|25925|lyfalmen|V1710|25925|00|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||18841|25925| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5889|8933|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||5889|8933| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|8558|12351|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||8558||8558|12351| 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|367|1379|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||367||367|1379| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|416|1446|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||416||416|1446| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2118|3775|lyfalmen|||00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2118||2118|3775| 121863|A07EC0204|Asacol|eþ-stíll|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3640|5857|lyfalmen|||98|30|0|10,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3640||3640|5857| 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|583|1675|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||583||583|1675| 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|909|2121|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||909||909|2121| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|DKK|2249|3954|lyfalmen|||00|100|1|40,0000|Parlogis hf|Parlogis - óskráð lyf|||2249||2249|3954| 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|25617|34428|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Alpharma ApS|Vankómýcín||||25617|34428| 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978|30.04.2010|R|A|5|0|0|B|0|GSK|0|0|0|100|XEU|437|1475|lyfalmen|||00|100|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||437||437|1475| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|47183|61494|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||47183||47183|61494| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|1924|3827|vetalmen|||00|42|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals|||||1924|3827| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|39382|51703|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||39382|51703| 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1242|2576|lyfalmen|||00|20|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|||1242||1242|2576| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1057|2323|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1057||1057|2323| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|612|1714|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||612||612|1714| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|878|2078|lyfalmen|V0168|2078|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||878||878|2078| 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|1961|3560|lyfalmen|V0144|3560|0|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1961||1961|3560| 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A||0|0|*|0|DAC|0|1|0|100|DKK|18513|25513|lyfalmen|V1701|25513|00|28|0|9,3330|D.A.C. ehf|D.A.C. ehf|Aripiprazól||18513||18513|25513| 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14213|20116|lyfalmen|V1732|20116|00|100|0|11,1100|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14213||14213|20116| 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14063|19928|lyfalmen|V1730|19928|00|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14063||14063|19928| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|15364|21561|lyfalmen|V1731|21561|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15364||15364|21561| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|Janssen-Cilag AB|Lóperamíð|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|115656|147031|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||115656|147031| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|29681|39132|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||29681|39132| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|26783|35495|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||26783||26783|35495| 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|3045|5043|lyfalmen|||00|56|0|56,0000|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||3045||3045|5043| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8927|12884|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8927||8927|12884| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|47907|62006|lyfsjukr|||00|50|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||47907||47907|62006| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|95814|122129|lyfsjukr|||00|100|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||95814||95814|122129| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|191628|242376|lyfsjukr|||00|200|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||191628||191628|242376| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1181|2493|lyfalmen|||10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||1181||1181|2493| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9206|6393|lyfalmen|V0810|5476|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4032||4032|6393| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6410|12481|vetalmen|||0|30|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||||6410|12481| 128173|C08DA0108|Verapamil Mylan|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|538|1613|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Verapamíl||538||538|1613| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1302|2658|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1302||1302|2658| 128777|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4663|6730|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||4663||4663|6730| 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31092|19407|lyfalmen|V0811|16436|00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13648||13648|19407| 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|36073|24073|lyfalmen|V0812|20441|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||17366||17366|24073| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0,0000|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3047| 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4934|7627|lyfalmen|||00|120|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4934||4934|7627| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|18017|22010|lyfalmen|V0726|19558|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||15722||15722|22010| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|28520|33516|lyfalmen|V0727|30240|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||24890||24890|33516| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2268|3980|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2268|3980| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4224|6655|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4224||4224|6655| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2362|4108|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2362|4108| 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12021|17365|lyfalmen|||0|53|0|20,6700|Vistor hf|Pfizer Limited|Vareniclin||||12021|17365| 130772|QI10A0001|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|66615|116207|vetorma|||0|500|0|0,0000|Vistor hf|PHARMAQ AS|||||66615|116207| 131136|R03CA0202|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||R03CA02|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3246|5318|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3246|5318| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|458|1504|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||458||458|1504| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|878|2078|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||878||878|2078| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|961|2192|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||961||961|2192| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1064|2333|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1064||1064|2333| 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6413|9650|lyfalmen|||23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||6413||6413|9650| 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|8729|12818|lyfalmen|||0|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||8729|12818| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|26188|35145|lyfalmen|||0|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||26188|35145| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|87293|111832|lyfalmen|||0|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||87293|111832| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|259|1151|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||200||200|1151| 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|270|1247|lyfalmen|||00|28|0|9,3300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||270||270|1247| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|IKR|14144|5166|lyfalmen|||00|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3135||3135|5166|30.04.2010 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|IKR|9789|5052|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3052||3052|5052|30.04.2010 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1689|3188|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1689||1689|3188| 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8663|12728|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||8663|12728| 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||23|8|0|8,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1183|2496|lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Proxýmetakaín||1183||1183|2496| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1340|2710|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1340||1340|2710| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|38343|50003|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||38343|50003| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|42839|55645|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||42839|55645| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|47598|61618|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||47598|61618| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|9478|13843|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||9478||9478|13843| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|115816|147232|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||115816||115816|147232| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2505|4304|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2505||2505|4304| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4219|6649|lyfalmen|||00|9|0||Icepharma hf|Santen Oy|Taflúprost||4219||4219|6649| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|12646|18150|lyfalmen|||00|27|0||Icepharma hf|Santen Oy|Taflúprost||12646||12646|18150| 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2688|3879|lyfsjukr|||0|5|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||2688|3879| 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4017|5798|lyfsjukr|||0|10|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||4017|5798| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4983|7192|lyfsjukr|||0|25|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||4983||4983|7192| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|92386|117827|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||92386||92386|117827| 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|145128|184018|lyfsjukr|||00|30|0|0,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||145128||145128|184018| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|55855|71981|lyfsjukr|||00|12|0|17,9910|Vistor hf|Pfizer ApS|Sómatrópín||55855||55855|71981| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|1067|2337|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1067||1067|2337| 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2289|4008|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2289||2289|4008| 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1771|3300|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1771||1771|3300| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|7135|10638|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||7135||7135|10638| 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|117173|148935|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||117173||117173|148935| 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|86766|110774|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||86766||86766|110774| 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18838|25524|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||18838|25524| 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|37944|49502|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||37944|49502| 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|93150|118786|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||93150|118786| 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17591|23959|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Mayne Pharma Plc|Paklítaxel||17591||17591|23959| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1612| 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||2011| 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|150830|191174|lyfsjukr|||00|0|0|0,0000|Vistor hf|Novartis Europharm Ltd|Ranibizumab||150830||150830|191174| 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4596|7164|lyfalmen|||10|100|0|100,0000|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4596||4596|7164| 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|32997|43294|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||32997||32997|43294| 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|13608|18961|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||13608||13608|18961| 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|17838|24269|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||17838||17838|24269| 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|6094|8795|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6094||6094|8795| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|557|804|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||557||557|804| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1593|2299|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1593||1593|2299| 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2119|3776|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||2119||2119|3776| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2250|3955|lyfalmen|||00|30|0|60,0000|Icepharma hf|Santen Oy|Tímólól||2250||2250|3955| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3150|5186|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3150||3150|5186| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|179743|227460|lyfsjukr|||00|20|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||||179743|227460| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|449360|565829|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||||449360|565829| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1792|3329|lyfalmen|V2010|2383|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1792||1792|3329| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|14858|20529|lyfsjukr|||02|10|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||14858||14858|20529| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|670|967|lyfsjukr|||02|5|0|3,3333|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||670||670|967| 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1418|2817|lyfalmen|||03|2|0|4,0000|Vistor hf|Pfizer ApS|Metýlprednisólón||1418||1418|2817| 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3539|5718|lyfalmen|V2002|5718|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Blöndur||3539||3539|5718| 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1428|2831|lyfalmen|||08|80|0|0,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1428||1428|2831| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9351|13496|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||9351||9351|13496| 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14686|20710|lyfalmen|||00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||14686||14686|20710|30.04.2010 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|23339|31173|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||23339||23339|31173| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3465|5617|lyfalmen|||00|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||3465||3465|5617| 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4722|5878|lyfalmen|||0|84|0|0,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3656||3656|5878| 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|688|1818|lyfalmen|||00|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||688|1818| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9051|13259|lyfalmen|V2020|9523|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||9051||9051|13259| 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|511|1576|lyfalmen|||00|100|0|6,2500|Actavis Group PTC ehf|Merck NM AB|Própranólól||511||511|1576| 142190|C07AA0511|Propranolol Mylan|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|656|1775|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||656||656|1775| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3381|4880|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3381||3381|4880| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1154|2456|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1154||1154|2456| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2790|4694|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2790||2790|4694| 142596|C07AA0511|Propranolol Mylan|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|908|2119|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||908||908|2119| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2160|3832|lyfalmen|||03|1|0|6,2500|Vistor hf|Pfizer ApS|Metýlprednisólón||2160||2160|3832| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2385|3442|lyfsjukr|||03|1|0|25,0000|Vistor hf|Pfizer ApS|Metýlprednisólón||2385||2385|3442| 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|768|1928|lyfalmen|||07|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Prednisólón||768||768|1928| 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|DKK|1320|2683|lyfalmen|||00|30|1|0,0000|Distica|Distica - óskráð lyf|||1320||1320|2683| 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3534|5712|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3534||3534|5712| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|977|2214|lyfalmen|||06|15|0|0,0000|K.Pétursson hf|Alcon|Trópíkamíð||977||977|2214| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1832|3383|lyfalmen|||00|2|0|3,3333|Vistor hf|Pfizer ApS|Azitrómýcín||1832||1832|3383| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2345|4085|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||2345||2345|4085| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|9119|13352|lyfalmen|||0|56|0|0,0000|Icepharma hf|M.S.D.|Metforminum og sitagliptinum||||9119|13352| 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|10457|6513|lyfalmen|||00|98|0|98,0000|D.A.C. ehf|D.A.C. ehf|Cítalópram||4120||4120|6513|31.03.2010 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|968|2201|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||968||968|2201| 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1265|2608|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1265||1265|2608| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2659|4515|lyfalmen|V0429|4441|00|3|0|5,0000|Vistor hf|Pfizer ApS|Azitrómýcín||2659||2659|4515| 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4440|6408|lyfsjukr|||02|5|0|0,0000|Vistor hf|Pfizer ApS|Epírúbicín||4440||4440|6408| 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8533|12315|lyfsjukr|||02|10|0|0,0000|Vistor hf|Pfizer ApS|Epírúbicín||8533||8533|12315| 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2704|4576|lyfalmen|||10|100|0|16,6667|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2704||2704|4576| 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4997|7713|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4997||4997|7713| 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15010|20720|lyfsjukr|||02|25|0|0,0000|Vistor hf|Pfizer ApS|Epírúbicín||15010||15010|20720| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|84803|108310|lyfsjukr|||AC|2|0|22,4888|Vistor hf|Novo-Nordisk|Sómatrópín||84803||84803|108310| 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009|30.04.2010|L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|63381|81426|lyfsjukr|||AC|2|0|15,0675|Vistor hf|Novo-Nordisk|Sómatrópín||63381||63381|81426| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|41210|53601|lyfsjukr|||AC|2|0|7,4213|Vistor hf|Novo-Nordisk|Sómatrópín||41210||41210|53601| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|945|2170|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||945||945|2170| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|439|1478|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||439||439|1478| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|759|1916|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||759||759|1916| 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3345|5453|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3345||3345|5453| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5192|7980|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||5192||5192|7980| 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|18787|12754|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||8682||8682|12754| 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|10928|15597|lyfsjukr|||0|2|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||||10928|15597| 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|6486|9361|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||6486||6486|9361| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|19011|26138|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||19011||19011|26138| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|902|2111|lyfalmen|||41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||902||902|2111| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|5075|7324|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||5075|7324| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4281|6179|lyfsjukr|||0|10|0|0,0000|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4281|6179| 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|14211|19717|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14211||14211|19717| 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|22717|30392|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||22717||22717|30392| 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|118876|151468|lyfalmen|||00|750|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||118876||118876|151468| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1116|2404|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1116||1116|2404| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|8208|11846|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||8208||8208|11846| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|12846|18004|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||12846||12846|18004| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|24772|32971|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||24772||24772|32971| 148961|N06DA0203|Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|50711|65921|lyfalmen|V0376|45478|00|98|0|130,6700|D.A.C. ehf|D.A.C. ehf|Dónepezíl||50711||50711|65921| 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|14884|5084|lyfalmen|||00|98|0|196,0000|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||3075||3075|5084|30.04.2010 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3828|7523|vetalmen|||27|25|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3828||3828|7523| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|2045|0|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráð lyf|Pímózíð||0||0|0| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2155|3825|lyfalmen|V1989|3810|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||2155||2155|3825| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|16615|23131|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16615||16615|23131| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|3984|6327|lyfalmen|||00|28|0||Icepharma hf|M.S.D.|||||3984|6327| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|6608|9917|lyfalmen|||00|56|0||Icepharma hf|M.S.D.|||||6608|9917| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3712|5955|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3712|5955| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7557|11215|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7557||7557|11215| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1216|2541|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1216||1216|2541| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|16806|23371|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16806|23371| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|51892|67404|lyfalmen|||00|28|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||51892|67404| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|7068|5322|lyfalmen|V0437|5191|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||3249||3249|5322| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1694|3195|lyfalmen|||10|100|0|25,0000|Vistor hf|Pfizer ApS|Doxepín||1694||1694|3195| 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1168|2475|lyfalmen|||10|100|0|10,0000|Vistor hf|Pfizer ApS|Doxepín||1168||1168|2475| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|737|1064|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||737||737|1064| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0,0000|Vistor hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4410|6910|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4410||4410|6910| 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6599|9904|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6599||6599|9904| 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|11427|16509|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||11427||11427|16509| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1855|3415|lyfalmen|||10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1855||1855|3415| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1737|3253|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||1737||1737|3253| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2248|3952|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2248||2248|3952| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1551|2999|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||1551||1551|2999| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2189|3872|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2189||2189|3872| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|241515|304984|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||241515||241515|304984| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6217|9382|lyfalmen|||10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6217||6217|9382| 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|K|2|0|0|E|0|HEX|0|0|1|100|DKK|9011|13204|lyfalmen|||02|5|0|250,0000|Vistor hf|Hexal A/S|Hýdroxókóbalamín||9011||9011|13204| 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|1713|3221|lyfalmen|||02|1|0|50,0000|Vistor hf|Hexal A/S|Hýdroxókóbalamín||1713||1713|3221| 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998|30.04.2010|R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4157|lyfsjukr|||00|1|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4157| 154464|D05AX5203|Xamiol|hlaup|||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4963|7666|lyfalmen|||00|30|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||4963|7666| 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|9504|13878|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||9504|13878| 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6601|9907|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6601||6601|9907| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1422|2822|lyfalmen|||10|20|0|10,0000|Vistor hf|Pfizer ApS|Díklófenaknatríum í blöndum||1422||1422|2822| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5153|7926|lyfalmen|V2130|7925|10|100|0|50,0000|Vistor hf|Pfizer ApS|Díklófenaknatríum í blöndum||5153||5153|7926| 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2097|3746|lyfalmen|V0954|3746|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||2097|3746| 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7610|11287|lyfalmen|V0438|9000|00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7610||7610|11287| 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|8505|8788|lyfalmen|V0955|7428|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||5783||5783|8788| 154750|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|3628|5840|lyfalmen|V0957|5840|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3628|5840| 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|14073|13770|lyfalmen|V0956|7428|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||9425||9425|13770| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|XEU|1659|3147|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1659||1659|3147| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|SEK|3157|5196|lyfalmen|V0709|5196|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||||3157|5196| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|SEK|5129|7893|lyfalmen|V0710|7893|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||||5129|7893| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|SEK|9272|13561|lyfalmen|V0711|13561|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||||9272|13561| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1775|3305|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1775||1775|3305| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|550|1630|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||550||550|1630| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|11762|16967|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||11762||11762|16967| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6677|10011|lyfalmen|||00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6677||6677|10011| 156563|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|18092|24588|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||18092||18092|24588| 156574|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|6142|8864|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||6142||6142|8864| 156585|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|20091|27097|lyfsjukr|||00|45|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||20091||20091|27097| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|8894|13044|lyfalmen|||00|84|0|28,0000|Icepharma hf|Roche|Orlístat||8894||8894|13044| 156597|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|37349|48755|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||37349||37349|48755| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|921|2137|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||921||921|2137| 156964|N07BA0137|Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2,5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 156986|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 156997|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157020|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157031|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7698|13429|vetorma|||16|260|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7698||7698|13429| 157419|N07BA0134|Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157430|N07BA0140|Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2,5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157463|N07BA0134|Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|524|1594|lyfalmen|||07|4|1|0,0000|Distica|Distica - óskráð lyf|||524||524|1594| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1609|3078|lyfalmen|||00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1609||1609|3078| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1063|2331|lyfalmen|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1063||1063|2331| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|109213|138945|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||109213|138945| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|218427|276008|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||218427|276008| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|619345|779160|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||619345|779160| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|55781|71888|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|||||55781|71888| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|79574|101748|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|||79574||79574|101748| 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1183|2496|lyfalmen|||23|5|0|13,3333|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1183||1183|2496| 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1000|2245|lyfalmen|V0608|2245|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1000|2245| 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2360|3806|lyfalmen|V2003|3099|00|98|0|31,0300|D.A.C. ehf|D.A.C. ehf|Metóprólól||2141||2141|3806| 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3706|5947|lyfalmen|V1050|5947|00|5|0|20,8333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3706|5947| 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7136|10639|lyfalmen|V1051|10639|00|5|0|41,6667|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||7136|10639| 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|9986|14538|lyfalmen|V1052|14538|00|5|0|62,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||9986|14538| 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12004|17344|lyfalmen|V1053|17344|00|5|0|83,3333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||12004|17344| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|6860|4772|lyfalmen|||00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2847||2847|4772| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|27161|36366|lyfalmen|||00|30|0|30,0000|Vistor hf|Pfizer ApS|Exemestan||27161||27161|36366| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|14042|12892|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8783||8783|12892| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|1985|2634|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1284||1284|2634| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|3437|3751|lyfalmen|V0923|2062|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2101||2101|3751| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|7083|5032|lyfalmen|V0927|2062|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3037||3037|5032| 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|482|1537|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||482||482|1537| 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1555|3004|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1555||1555|3004| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|179437|227076|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||179437||179437|227076| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2401|3465|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2401||2401|3465| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|85972|109777|lyfsjukr|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||85972||85972|109777| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|108634|138218|lyfsjukr|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||108634||108634|138218| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1029|2285|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1029||1029|2285| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2500|4297|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2500||2500|4297| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|171942|217670|lyfsjukr|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||171942||171942|217670| 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|378|1394|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||378|1394| 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1493|2920|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1493||1493|2920| 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|401|1426|lyfalmen|||14|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||401||401|1426| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|88304|112704|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|||||88304|112704| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|809|1984|lyfalmen|||03|1|0|2,0000|Vistor hf|Pfizer ApS|Metýlprednisólón||809||809|1984| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1894|2734|lyfsjukr|||03|1|0|8,3333|Vistor hf|Pfizer ApS|Hýdrókortisón||1894||1894|2734| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1199|1730|lyfsjukr|||03|5|0|16,6667|Vistor hf|Pfizer ApS|Hýdrókortisón||1199||1199|1730| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|742|1892|lyfalmen|||03|1|0|3,3333|Vistor hf|Pfizer ApS|Hýdrókortisón||742||742|1892| 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5709|8687|lyfalmen|||23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5709||5709|8687| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|63754|82290|lyfalmen|||00|100|0|100,0000|Vistor hf|Pfizer ApS|Exemestan||63754||63754|82290| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|DKK|3239|4675|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||3239||3239|4675| 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120,0000|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|DKK|6362|9182|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||6362||6362|9182| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|DKK|20091|27097|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||20091||20091|27097| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2502|4300|lyfalmen|||00|100|0|25,0000|Vistor hf|Pfizer ApS|Súlfasalazín||2502||2502|4300| 162929|G04CA0205|Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|5022|5768|lyfalmen|V0437|5768|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||3575||3575|5768| 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2289|4008|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2289||2289|4008| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1211|2534|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1211||1211|2534| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1985|3593|lyfalmen|||41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1985||1985|3593| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|214|1170|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíð||||214|1170| 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3050|4855|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2908||2908|4855| 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12012|lyfalmen|||00|454|1|0,0000|Distica|Distica - óskráð lyf|||8140||8140|12012| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|XEU|3656|5878|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||3656||3656|5878| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1,5|0|0|E|0|MYL|0|0|0|100|SEK|2919|4870|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||2919|4870| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|9624|14042|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||9624||9624|14042| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|929|2148|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||929|2148| 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7130|10631|lyfalmen|V0299|10631|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7130||7130|10631| 165001|C05AA0102|Proctosedyl|eþ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5658|8617|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5658||5658|8617| 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4939|7634|lyfalmen|V0324|3967|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4939||4939|7634| 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3188|5238|lyfalmen|V0316|2821|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3188||3188|5238| 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|15262|21433|lyfalmen|||23|4|0|15,0000|Vistor hf|Pfizer ApS|Nafarelín||15262||15262|21433| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|1005|2252|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||1005||1005|2252| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|356|1364|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||356||356|1364| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|372292|469109|lyfsjukr|||00|500|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||372292||372292|469109| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|4955|9687|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||4955|9687| 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2620|4461|lyfalmen|||10|100|0|100,0000|Vistor hf|Schering-Plough|Dexklórfeníramín||2620||2620|4461| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1043|2304|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1043||1043|2304| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2730|4612|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2730||2730|4612| 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16089|22471|lyfalmen|||23|8|0|30,0000|Vistor hf|Pfizer ApS|Nafarelín||16089||16089|22471| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2163|3836|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2163||2163|3836| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|4095|6479|lyfalmen|||10|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4095||4095|6479| 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|10452|9000|lyfalmen|V0438|9000|00|90|0|120,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||5938||5938|9000| 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996|31.05.2010|R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|29990|39520|lyfsjukr|||00|1|0|1,4286|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||29990||29990|39520| 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996|31.05.2010|R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|59978|77155|lyfsjukr|||00|1|0|2,8571|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||59978||59978|77155| 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|525|1595|lyfalmen|V0953|1595|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||525|1595| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|637|1749|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||637|1749| 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|XEU|5230|6662|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4229||4229|6662| 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1212|2535|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1212||1212|2535| 168739|C07AB0209|Metoprolol Actavis|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.12.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2135|3798|lyfalmen|V0091|3798|00|100|0|15,8300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||||2135|3798| 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3232|5298|lyfalmen|V0789|5297|10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3232||3232|5298| 168750|C07AB0209|Metoprolol Actavis|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1804|3099|lyfalmen|V2003|3099|00|98|0|31,0300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1624||1624|3099| 168761|C07AB0209|Metoprolol Actavis|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2832|4400|lyfalmen|V2004|4400|00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2575||2575|4400| 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1269|2613|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1269||1269|2613| 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5965|9037|lyfalmen|V0713|9036|10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5965||5965|9037| 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|53069|68484|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||53069||53069|68484| 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|228647|288834|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||228647||228647|288834| 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2929|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráð lyf|Prógvaníl||1500||1500|2929| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|25687|34120|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||25687||25687|34120| 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5700|8675|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5700||5700|8675| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2725|lyfalmen|||67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2725|31.05.2010 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4095|lyfalmen|||67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4095| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2475|lyfalmen|V0526|2475|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2475| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1762|lyfalmen|V0522|1762|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1762| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1750|lyfalmen|V0518|1750|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1750| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1415|lyfalmen|V0514|1415|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1415| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3380|5501|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3380||3380|5501| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3632|5846|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3632||3632|5846| 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|25722|34164|lyfsjukr|||00|4|0|0,0000|Icepharma hf|Roche Registration Limited|||||25722|34164| 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|63839|82000|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Roche Registration Limited|||||63839|82000| 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5220|8018|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||5220||5220|8018| 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|127022|161295|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|||||127022|161295| 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5169|7948|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||5169||5169|7948| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9493|13863|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||9493||9493|13863| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2436|4210|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||2436||2436|4210| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|4095|5858|lyfalmen|V0718|5762|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||3641||3641|5858| 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14557|lyfalmen|||10|30|0|1,8750|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14557| 170997|L01BC0701|Vidaza|irþ|25|mg/ml|100|mg|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|69551|89169|lyfsjukr|||00|100|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||69551|89169| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3567|5757|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3567||3567|5757| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3843|6134|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3843||3843|6134| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1610|3080|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||1610||1610|3080| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4354|6833|lyfalmen|V0709|5196|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4354||4354|6833| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7167|10681|lyfalmen|V0710|7893|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7167||7167|10681| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|43944|57032|lyfsjukr|||02|75|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||43944||43944|57032| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|29296|38649|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||29296||29296|38649| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|12943|18523|lyfalmen|V0711|13561|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||12943||12943|18523| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|26544|35592|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||26544||26544|35592| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|79516|101675|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||79516||79516|101675| 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|XEU|3693|5929|lyfalmen|||00|100|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||3693||3693|5929| 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14494|20469|lyfalmen|||00|98|0|0,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||14494||14494|20469| 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7036|10502|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||7036||7036|10502| 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13427|19130|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||13427||13427|19130| 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|22332|30306|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||22332||22332|30306| 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2428|4199|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2428||2428|4199| 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2428|4199|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2428||2428|4199| 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|25638|34455|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||25638||25638|34455| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|829|2011|lyfalmen|V0901|1991|00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||829||829|2011| 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2808|4718|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Merck NM AB (A)|Búspírón hýdróklóríð||2808||2808|4718| 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3625| 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5995|9078|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Merck NM AB (A)|Búspírón hýdróklóríð||5995||5995|9078| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1077|2351|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1077||1077|2351| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|344|1348|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||344||344|1348| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|2864|4795|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráð lyf|Pyridostigmin||2864||2864|4795| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|12541|18018|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráð lyf|Pyridostigmin||12541||12541|18018| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1458|2104|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1458||1458|2104| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|657|1776|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||657||657|1776| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|672|1797|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||672||672|1797| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|2009|3625|lyfalmen|||00|5|0|25,0000|Vistor hf|Allergan|Brímónidín||||2009|3625| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|254|1225|lyfalmen|V0886|1225|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||254|1225| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5894|8940|lyfalmen|||00|15|0|150,0000|Vistor hf|Allergan|Brímónidín||||5894|8940| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2594|3454|lyfalmen|V0507|3145|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1884||1884|3454| 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7014|5089|lyfalmen|V0809|4385|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3079||3079|5089| 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4840|7498|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4840||4840|7498| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|846|2035|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||846||846|2035| 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004|31.05.2010|L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|670|1333|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||670||670|1333| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|610|1712|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||610||610|1712| 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10685|15292|lyfsjukr|||00|60|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||10685||10685|15292| 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6095|9215|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||6095||6095|9215| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|16247|22669|lyfalmen|||00|98|0|65,3400|Vistor hf|Bristol-Myers Squibb|Pravastatín||16247||16247|22669| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|844|2032|lyfalmen|||30|5|0|0,0000|Vistor hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||844||844|2032| 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|781|1946|lyfalmen|||01|100|0|2,5000|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||781||781|1946| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7892|15326|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer vet.|||7892||7892|15326| 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|10361|14886|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||10361||10361|14886| 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|39110|50966|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||39110||39110|50966| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|5169|10098|vetalmen|||16|100|0|0,0000|Vistor hf|Intervet International BV|||5169||5169|10098| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5713|11142|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||5713||5713|11142| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1260|2601|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1260||1260|2601| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|990|2232|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||990||990|2232| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1475|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1475| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1965|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1965| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1636|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1636| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4946|7643|lyfalmen|||98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4946||4946|7643| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|24704|33283|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||24704||24704|33283| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|58520|75722|lyfalmen|V0563|75720|00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||58520||58520|75722| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2387|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2387| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5425|8298|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5425||5425|8298| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5599|8536|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráð lyf|||5599||5599|8536| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3102|5121|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3102||3102|5121| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2154|3824|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2154||2154|3824| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11031|15726|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||11031||11031|15726| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3219|5281|lyfalmen|||03|5|0|10,0000|Vistor hf|Pfizer ApS|Metýlprednisólón||3219||3219|5281| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1088|2366|lyfalmen|||03|2|0|4,0000|Vistor hf|Pfizer ApS|Metýlprednisólón||1088||1088|2366| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|527|1598|lyfalmen|||03|1|0|2,0000|Vistor hf|Pfizer ApS|Metýlprednisólón||527||527|1598| 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|855|2047|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||855||855|2047| 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|463|1511|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||463||463|1511| 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4737|6837|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4737||4737|6837| 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4831|6972|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4831||4831|6972| 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|4023|5806|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4023||4023|5806| 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1703|3207|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1703||1703|3207| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|474|1526|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||474||474|1526| 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|21,6000|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2132| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1193|2509|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1193||1193|2509| 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4495|lyfalmen|||00|20|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4495| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|DKK|1128|1628|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Wyeth AB|Metótrexat||1128||1128|1628| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2178|3857|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2178||2178|3857| 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|524|1594|lyfalmen|||00|20|0|3,3333|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||524||524|1594| 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BAP|0|0|1|100|SEK|2075|3716|lyfalmen|||00|10|0|2,5000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||2075||2075|3716| 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BAP|0|0|1|100|SEK|4500|7033|lyfalmen|||00|20|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||4500||4500|7033| 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BAP|0|0|1|100|SEK|4407|6906|lyfalmen|||00|10|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||4407||4407|6906| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1388|2776|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||||1388|2776| 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BAP|0|0|1|100|SEK|8548|12570|lyfalmen|||00|20|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||8548||8548|12570| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2040|3668|lyfalmen|||03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2040||2040|3668| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|834|2018|lyfalmen|||03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||834||834|2018| 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1014|2264|lyfalmen|||10|40|0|8,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||1014||1014|2264| 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|22989|31130|lyfalmen|||00|1|0|1014,9254|Vistor hf|N.V. Organon|Etónógestrel||22989||22989|31130| 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|783|1948|lyfalmen|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||783||783|1948| 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|377|1393|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||377||377|1393| 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|893|2099|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||893||893|2099| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1615|3086|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||||1615|3086| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1423|2824|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1423||1423|2824| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2709|5374|vetalmen|||27|10|0|0,0000|Icepharma hf|Intervet International B.V.|||2709||2709|5374| 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12897|24937|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||12897||12897|24937| 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60,0000|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6272| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|806|1980|lyfalmen|||06|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||806||806|1980| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|902|2111|lyfalmen|V0857|1739|00|20|0|20,0000|Vistor hf|Pfizer ApS|Alprazólam||902||902|2111| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4273|6722|lyfalmen|||00|100|0|100,0000|Vistor hf|Pfizer ApS|Alprazólam||4273||4273|6722| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2264|3974|lyfalmen|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2264||2264|3974| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|XEU|2231|3929|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||2231||2231|3929| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|10757|15383|lyfsjukr|||02|200|0|0,0000|Vistor hf|Pfizer ApS|Flúóróúracíl||10757||10757|15383| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|440|635|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||440||440|635| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|39264|51555|lyfalmen|||00|100|0|0,0000|Vistor hf|Pfizer ApS|Estramústín||39264||39264|51555| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|666|1788|lyfalmen|||00|30|0|30,0000|Vistor hf|Pfizer ApS|Tríazólam||666||666|1788| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6630|9947|lyfalmen|||44|8|0|4,0000|Vistor hf|Pfizer ApS|Kabególín||6630||6630|9947| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|59597|76677|lyfsjukr|||00|5|0|0,4000|Icepharma hf|Centocor -|Abciximab||59597||59597|76677| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5473|8189|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráð lyf|||5345||5345|8189| 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|5122|7884|lyfalmen|||00|100|1|1,2500|Parlogis hf|Parlogis - óskráð lyf|||5122||5122|7884| 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9131|lyfalmen|||00|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9131| 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3784|lyfalmen|||00|100|1|1,2500|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3784| 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000|30.04.2010|R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5686|lyfsjukr|||00|20|1|3,3333|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5686| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|604|872|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||604||604|872| 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|20580|27710|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||20580||20580|27710| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|618|892|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||618||618|892| 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9605| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3315|5412|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3315||3315|5412| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|7746|11473|lyfalmen|V0104|11472|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||7746||7746|11473| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4357|6837|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4357||4357|6837| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|11083|16038|lyfalmen|||00|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||11083||11083|16038| 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|110297|140305|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||110297||110297|140305| 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|219985|277964|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||219985||219985|277964| 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|581967|732251|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||581967||581967|732251| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2642|4491|lyfalmen|||23|66|0|88,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2642||2642|4491| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|21483|29240|lyfalmen|V0105|29239|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||21483||21483|29240| 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|4452|6967|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4452||4452|6967| 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|7631|11316|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7631||7631|11316| 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|10198|14828|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10198||10198|14828| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3082|5093|lyfalmen|||44|2|0|1,0000|Vistor hf|Pfizer ApS|Kabególín||3082||3082|5093| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|665|1787|lyfalmen|||00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||665||665|1787| 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|4841|7499|lyfalmen|||00|30|0|30,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4841||4841|7499| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11693|16873|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11693||11693|16873| 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2991|4969|lyfalmen|||23|15|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2991||2991|4969| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9628|14048|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9628||9628|14048| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|11591|16733|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11591||11591|16733| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|13406|19104|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13406||13406|19104| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|21395|29130|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||21395||21395|29130| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|98036|125314|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||98036||98036|125314| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4732|7350|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4732||4732|7350| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11325|12788|lyfalmen|V0508|12252|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||8707||8707|12788| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|128238|162821|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||128238||128238|162821| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|173056|219068|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||173056||173056|219068| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|216981|274194|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||216981||216981|274194| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1590|3052|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1590||1590|3052| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1966|3567|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1966||1966|3567| 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|31306|41172|lyfsjukr|||00|0|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||31306||31306|41172| 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|121031|153776|lyfsjukr|||00|2|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||121031||121031|153776| 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6317|9519|lyfalmen|||17|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6317||6317|9519| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5893|8939|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5893||5893|8939| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6813|10197|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6813||6813|10197| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1355|2364|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1355|2364| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8163|14240|vetorma|||00|20|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||8163||8163|14240| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|61397|79332|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||61397||61397|79332| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|771|1534|vetalmen|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||771||771|1534| 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|187547|237254|lyfsjukr|||00|200|0|28,5714|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||187547||187547|237254| 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3611|5817|lyfalmen|V2002|5718|00|25|0|5,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||3611||3611|5817| 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4073|6449|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||4073||4073|6449| 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|7921|11713|lyfalmen|||23|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||7921||7921|11713| 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4935|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4935| 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2508|4308|lyfalmen|V0388|4308|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2508||2508|4308| 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2291|4011|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2291||2291|4011| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|727|1872|lyfalmen|V0408|1872|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||727||727|1872| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|672|1797|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||672||672|1797| 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|360530|454348|lyfsjukr|||02|4000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||360530||360530|454348| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1024|2278|lyfalmen|||00|3|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1024||1024|2278| 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12614|18110|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Granisetrón||12614||12614|18110| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3089|5103|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||3089||3089|5103| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7402|11003|lyfalmen|||00|100|0|50,0000|Vistor hf|Pfizer ApS|Celekoxíb||7402||7402|11003| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|2924|4877|lyfalmen|||00|20|0|20,0000|Vistor hf|Pfizer ApS|Celekoxíb||2924||2924|4877| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|14265|20182|lyfalmen|||00|100|0|100,0000|Vistor hf|Pfizer ApS|Celekoxíb||14265||14265|20182| 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3289|5376|lyfalmen|||00|50|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||3289||3289|5376| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17339|lyfalmen|||00|50|1||Distica|Distica - óskráð lyf|Ondansetrón||||12000|17339| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5298|10346|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5298||5298|10346| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|175774|222479|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||175774||175774|222479| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|11356|16134|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche|Capecitabín||11356||11356|16134| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|60039|77231|lyfsjukr|||00|120|0|0,0000|Icepharma hf|Roche|Capecitabín||60039||60039|77231| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3400|lyfalmen|V0703|3400|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3400| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|9545|13934|lyfalmen|||02|3|0|30,0000|Vistor hf|Pfizer ApS|Dalteparín||9545||9545|13934| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1844|3400|lyfalmen|||06|8|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1844||1844|3400| 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5890|8934|lyfalmen|||10|100|0|25,0000|Vistor hf|Pfizer ApS|Gemfíbrózíl||5890||5890|8934| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|383|1401|lyfalmen|||00|25|0|12,5000|Vistor hf|Pfizer ApS|Oxazepam||383||383|1401| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|456|1501|lyfalmen|||00|100|0|30,0000|Vistor hf|Pfizer ApS|Oxazepam||456||456|1501| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|272|1249|lyfalmen|||00|25|0|7,5000|Vistor hf|Pfizer ApS|Oxazepam||272||272|1249| 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|802|1974|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||802||802|1974| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1284|2634|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1284||1284|2634| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2582|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2582| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3613|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3613| 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|689|1820|lyfalmen|||51|0|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||689||689|1820| 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1683|3348|vetalmen|||58|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1683||1683|3348| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5436|10610|vetalmen|||27|20|0|0,0000|Vistor hf|Intervet International BV|||5436||5436|10610| 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7405|11007|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7405||7405|11007| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1474|2894|lyfalmen|||06|14|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1474||1474|2894| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1805| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|79707|101915|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||79707||79707|101915| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|663|957|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||663||663|957| 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1821|3368|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1821||1821|3368| 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|22462|30469|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||22462||22462|30469| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21811|29652|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21811||21811|29652| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21811|29652|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21811||21811|29652| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21811|29652|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21811||21811|29652| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22029|29925|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22029||22029|29925| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|66411|85625|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||66411||66411|85625| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|72030|92677|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||72030||72030|92677| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|77649|99729|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||77649||77649|99729| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7360|10945|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||7360||7360|10945| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2221|3915|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2221||2221|3915| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|258|1230|lyfalmen|||00|25|0|5,0000|Vistor hf|Pfizer ApS|Oxazepam||258||258|1230| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|400|1424|lyfalmen|||00|100|0|20,0000|Vistor hf|Pfizer ApS|Oxazepam||400||400|1424| 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977|31.05.2010|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1154|2456|lyfalmen|||20|20|0|20,0000|Vistor hf|Schering-Plough|Betametasón||1154||1154|2456| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5152|7925|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||5152||5152|7925| 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977|31.05.2010|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1154|2456|lyfalmen|||20|20|0|20,0000|Vistor hf|Schering-Plough|Betametasón||1154||1154|2456| 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3068|5074|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||3068||3068|5074| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5515|8421|lyfalmen|||08|35|0|1,7500|Vistor hf|Pfizer ApS|Flúkónazól||5515||5515|8421| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|4073|6449|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||4073||4073|6449| 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4327|6796|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4327||4327|6796| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|13159|18794|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||13159||13159|18794| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3210|5268|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3210||3210|5268| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11199|21676|vetalmen|||27|120|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||11199||11199|21676| 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1664|lyfalmen|V0290|1664|00|100|0|33,3333|Actavis Group hf|Actavis hf|Atenólól||||575|1664| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|10663|15464|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10663||10663|15464| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1291|2643|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Klórókín||1291||1291|2643| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|756|1911|lyfalmen|||23|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Tretínóín||756||756|1911| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|661|1781|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||661||661|1781| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|4381|6323|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4381||4381|6323| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|25792|34251|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||25792||25792|34251| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1968|3569|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1968||1968|3569| 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7852|11618|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7852||7852|11618| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|25394|34149|lyfalmen|V0564|34147|00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||25394||25394|34149| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|4384|6327|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4384||4384|6327| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10588|20503|vetalmen|||02|100|0|0,0000|Vistor hf|Merial|||10588||10588|20503| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3323|5423|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3323||3323|5423| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4619|7196|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4619||4619|7196| 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|123156|156443|lyfsjukr|||00|12|0|0,0000|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||123156||123156|156443| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2266|3977|lyfalmen|||00|2|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2266||2266|3977| 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4803|7448|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíð||4803||4803|7448| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1534|2976|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1534||1534|2976| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2007|3623|lyfalmen|||05|15|0|15,0000|Vistor hf|Novo-Nordisk|Estradíól||2007||2007|3623| 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|3783|6052|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||3783||3783|6052| 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|10020|9918|lyfalmen|V2219|5241|00|98|0|98,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||6609||6609|9918| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5168|7947|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráð lyf|Ranitidín||5168||5168|7947| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3055|5056|lyfalmen|||23|10|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3055||3055|5056| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|25688|34518|lyfalmen|||23|150|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||25688||25688|34518| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1198|2516|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1198||1198|2516| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|42216|54864|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||42216||42216|54864| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|5011|7732|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5011||5011|7732| 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1841|3396|lyfalmen|||20|50|0|50,0000|Vistor hf|Schering-Plough|Betametasón||1841||1841|3396| 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|10191|14818|lyfalmen|V0299|10631|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||10191||10191|14818| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2060|4098|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2060||2060|4098| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2674|5307|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2674||2674|5307| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4319|6785|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||4319||4319|6785| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7523|11168|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7523||7523|11168| 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|64179|82427|lyfsjukr|||00|10|0|0,0000|Vistor hf|Schering-Plough|Doxórúbicín||64179||64179|82427| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|58547|75359|lyfsjukr|||00|180|0|30,0000|Icepharma hf|M.S.D.|Indínavír||58547||58547|75359| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|49524|64035|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||49524||49524|64035| 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|853|2044|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||853||853|2044| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|12753|18284|lyfalmen|||02|10|0|40,0000|Vistor hf|Pfizer ApS|Dalteparín||12753||12753|18284| 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3809|6088|lyfalmen|||02|2|0|10,0000|Vistor hf|Pfizer ApS|Dalteparín||3809||3809|6088| 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6500|9769|lyfalmen|||02|2|0|20,0000|Vistor hf|Pfizer ApS|Dalteparín||6500||6500|9769| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1962|3561|lyfalmen|V0144|3560|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1962||1962|3561| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1653|3138|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1653|3138| 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3632|5166|lyfalmen|V2004|4400|43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3135||3135|5166| 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7153|10662|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||7153||7153|10662| 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|9295|13592|lyfalmen|||49|100|0|50,0000|Vistor hf|Meda AS|Brómókriptín||9295||9295|13592| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|1715|2992|vetorma|||16|24|0|0,0000|Icepharma hf|Intervet International B.V.|||||1715|2992| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|1039|2299|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1039||1039|2299| 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|32254|42758|lyfalmen|||52|100|0|25,0000|Vistor hf|Meda AS|Brómókriptín||32254||32254|42758| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3618|5826|lyfalmen|V0555|2848|10|2|0|1,5000|Vistor hf|Pfizer ApS|Flúkónazól||3618||3618|5826| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|657|1776|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||657||657|1776| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|858|2051|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||858||858|2051| 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2636| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1052|2316|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1052||1052|2316| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1044|2305|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1044||1044|2305| 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|33897|44423|lyfsjukr|||00|1000|0|4,0000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||33897||33897|44423| 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|53084|68503|lyfsjukr|||00|2000|0|8,0000|Icepharma hf|Bayer Schering Pharma AG|Cíprófloxacín||53084||53084|68503| 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|530|1602|lyfalmen|||23|14|0|1,7500|Vistor hf|Astellas Pharma A/S|Amoxicillín||530||530|1602| 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|874|2073|lyfalmen|||23|14|0|3,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||874||874|2073| 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1123|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Atenólól||180||180|1123| 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5871|8908|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5871||5871|8908| 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|43914|57391|lyfalmen|||AC|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||43914||43914|57391| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6064|9172|lyfalmen|||00|100|0|133,3333|Vistor hf|Pfizer ApS|Spírónólaktón||6064||6064|9172| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1658|2393|lyfsjukr|||02|50|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||1658||1658|2393| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2063|2977|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||2063||2063|2977| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4048|7945|vetalmen|||27|100|0|0,0000|Vistor hf|Intervet International BV|||4048||4048|7945| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2684|4549|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2684||2684|4549| 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|805|1978|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||805||805|1978| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1329|2695|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||1329||1329|2695| 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 431759|M01AB5503|Arthrotec Forte|töflur|75,02|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PFI|0|0|1|100|DKK|1495|2922|lyfalmen|||00|20|0|15,0000|Vistor hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1495|2922| 431783|M01AB5503|Arthrotec Forte|töflur|75,02|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PFI|0|0|1|100|DKK|6787|10162|lyfalmen|||00|100|0|75,0000|Vistor hf|Pfizer ApS|Díklófenaknatríum í blöndum||||6787|10162| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2180|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||952||952|2180| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11696|16877|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11696||11696|16877| 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2623|4465|lyfalmen|||00|28|0|8,4000|Vistor hf|Pfizer ApS|Morfín||2623||2623|4465| 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6434|9679|lyfalmen|||00|28|0|25,2000|Vistor hf|Pfizer ApS|Morfín||6434||6434|9679| 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9281|13573|lyfalmen|||00|28|0|42,0000|Vistor hf|Pfizer ApS|Morfín||9281||9281|13573| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1201|2095|vetorma|||99|10|0|0,0000|Icepharma hf|Intervet International B.V.|||||1201|2095| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCS|0|0|1|100|SEK|1613|3084|lyfalmen|||20|50|0|50,0000|Vistor hf|McNeil Sweden AB|Blöndur||1613||1613|3084| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6134|9268|lyfalmen|||00|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||6134||6134|9268| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6134|9268|lyfalmen|||00|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||6134||6134|9268| 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|XEU|10858|15730|lyfalmen|V0915|7188|00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10858||10858|15730| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6539|9822|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6539||6539|9822| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5107|7863|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5107||5107|7863| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8069|10509|lyfalmen|V0725|9125|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7041||7041|10509| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|3093|5108|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíð dínítrat||3093||3093|5108| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3937|6263|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||3937||3937|6263| 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10380|15077|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||10380||10380|15077| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|784|1950|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||784||784|1950| 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995|31.05.2010|R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|882|2084|lyfalmen|||10|20|0|15,0000|Actavis Group PTC ehf|Merck NM AB|Naproxen||882||882|2084| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|1008|2256|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1008||1008|2256| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3533|5710|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3533||3533|5710| 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|12123|17493|lyfalmen|V0955|7580|00|100|0|75,0000|Icepharma hf|Wyeth AB|Venlafaxín||12123||12123|17493| 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|6519|9795|lyfalmen|V0957|5840|00|28|0|42,0000|Icepharma hf|Wyeth AB|Venlafaxín||6519||6519|9795| 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1892|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|||742||742|1892| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1307|2665|lyfalmen|||00|10|0|0,0000|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1307||1307|2665| 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|3415|5549|lyfalmen|V0954|3746|00|28|0|21,0000|Icepharma hf|Wyeth AB|Venlafaxín||3415||3415|5549| 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|11743|16941|lyfalmen|V0955|7428|00|98|0|73,5000|Icepharma hf|Wyeth AB|Venlafaxín||11743||11743|16941| 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|22296|30261|lyfalmen|V0956|7428|00|98|0|147,0000|Icepharma hf|Wyeth AB|Venlafaxín||22296||22296|30261| 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|0|0|WAB|0|1|0|100|DKK|20553|28073|lyfalmen|V0956|7580|00|100|0|150,0000|Icepharma hf|Wyeth AB|Venlafaxín||20553||20553|28073| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2074|3714|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||2074||2074|3714| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6263|9445|lyfalmen|V0984|3174|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6263||6263|9445| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2344|4084|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2344||2344|4084| 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9432|13780|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||9432||9432|13780| 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2335|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2335| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1566|2260|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1566||1566|2260| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2472|3568|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2472||2472|3568| 440933|M01AB0507|Vostar|eþ-stíll|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1627|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis hf|Díklófenak||548||548|1627| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1530|2970|lyfalmen|V0221|2848|00|100|0|33,3333|Vistor hf|Pfizer ApS|Spírónólaktón||1530||1530|2970| 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1397|2788|lyfalmen|||20|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Blöndur||1397||1397|2788| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0,0000|Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|972|2207|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||972||972|2207| 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|31036|40833|lyfsjukr|||61|40|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||31036||31036|40833| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3877|6181|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk|Glúkagon||3877||3877|6181| 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|28545|38103|lyfalmen|||10|90|0|180,0000|Vistor hf|Pfizer ApS|Morfín||28545||28545|38103| 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|47725|61777|lyfsjukr|||00|56|0|21,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||47725||47725|61777| 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|48407|62633|lyfsjukr|||00|56|0|28,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||48407||48407|62633| 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|DKK|3305|3174|lyfalmen|V0914|3174|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||1679||1679|3174| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2309|4036|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2309||2309|4036| 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|15915|21856|lyfsjukr|||00|2|0|0,3300|Icepharma hf|Roche|Íbandrónsýra||15915||15915|21856| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1781|3314|lyfalmen|||00|30|0|30,0000|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1781||1781|3314| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1529|3041|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||1529||1529|3041| 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4274|6724|lyfalmen|V0551|3257|10|7|0|1,7500|Vistor hf|Pfizer ApS|Flúkónazól||4274||4274|6724| 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1821|3368|lyfalmen|V0554|1909|10|1|0|0,7500|Vistor hf|Pfizer ApS|Flúkónazól||1821||1821|3368| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11914|17175|lyfalmen|||00|4|0|3,6000|Vistor hf|Pfizer ApS|Dalteparín||11914||11914|17175| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6796|10174|lyfalmen|||00|2|0|2,0000|Vistor hf|Pfizer ApS|Dalteparín||6796||6796|10174| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8325|12265|lyfalmen|||00|2|0|2,5000|Vistor hf|Pfizer ApS|Dalteparín||8325||8325|12265| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9996|14551|lyfalmen|||00|3|0|3,0000|Vistor hf|Pfizer ApS|Dalteparín||9996||9996|14551| 448217|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|616|1720|lyfalmen|||04|10|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||616||616|1720| 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1202|2522|lyfalmen|||00|30|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1202||1202|2522| 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|8230|12135|lyfalmen|||02|100|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|||8230||8230|12135| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2493|4288|lyfalmen|V0712|2861|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2493||2493|4288| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1359|2736|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1359||1359|2736| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5863|8462|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5863||5863|8462| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2281|lyfalmen|V0466|2266|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2281| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1153|1902|lyfalmen|V0902|1728|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||749||749|1902| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|4058|5606|lyfalmen|V0903|4870|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3457||3457|5606| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|56815|73582|lyfalmen|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||56815||56815|73582| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|85223|109234|lyfalmen|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||85223||85223|109234| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|113629|144883|lyfalmen|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||113629||113629|144883| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6053|8330|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5448||5448|8330| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|15985|22340|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15985||15985|22340| 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|17543|24296|lyfalmen|V0552|8858|10|30|0|7,5000|Vistor hf|Pfizer ApS|Flúkónazól||17543||17543|24296| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1228|2557|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1228||1228|2557| 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|58754|76015|lyfalmen|||10|100|0|25,0000|Vistor hf|Pfizer ApS|Flúkónazól||58754||58754|76015| 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|15058|21177|lyfalmen|||00|3000|0|3,0000|Vistor hf|Laboratories 3M Santé|Imikvímóð||15058||15058|21177| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3196|5249|lyfalmen|||00|90|0|0,0000|Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3196||3196|5249| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2703|4575|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2703||2703|4575| 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7863|11633|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7863||7863|11633| 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|2628|4472|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2628||2628|4472| 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5105|7861|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||5105||5105|7861| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1558|2718|vetorma|||16|6|0|0,0000|Vistor hf|Merial (MSD)|||||1558|2718| 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|15251|21419|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||15251||15251|21419| 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10283|14944|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||10283||10283|14944| 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|26071|34998|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||26071||26071|34998| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3818|5510|lyfsjukr|||02|1|0|0,5000|Vistor hf|Pfizer ApS|Ziprasidon||3818||3818|5510| 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2429|4200|lyfalmen|||00|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2429||2429|4200| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16257|22682|lyfalmen|||00|28|0|18,6667|Vistor hf|Pfizer ApS|Dónepezíl||16257||16257|22682| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|46029|40811|lyfalmen|V0375|40809|00|98|0|65,3333|Vistor hf|Pfizer ApS|Dónepezíl||30703||30703|40811| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|18341|25297|lyfalmen|||00|28|0|37,3333|Vistor hf|Pfizer ApS|Dónepezíl||18341||18341|25297| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|50712|45528|lyfalmen|V0376|45478|00|98|0|130,6667|Vistor hf|Pfizer ApS|Dónepezíl||34461||34461|45528| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|SKB|0|0|0|100|GBP|54396|70149|lyfsjukr|||00|1|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||54396||54396|70149| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1157|2301|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1157||1157|2301| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|991|2233|lyfalmen|||00|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||991||991|2233| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|3562|5750|lyfalmen|||00|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3562||3562|5750| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|23195|31389|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||23195||23195|31389| 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Icepharma hf|Doetsch Grether|Lídókaín|||||| 455725|C05AD0102|Sulgan|eþ-stíll|||10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Icepharma hf|Doetsch Grether|Lídókaín|||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1054|2319|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1054||1054|2319| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1150|2450|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1150||1150|2450| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2519|4323|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2519||2519|4323| 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4765|6877|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||4765||4765|6877| 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4765|6877|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||4765||4765|6877| 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5202|7508|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5202||5202|7508| 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5202|7508|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5202||5202|7508| 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7788|11240|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7788||7788|11240| 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7788|11240|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7788||7788|11240| 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7788|11240|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7788||7788|11240| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9749|14070|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9749||9749|14070| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9503|13715|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9503||9503|13715| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12634|17738|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12634||12634|17738| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1144|2442|lyfalmen|||00|25|0|5,0000|Vistor hf|Astra|Clómetíazól||1144||1144|2442| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1525|2963|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1525||1525|2963| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2217|3910|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2217||2217|3910| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9241|13518|lyfalmen|V0456|13518|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9241||9241|13518| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12734|17864|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12734||12734|17864| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12734|17864|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12734||12734|17864| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12734|17864|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12734||12734|17864| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1505|2172|lyfsjukr|||02|2|0|0,1667|Vistor hf|Pfizer ApS|Klindamýcín||1505||1505|2172| 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|90348|115269|lyfsjukr|||00|10|0|1,6700|Icepharma hf|Roche|Íbandrónsýra||90348||90348|115269| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1659|2394|lyfsjukr|||02|4|0|0,3333|Vistor hf|Pfizer ApS|Klindamýcín||1659||1659|2394| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2135|3798|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||2135||2135|3798| 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2341|4080|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||2341||2341|4080| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2599|4433|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2599||2599|4433| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4678|7277|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4678||4678|7277| 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1063|2331|lyfalmen|||23|20|0|5,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1063||1063|2331| 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4486|7014|lyfalmen|||51|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4486||4486|7014| 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1166|2472|lyfalmen|||23|20|0|10,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1166||1166|2472| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2439|4214|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2439||2439|4214| 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|20292|27349|lyfsjukr|||00|20|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||20292||20292|27349| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól|||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6418|9657|lyfalmen|||51|5|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6418||6418|9657| 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|81164|103743|lyfsjukr|||00|20|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||81164||81164|103743| 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|80160|102483|lyfsjukr|||00|5|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||80160||80160|102483| 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001|31.03.2010|R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|199038|251675|lyfsjukr|||00|5|0|0,0000|Vistor hf|Schering-Plough|Temozolomid||199038||199038|251675| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1141|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1141| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|681|1809|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||681||681|1809| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|681|1809|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||681||681|1809| 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8366|12322|lyfalmen|||56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||8366||8366|12322| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7093|13792|vetalmen|||02|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7093||7093|13792| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5658|11037|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5658||5658|11037| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPI|0|1|0|100|DKK|1872|3438|lyfalmen|||00|100|0|8,3333|Swedish Orphan International AB|Lundbeck Pharmaceuticals Ireland Ltd.|Melperón||1872||1872|3438| 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1257|2500|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1257||1257|2500| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1187|2361|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1187||1187|2361| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1272|2530|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1272||1272|2530| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|670|1333|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||670||670|1333| 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|794|1963|lyfalmen|||10|25|0|2,5000|Vistor hf|Pfizer ApS|Morfín||794||794|1963| 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2185|3866|lyfalmen|||10|100|0|10,0000|Vistor hf|Pfizer ApS|Morfín||2185||2185|3866| 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1688|3186|lyfalmen|||10|25|0|7,5000|Vistor hf|Pfizer ApS|Morfín||1688||1688|3186| 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6463|9718|lyfalmen|||10|100|0|30,0000|Vistor hf|Pfizer ApS|Morfín||6463||6463|9718| 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3247|5319|lyfalmen|||10|25|0|15,0000|Vistor hf|Pfizer ApS|Morfín||3247||3247|5319| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8375|12334|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8375||8375|12334| 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5198|7988|lyfalmen|||10|25|0|25,0000|Vistor hf|Pfizer ApS|Morfín||5198||5198|7988| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5622|8568|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||5622||5622|8568| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|16785|22948|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||16785||16785|22948| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|26307|34898|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||26307||26307|34898| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|28484|37630|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||28484||28484|37630| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|46397|60111|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||46397||46397|60111| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|35836|47253|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||35836||35836|47253| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|16338|22783|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16338||16338|22783| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|94973|121074|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||94973||94973|121074| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|31108|41320|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||31108||31108|41320| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|814|1175|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||814||814|1175| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6780|6888|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4394||4394|6888| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|375|541|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||375||375|541| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|9872|6556|lyfalmen|V0926|4374|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4151||4151|6556| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|24943|13360|lyfalmen|||00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9125||9125|13360| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10753|15587|lyfalmen|||00|98|0|49,0000|Vistor hf|Pfizer ApS|Gemfíbrózíl||10753||10753|15587| 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3070|5077|lyfalmen|||00|20|0|13,3333|Icepharma hf|Grunenthal|Tramadól||3070||3070|5077| 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|12515|17985|lyfalmen|V0738|13153|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||12515||12515|17985| 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2401|4162|lyfalmen|||00|20|0|10,0000|Icepharma hf|Grunenthal|Tramadól||2401||2401|4162| 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9503|13877|lyfalmen|V0736|8985|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||9503||9503|13877| 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1631|3108|lyfalmen|V0733|2564|00|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||1631||1631|3108| 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6491|9757|lyfalmen|V0734|6160|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||6491||6491|9757| 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5502|8404|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5502||5502|8404| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|12230|17231|lyfsjukr|||02|150|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||12230||12230|17231| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9883|14264|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9883||9883|14264| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9231|lyfsjukr|||02|100|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9231| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|16499|22589|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||16499||16499|22589| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|14180|19678|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||14180||14180|19678| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2106|3758|lyfalmen|||68|100|0|50,0000|Vistor hf|Pfizer ApS|Glípízíð||2106||2106|3758| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|2248|3922|vetorma|||99|20|0|0,0000|Icepharma hf|Intervet International B.V.|||||2248|3922| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2502|4300|lyfalmen|||00|100|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2502||2502|4300| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5037|9844|vetalmen|||27|10|0|0,0000|Vistor hf|Orion Corporation|||5037||5037|9844| 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2407|3610|lyfalmen|V2003|3099|43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1998||1998|3610| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2548|4363|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2548||2548|4363| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15101|20834|lyfsjukr|||00|400|0|0,4000|Vistor hf|Meda AB|Dextran||15101||15101|20834| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1083|2359|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1083||1083|2359| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|44079|57202|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||44079||44079|57202| 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1958|3556|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough|Mómetasón||1958||1958|3556| 475327|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1862|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||720||720|1862| 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4407|6906|lyfalmen|||23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||4407||4407|6906| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|246|1214|lyfalmen|V0775|1214|00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||246||246|1214| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|342|1345|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||342||342|1345| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|958|2188|lyfalmen|V0780|2188|00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||958||958|2188| 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3603|5806|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3603||3603|5806| 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|4819|7469|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4819||4819|7469| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5895|8941|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5895||5895|8941| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5006|7725|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5006||5006|7725| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1176|2486|lyfalmen|||00|50|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1176||1176|2486| 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|7350|10932|lyfalmen|||00|30|0|7,5000|Vistor hf|AstraZeneca AB|Quetíapín||7350||7350|10932| 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|11168|16155|lyfalmen|||00|30|0|15,0000|Vistor hf|AstraZeneca AB|Quetíapín||11168||11168|16155| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4616|7192|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4616||4616|7192| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|10784|15629|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||10784||10784|15629| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|23134|31312|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||23134||23134|31312| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4989|7702|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4989||4989|7702| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|12918|18491|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12918||12918|18491| 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11930|17197|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||11930||11930|17197| 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|36147|47247|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||36147||36147|47247| 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000|30.04.2010|R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|68242|87923|lyfalmen|||10|28|0|28,0000|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||68242||68242|87923| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3807|5494|lyfsjukr|||00|50|0|0,5000|Vistor hf|Pfizer ApS|Flúkónazól||3807||3807|5494| 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5062|7306|lyfsjukr|||00|100|0|1,0000|Vistor hf|Pfizer ApS|Flúkónazól||5062||5062|7306| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|87060|111143|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||87060||87060|111143| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6273|9458|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Fínasteríð||6273||6273|9458| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1423|2824|lyfalmen|||00|300|0|0,0000|Vistor hf|Meda AB (V)|Benzýdamín||1423||1423|2824| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|499|1560|lyfalmen|||29|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||499||499|1560| 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|712|1851|lyfalmen|||29|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||712||712|1851| 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|2633|4479|lyfalmen|||00|30|0|15,0000|Icepharma hf|Servier|Perindópríl||2633||2633|4479| 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|3843|6134|lyfalmen|||00|30|0|30,0000|Icepharma hf|Servier|Perindópríl||3843||3843|6134| 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|863|2058|lyfalmen|||00|25|0|6,2500|Vistor hf|Recip AB|Nítrófúrantóín||863||863|2058| 487959|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|928|2147|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||928||928|2147| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2762|4656|lyfalmen|||00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2762||2762|4656| 488114|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1315| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6645|9967|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6645||6645|9967| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|18592|25612|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||18592||18592|25612| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1140|lyfalmen|||67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1140| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|882|1516|lyfalmen|V0609|1465|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1516| 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2596|4428|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2596||2596|4428| 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2893|4835|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2893||2893|4835| 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9074|13290|lyfalmen|||00|5|0|1,6667|Icepharma hf|Roche A.S.|Granisetrón||9074||9074|13290| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4992|7706|lyfalmen|||00|30|0|15,0000|Vistor hf|Pfizer ApS|Atorvastatín||4992||4992|7706| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11452|11036|lyfalmen|||00|100|0|50,0000|Vistor hf|Pfizer ApS|Atorvastatín||7426||7426|11036| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|7748|11476|lyfalmen|||00|30|0|30,0000|Vistor hf|Pfizer ApS|Atorvastatín||7748||7748|11476| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|16253|15016|lyfalmen|V2207|3144|00|100|0|100,0000|Vistor hf|Pfizer ApS|Atorvastatín||10336||10336|15016| 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12027|17373|lyfalmen|||00|30|0|60,0000|Vistor hf|Pfizer ApS|Atorvastatín||12027||12027|17373| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|20671|18644|lyfalmen|V0339|5945|00|100|0|200,0000|Vistor hf|Pfizer ApS|Atorvastatín||13040||13040|18644| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|47978|62095|lyfsjukr|||00|3|0|21,0084|Vistor hf|N.V. Organon|BCG bóluefni||47978||47978|62095| 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3506|5673|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3506||3506|5673| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12264|17670|lyfalmen|V2206|7650|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12264||12264|17670| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4531|7075|lyfalmen|||00|28|0|18,6667|Vistor hf|Bristol-Myers Squibb|Pravastatín||4531||4531|7075| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1753|3275|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1753||1753|3275| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4155|6561|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4155||4155|6561| 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|85508|109195|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||85508||85508|109195| 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|213769|270163|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||213769||213769|270163| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2399|4159|lyfalmen|||00|60|0|60,0000|Vistor hf|Pfizer ApS|Klindamýcín||2399||2399|4159| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2737|4621|lyfalmen|V0408|1872|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Estradíól||2737||2737|4621| 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3472|5627|lyfalmen|V0388|4308|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3472||3472|5627| 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|2324|4056|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2324||2324|4056| 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990|30.04.2010|L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyfalmen|||14|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||4160| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18943|26053|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||18943||18943|26053| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7368|10956|lyfalmen|V1088|8461|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7368||7368|10956| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10526|15276|lyfalmen|V1089|13040|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10526||10526|15276| 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2890|4831|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2890||2890|4831| 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4469|8754|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||4469|8754| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4175|6588|lyfalmen|||02|100|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4175||4175|6588| 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1054|2319|lyfalmen|||00|50|0|8,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1054||1054|2319| 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3308|5402|lyfalmen|||00|100|0|33,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3308||3308|5402| 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|590|1684|lyfalmen|||04|10|0|4,0000|Vistor hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||590||590|1684| 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|896|2103|lyfalmen|||00|20|0|2,0000|Vistor hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||896||896|2103| 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3414|5547|lyfalmen|||00|100|0|10,0000|Vistor hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3414||3414|5547| 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2294|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2294| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|419|1450|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||419||419|1450| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|527|1598|lyfalmen|V0167|1598|00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||527||527|1598| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1094|2374|lyfalmen|V0169|2374|00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1094||1094|2374| 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|858|2051|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||858||858|2051| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1439|2846|lyfalmen|||03|2|0|35,0000|Vistor hf|Schering-Plough|Betametasón||1439||1439|2846| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|17933|24785|lyfalmen|||00|56|0|14,0000|Vistor hf|Pfizer ApS|Ziprasidon||17933||17933|24785| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|19130|26287|lyfalmen|||00|56|0|28,0000|Vistor hf|Pfizer ApS|Ziprasidon||19130||19130|26287| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|28253|37737|lyfalmen|||00|56|0|42,0000|Vistor hf|Pfizer ApS|Ziprasidon||28253||28253|37737| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|28788|38408|lyfalmen|||00|56|0|56,0000|Vistor hf|Pfizer ApS|Ziprasidon||28788||28788|38408| 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|858|2051|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||858||858|2051| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5253|lyfalmen|||67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5253| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3096|5112|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3096||3096|5112| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3156|5194|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Ltd|Maprótilín||3156||3156|5194| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|32663|42875|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||32663||32663|42875| 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2444|4221|lyfalmen|||20|50|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2444||2444|4221| 504191|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2349|4091|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2349||2349|4091| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1227|2556|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1227||1227|2556| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8683|12755|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Ltd|Maprótilín||8683||8683|12755| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3495|5044|lyfsjukr|||02|5|0|0,0000|Vistor hf|Pfizer ApS|Doxórúbicín||3495||3495|5044| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6803|9818|lyfsjukr|||02|10|0|0,0000|Vistor hf|Pfizer ApS|Doxórúbicín||6803||6803|9818| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|8698|12553|lyfsjukr|||02|25|0|0,0000|Vistor hf|Pfizer ApS|Doxórúbicín||8698||8698|12553| 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|30634|40328|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Ísóflúran||30634||30634|40328| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2590|4420|lyfalmen|||10|100|0|50,0000|Vistor hf|Pfizer ApS|Doxepín||2590||2590|4420| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|423|1456|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||423||423|1456| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|697|1216|vetorma|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||697|1216| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2962|5167|vetorma|||16|120|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2962|5167| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|9613|16769|vetorma|||13|1000|0|0,0000|Icepharma hf|Intervet International B.V.|||9613||9613|16769| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2659|5278|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||2659||2659|5278| 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2704|4576|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2704||2704|4576| 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5404|10549|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||5404|10549| 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4334|8494|vetalmen|||0|50|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4334||4334|8494| 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13408|25918|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||13408||13408|25918| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10555|15316|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10555||10555|15316| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2824| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|48994|63370|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||48994||48994|63370| 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002|30.04.2010|R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14442|20007|lyfsjukr|||00|2|0|6,0000|Icepharma hf|Roche|Epóetín||14442||14442|20007| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|25283|33613|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||25283||25283|33613| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|30980|40762|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||30980||30980|40762| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|49634|64173|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||49634||49634|64173| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|96444|122920|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||96444||96444|122920| 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002|30.04.2010|R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|270112|340873|lyfsjukr|||00|4|0|120,0000|Icepharma hf|Roche|Epóetín||270112||270112|340873| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4403|5680|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||3511||3511|5680| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3015|5002|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3015||3015|5002| 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2847|4772|lyfalmen|V0385|4676|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2847||2847|4772| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|22717|30392|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||22717||22717|30392| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14211|19717|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14211||14211|19717| 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10056|14503|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||10056||10056|14503| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2133|3795|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2133||2133|3795| 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2220|1483|lyfalmen|||00|20|0|10,0000|Vistor hf|Pfizer ApS|Reboxetin||443||443|1483| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|4671|4401|lyfalmen|||00|60|0|30,0000|Vistor hf|Pfizer ApS|Reboxetin||2576||2576|4401| 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|1962|3561|lyfalmen|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||1962||1962|3561| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3124|5151|lyfalmen|||00|90|0|11,2500|Vistor hf|Novo-Nordisk|Repaglíníð||3124||3124|5151| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3401|5530|lyfalmen|||00|90|0|22,5000|Vistor hf|Novo-Nordisk|Repaglíníð||3401||3401|5530| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3657|5880|lyfalmen|||00|90|0|45,0000|Vistor hf|Novo-Nordisk|Repaglíníð||3657||3657|5880| 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|970|2204|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||970||970|2204| 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3575|5768|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3575||3575|5768| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2204|3892|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2204||2204|3892| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1076|2349|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1076||1076|2349| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|8750|12847|lyfalmen|||02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||8750||8750|12847| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5090|7840|lyfalmen|V0096|7701|00|4|0|2,0000|Vistor hf|Pfizer ApS|Síldenafíl||5090||5090|7840| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5748|8740|lyfalmen|V0097|8583|00|4|0|4,0000|Vistor hf|Pfizer ApS|Síldenafíl||5748||5748|8740| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|16196|22605|lyfalmen|||00|12|0|12,0000|Vistor hf|Pfizer ApS|Síldenafíl||16196||16196|22605| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6165|9311|lyfalmen|||00|4|0|8,0000|Vistor hf|Pfizer ApS|Síldenafíl||6165||6165|9311| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17057|23686|lyfalmen|||00|12|0|24,0000|Vistor hf|Pfizer ApS|Síldenafíl||17057||17057|23686| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2683|lyfalmen|V0308|2683|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||1320||1320|2683| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3798|lyfalmen|V0310|3779|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||2135||2135|3798| 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|434|1471|lyfalmen|||00|30|0|8,7500|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||434||434|1471| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|33903|44827|lyfalmen|V2030|33739|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||33903||33903|44827| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12522|lyfsjukr|||00|100|1|0,0000|Distica|Distica - óskráð lyf|||8676||8676|12522| 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8448|16394|vetalmen|||16|320|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||8448||8448|16394| 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3511|5680|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3511||3511|5680| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|218526|276133|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||218526||218526|276133| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|474|1526|lyfalmen|||00|20|0|3,3300|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||474||474|1526| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|824|2004|lyfalmen|||00|100|0|16,6700|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||824||824|2004| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|10295|14960|lyfalmen|||00|250|0|208,3333|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||10295||10295|14960| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|910|2122|lyfalmen|V0732|2122|02|10|0|1,6667|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||910||910|2122| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9398|13733|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||9398||9398|13733| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|438|1476|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||438||438|1476| 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1293| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1305|2662|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1305||1305|2662| 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|25233|33946|lyfalmen|||00|84|0|28,0000|Vistor hf|Schering-Plough|Flútamíð||25233||25233|33946| 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1091|2370|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1091||1091|2370| 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2774|4672|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2774||2774|4672| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1181| 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1160| 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1191|2506|lyfalmen|||00|100|0|29,2000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1191||1191|2506| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1069|2340|lyfalmen|||00|15|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1069||1069|2340| 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2973|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2973| 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7861|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7861| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|10697|15510|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10697||10697|15510| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|7711|11426|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||7711||7711|11426| 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4385|6876|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4385||4385|6876| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|7046|13702|vetalmen|||16|188|0|0,0000|Vistor hf|Intervet International BV|||7046||7046|13702| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3751|6008|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3751||3751|6008| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|15771|21675|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15771||15771|21675| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1319|2682|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Emedastín||1319||1319|2682| 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2027|2925|lyfsjukr|||00|7|0|1,7500|Vistor hf|Schering-Plough|Búprenorfín||2027||2027|2925| 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1,5|0|0|0|0|PAL|0|0|0|100|DKK|4521|8854|vetalmen|||16|72|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4521||4521|8854| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3894|7650|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||3894||3894|7650| 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5185|7483|lyfsjukr|||00|7|0|7,0000|Vistor hf|Schering-Plough|Búprenorfín||5185||5185|7483| 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|72474|92837|lyfsjukr|||00|100|0|11,1000|Vistor hf|Pfizer ApS|Fosfenýtóín||72474||72474|92837| 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|11354|16132|lyfsjukr|||00|1|0|0,0000|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||11354||11354|16132| 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|61578|79163|lyfsjukr|||00|6|0|0,0000|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||61578||61578|79163| 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3278|5361|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3278||3278|5361| 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2904|4850|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2904||2904|4850| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9577|13822|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||9577||9577|13822| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|868|2065|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||868||868|2065| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|339|1341|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||339||339|1341| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|982|2221|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||982||982|2221| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|272|1249|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||272||272|1249| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1730|3244|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1730||1730|3244| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1961|3560|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1961||1961|3560| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6751|10112|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6751||6751|10112| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|465|1513|lyfalmen|||06|10|0|25,0000|K.Pétursson hf|Alcon|Pílókarpín||465||465|1513| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|593|1688|lyfalmen|||06|10|0|25,0000|K.Pétursson hf|Alcon|Pílókarpín||593||593|1688| 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|16726|23270|lyfalmen|||52|100|0|12,5000|Vistor hf|Meda AS|Brómókriptín||16726||16726|23270| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|623|1087|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||623|1087| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2390| 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|137774|174789|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||137774||137774|174789| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|11182|16174|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||11182||11182|16174| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|185|1130|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||185||185|1130| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|403|1429|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||403||403|1429| 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2689|4556|lyfalmen|||23|40|0|8,0000|Vistor hf|Pfizer ApS|Klindamýcín||2689||2689|4556| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2946|4907|lyfalmen|||00|250|0|250,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2946||2946|4907| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|6203|9363|lyfalmen|||06|15|0|0,0000|Icepharma hf|M.S.D.|Tímólól í blöndum||6203||6203|9363| 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2076|3717|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2076||2076|3717| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10050|14625|lyfalmen|||10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10050||10050|14625| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|16280|22710|lyfalmen|||10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||16280||16280|22710| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1582|3041|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1582||1582|3041| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1817|3363|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráð lyf|||1817||1817|3363| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4652|7241|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||4652||4652|7241| 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2,5000|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum|||||| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A|3|0|1|*|0|ASP|0|0|0|100|XEU|13730|19510|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13730||13730|19510| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002|30.04.2010|R|A|2|0|1|E|0|MSE|0|0|0|100|SEK|27808|37178|lyfalmen|||00|10|0|5,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||27808||27808|37178| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|749|1902|lyfalmen|||00|15|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||749||749|1902| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1258|2598|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1258||1258|2598| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3344|5452|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3344||3344|5452| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|31945|42370|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||31945||31945|42370| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|25756|34603|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||25756||25756|34603| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32133|42606|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||32133||32133|42606| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27299|36539|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||27299||27299|36539| 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1590|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||521||521|1590| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|8730|12819|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráð lyf|||8730||8730|12819| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4690| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10462|15012|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10462||10462|15012| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3448|4976|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3448||3448|4976| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9060|13271|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||9060||9060|13271| 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4653|7242|lyfalmen|||63|0|0|0,6667|Vistor hf|N.V. Organon|Follitrópín beta||4653||4653|7242| 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2218|3201|lyfsjukr|||03|10|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2218||2218|3201| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|6317|9519|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||6317||6317|9519| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|17244|23920|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||17244||17244|23920| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|109644|139486|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||109644||109644|139486| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9240|13517|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9240||9240|13517| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|156391|198153|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||156391||156391|198153| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2184|3865|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefnavakar||2184||2184|3865| 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||1490| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|10686|15495|lyfalmen|||00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10686||10686|15495| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1781|3314|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1781||1781|3314| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4060|6431|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4060||4060|6431| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2115|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2115| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|2240|lyfalmen|||00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||996||996|2240| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|4424|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||2593||2593|4424| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2649|4501|lyfalmen|||00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||2649||2649|4501| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|4233|2212|lyfalmen|||00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||976||976|2212| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|4480|lyfalmen|||00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||2634||2634|4480| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAP|0|0|0|100|SEK|4186|6603|lyfalmen|||63|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||4186||4186|6603| 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|634|1745|lyfalmen|||00|10|0|7,5000|Actavis Group hf|Actavis Group hf|Díklófenak||634||634|1745| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|4900|7580|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||4900||4900|7580| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3693|5929|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3693||3693|5929| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3666|5892|lyfalmen|||00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3666||3666|5892| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PFI|0|0|0|100|DKK|12686|18200|lyfalmen|||00|18|0|18,0000|Vistor hf|Pfizer ApS|Eletriptan||||12686|18200| 553313|N02CC0601|Relpax|filmhtfl|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2518|4322|lyfalmen|||00|3|0|3,0000|Vistor hf|Pfizer ApS|Eletriptan||2518||2518|4322| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4338|6811|lyfalmen|||00|6|0|6,0000|Vistor hf|Pfizer ApS|Eletriptan||4338||4338|6811| 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7658|14877|vetalmen|||27|500|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||7658||7658|14877| 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002|31.05.2010|R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3430|4950|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3430||3430|4950| 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004|31.05.2010|R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6600|9525|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6600||6600|9525| 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002|31.05.2010|R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5596|8076|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5596||5596|8076| 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4011|5789|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4011||4011|5789| 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002|31.05.2010|R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3833|5532|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3833||3833|5532| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5153|7926|lyfalmen|||00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5153||5153|7926| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7110|10603|lyfalmen|||00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7110||7110|10603| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|10046|14620|lyfalmen|||00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10046||10046|14620| 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1686|3184|lyfalmen|||38|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1686||1686|3184| 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|177597|224767|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Schering AG|Gadópentetat||177597||177597|224767| 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1034|2292|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1034||1034|2292| 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2054|3687|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2054||2054|3687| 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1037|2296|lyfalmen|||10|100|0|16,6667|Icepharma hf|Grunenthal|Tramadól||1037||1037|2296| 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|620|1725|lyfalmen|||10|20|0|3,3333|Icepharma hf|Grunenthal|Tramadól||620||620|1725| 559104|N02AX0201|Nobligan|eþ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1730|3244|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||1730||1730|3244| 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|994|2237|lyfalmen|V0732|2122|02|10|0|1,6667|Icepharma hf|Grunenthal|Tramadól||994||994|2237| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2560|4379|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2560||2560|4379| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6050|9153|lyfalmen|||23|1|0|90,0000|Vistor hf|Pfizer ApS|Estradíól||6050||6050|9153| 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3080|5091|lyfalmen|||23|30|0|30,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3080||3080|5091| 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3402|5531|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3402||3402|5531| 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|16042|22015|lyfsjukr|||00|240|0|0,0000|Icepharma hf|Baxter|Desflúran||16042||16042|22015| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1345| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3117|5141|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3117||3117|5141| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1778|3309|lyfalmen|||07|4|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1778||1778|3309| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5941|9004|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5941||5941|9004| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6442|9690|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6442||6442|9690| 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|105928|134822|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||105928||105928|134822| 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|603037|570897|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||453398||453398|570897| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2566|4387|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2566||2566|4387| 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|35201|46456|lyfalmen|||00|250|0|250,0000|Vistor hf|N.V. Organon|Mirtazapín||35201||35201|46456| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|26306|35293|lyfalmen|||02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||26306||26306|35293| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|40495|53100|lyfalmen|||02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||40495||40495|53100| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|693|1825|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||693||693|1825| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|693|1825|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||693||693|1825| 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1713|3221|lyfalmen|||10|100|0|5,0000|Vistor hf|Pfizer ApS|Morfín||1713||1713|3221| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|217540|275292|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||217540||217540|275292| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5011|7732|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5011||5011|7732| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5278|8097|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5278||5278|8097| 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9332|13643|lyfalmen|||00|98|0|32,6667|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||9332||9332|13643| 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|11816|17041|lyfalmen|||00|98|0|65,3400|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||11816||11816|17041| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|160425|203216|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||160425||160425|203216| 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|5464|8352|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||5464||5464|8352| 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|8199|12093|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||8199||8199|12093| 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|1450|2861|lyfalmen|||00|28|1|4,6667|Parlogis hf|Parlogis - óskráð lyf|||1450||1450|2861| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12206|17598|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||12206||12206|17598| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1473|2892|lyfalmen|||06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíð||1473||1473|2892| 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|78009|99784|lyfsjukr|||00|100|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||78009||78009|99784| 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6109|9234|lyfalmen|V0556|4297|10|4|0|3,0000|Vistor hf|Pfizer ApS|Flúkónazól||6109||6109|9234| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2322|4054|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2322||2322|4054| 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8140|12012|lyfalmen|||00|56|0|37,3333|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||8140|12012| 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6445|9694|lyfalmen|||00|28|0|37,3333|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||6445||6445|9694| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6327|9532|lyfalmen|V0791|4103|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6327||6327|9532| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|14596|20597|lyfalmen|V0793|7294|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||14596||14596|20597| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|24260|32725|lyfalmen|V0794|11833|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||24260||24260|32725| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|32145|42621|lyfalmen|V0795|18555|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||32145||32145|42621| 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|Janssen-Cilag AB|Levókabastín|||||| 567636|N05BA1205|Alprazolam Mylan|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|630|1739|lyfalmen|V0857|1739|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||630|1739| 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|9601|lyfalmen|||00|120|0|120,0000|Vistor hf|Eisai Ltd|Rabeprazól||6377||6377|9601| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1114|2401|lyfalmen|||00|3|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1114||1114|2401| 568790|N02AA5902|Parkodin forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1546|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1546| 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2879|lyfalmen|V0316|2879|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2879| 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|4048|lyfalmen|V0324|4048|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2318||2318|4048| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|16703|22845|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||16703||16703|22845| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|18794|25469|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||18794||18794|25469| 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2428|4199|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2428||2428|4199| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|145017|183879|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||145017||145017|183879| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|189818|240104|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||189818||189818|240104| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|357096|450038|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||357096||357096|450038| 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3944|6272|lyfalmen|||23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3944||3944|6272| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|102134|130061|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Roche|Trastuzumab||102134||102134|130061| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|23297|31120|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||23297||23297|31120| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|44203|57357|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||44203||44203|57357| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2557|lyfalmen|V0610|2501|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2557| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3135|2067|lyfalmen|V0931|2067|00|28|0|28,0000|Vistor hf|Pfizer ApS|Sertralín||870||870|2067| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|8145|7174|lyfalmen|V0933|5003|00|98|0|98,0000|Vistor hf|Pfizer ApS|Sertralín||4603||4603|7174| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|6518|2067|lyfalmen|V0935|2067|00|28|0|56,0000|Vistor hf|Pfizer ApS|Sertralín||870||870|2067| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|14510|7174|lyfalmen|V0937|7174|00|98|0|196,0000|Vistor hf|Pfizer ApS|Sertralín||4603||4603|7174| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|16490|22577|lyfsjukr|||00|12|0|0,0000|Vistor hf|Sanofi - Aventis|Adenósín||16490||16490|22577| 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|93163|118802|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||93163||93163|118802| 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3277|5360|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||3277||3277|5360| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1276|2623|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1276||1276|2623| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|DKK|746|1898|lyfalmen|||00|30|0|30,0000|Icepharma hf|Wyeth AB|Metótrexat||746||746|1898| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|32410|42557|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||32410||32410|42557| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|64527|82864|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||64527||64527|82864| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|123664|157081|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||123664||123664|157081| 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5249|9157|vetorma|||16|50|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5249||5249|9157| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|19779|34503|vetorma|||16|200|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||19779||19779|34503| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|60404|77690|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||60404||60404|77690| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|104265|132735|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||104265||104265|132735| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|795|1965|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||795||795|1965| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|50521|65286|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||50521||50521|65286| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|100467|127969|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||100467||100467|127969| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1157|2460|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1157||1157|2460| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|119916|152377|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||119916||119916|152377| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|54756|70601|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||54756||54756|70601| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|119064|151308|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||119064||119064|151308| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|123299|156623|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||123299||123299|156623| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4018|5799|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||4018||4018|5799| 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002|31.05.2010|R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2151|3104|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2151||2151|3104| 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002|31.05.2010|R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7943|11464|lyfsjukr|||00|1500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||7943||7943|11464| 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6516|9404|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6516||6516|9404| 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3079|4444|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3079||3079|4444| 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002|31.05.2010|R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9047|13057|lyfsjukr|||00|3000|0|3,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9047||9047|13057| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3482|5025|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3482||3482|5025| 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002|31.05.2010|R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4267|6158|lyfsjukr|||00|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4267||4267|6158| 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2347|3387|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2347||2347|3387| 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007|31.05.2010|L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|3982|6324|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíð||3982||3982|6324| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10506|15068|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10506||10506|15068| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3827|5523|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3827||3827|5523| 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|37572|49035|lyfsjukr|||00|12|0|3,0000|Icepharma hf|M.S.D.|Imipenem og ensímhemill||37572||37572|49035| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3699|5937|lyfalmen|||02|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3699||3699|5937| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|36439|48010|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||36439||36439|48010| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2769|4665|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2769||2769|4665| 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3261|4706|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3261||3261|4706| 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1620|3093|lyfalmen|||06|5|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1620||1620|3093| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2311|4039|lyfalmen|V0426|3973|43|20|0|5,0000|Vistor hf|Pfizer ApS|Klindamýcín||2311||2311|4039| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|14297|20222|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||14297||14297|20222| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9248|13528|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9248||9248|13528| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6408|11178|vetorma|||16|3|0|0,0000|Icepharma hf|Pfizer Animal Health|||6408||6408|11178| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2483|4331|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||2483||2483|4331| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6182|10784|vetorma|||16|6|0|0,0000|Icepharma hf|Pfizer Animal Health|||6182||6182|10784| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3339|5825|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||3339||3339|5825| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3468|6050|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3468||3468|6050| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2687|4687|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||2687||2687|4687| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4387|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4387| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8374|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8374| 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|160142|202861|lyfsjukr|||00|250|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||160142||160142|202861| 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|90425|115366|lyfsjukr|||00|336|0|28,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||90425||90425|115366| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAI|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf|||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2798|lyfalmen|V0139|2798|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2798| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|27926|37326|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||27926||27926|37326| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|205938|260335|lyfsjukr|||00|1|0|1,2500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||205938||205938|260335| 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3427|4946|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||3427||3427|4946| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|545|1623|lyfalmen|||00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||545||545|1623| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|945|2170|lyfalmen|||00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||945||945|2170| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1408|2803|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1408||1408|2803| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|20873|28475|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||20873||20873|28475| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|356|621|vetorma|||16|10|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||356|621| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2962|5167|vetorma|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2962|5167| 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3006|4338|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3006||3006|4338| 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982|30.04.2010|R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1121|2230|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1121||1121|2230| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9176|13243|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9176||9176|13243| 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|630|1739|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||630||630|1739| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4093|6476|lyfalmen|||43|24|0|3,0000|Vistor hf|Pfizer ApS|Klindamýcín||4093||4093|6476| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1079|2353|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||1079||1079|2353| 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|LDR|0|0|0|100|DKK|1403|2796|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1403||1403|2796| 908048|J07AM5201|Tetagam P/Tetanogamma P|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|19419|26650|lyfalmen|||00|1|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||19419||19419|26650| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|4932|0|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráð lyf|Flunarizín||0||0|0| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2688|0|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráð lyf|Dómíperídón||0||0|0| 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|DKK|2938|4240|lyfsjukr|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2938||2938|4240| 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1534|lyfalmen|||00|4|1|0,0000|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1534| 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6978|lyfalmen|||00|100|1|100,0000|Distica|Distica - óskráð lyf|||4460||4460|6978| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17458|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráð lyf|||12095||12095|17458| 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998|30.04.2010|R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3296|lyfalmen|||00|180|1|15,0300|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3296| 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2064|2979|lyfsjukr|||02|10|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Adrenalín tartrat||2064||2064|2979| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16358|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráð lyf|||11317||11317|16358| 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|2403|4164|lyfalmen|||00|11|1|4,4000|Parlogis hf|Parlogis - óskráð lyf|||2403||2403|4164| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|4744|7367|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|||4744||4744|7367| 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4669|7264|lyfalmen|||00|10|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|Papaverín||4669||4669|7264| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|44432|58041|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||44432||44432|58041| 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6446|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6446| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|10017|14580|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||10017||10017|14580| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|GBP|10862|15736|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráð lyf|||10862||10862|15736| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3948|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3948| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|7019|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráð lyf|Estradíól||4490||4490|7019| 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12361|lyfalmen|||00|1|1|333,3300|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12361| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|2946|4907|lyfalmen|||00|1|1|1,3900|Distica|Distica - óskráð lyf|Testósterón||2946||2946|4907| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|4990|7703|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráð lyf|||4990||4990|7703| 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002|31.03.2010|R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2329|lyfalmen|||00|1|1|8,3330|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2329| 944852|A06AX0102|Glycerol infant|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1345|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1345| 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1044|lyfalmen|||00|28|1|2,8000|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1044| 944985|A06AX0103|Glycerol adult|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1345|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1345| 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|GBP|18414|24992|lyfsjukr|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||18414||18414|24992| 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1533|2974|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1533||1533|2974| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4014|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4014| 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|3009|lyfalmen|||00|50|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|3009| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7762|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||5033||5033|7762| 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12855|lyfalmen|||00|50|1|133,3300|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12855| 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000|30.04.2010|R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1673|lyfalmen|||00|20|1|1,5625|Parlogis hf|Parlogis - óskráð lyf|||582||582|1673| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3710|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3710| 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2363|4110|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|||2363||2363|4110| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1436|2073|lyfsjukr|||55|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1436||1436|2073| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2024|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráð lyf|||838||838|2024| 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5818|8397|lyfsjukr|||00|10|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|||5818||5818|8397| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4851|7513|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Hýdrókortisón||||4851|7513| 952251|J01CA0101|Ampicillin|sts|500|mg|10|hgl|1|pakki||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6355|lyfsjukr|||00|5000|1|2,5000|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6355| 952855|N02AA0102|Morfin|eþ-stíll|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|8143|12016|lyfalmen|||00|12|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||8143||8143|12016| 952929|A03AA0403|Duspatalin|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5186|7971|lyfalmen|||00|100|1|45,0000|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||5186|7971| 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004|30.04.2010|R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1273|lyfalmen|||00|5|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|||289||289|1273| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3435|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||1870|3435| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8661|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||5690|8661| 954645|N03AB0207|Phenytoin|mixtúra|25|mg/ml|237|ml|1|glas||N03AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2953|4917|lyfalmen|||00|237|1||Parlogis hf|Parlogis - óskráð lyf|Fenýtóín||||2953|4917| 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1631|lyfalmen|||00|25|1|12,5000|Parlogis hf|Parlogis - óskráð lyf|||551||551|1631| 955578|A03AA0403|Duspatalin|töflur|135|mg|50|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2593|4424|lyfalmen|||00|50|1|22,5000|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||2593|4424| 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|2037|lyfalmen|||00|10|1|2,5000|Parlogis hf|Parlogis - óskráð lyf|||848||848|2037| 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|17077|lyfsjukr|||00|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|17077| 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3740|lyfalmen|||00|238|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3740| 959132|J01XE0103|Nitrofurantoin|mixtúra|5|mg/ml|300|ml|1|glas||J01XE01|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|23718|32045|lyfalmen|||00|300|1||Parlogis hf|Parlogis - óskráð lyf|Nítrófúrantóín||||23718|32045| 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|DKK|18104|24603|lyfsjukr|||00|30|1|112,0000|Distica|Distica - óskráð lyf|||18104||18104|24603| 961202|A03AA0405|Mebeverine|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|GBP|1596|3060|lyfalmen|||00||1||Distica|Distica - óskráð lyf|Mebeverín||||1596|3060| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2471|4257|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|||2471||2471|4257| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2150|3818|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||||2150|3818| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5051|7787|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||5051||5051|7787| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5598|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráð lyf|||||3451|5598| 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|11181|15915|lyfsjukr|||0|1000|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||11181||11181|15915| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2936|4894|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|||2936||2936|4894|